Live Oak Bancshares (LOB) 10-Q 6 Aug 19 2019 Q2 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	6 Months Ended
	Jun. 30, 2019	Aug. 05, 2019
Document Information [Line Items]
Entity Registrant Name	Live Oak Bancshares, Inc.
Entity Central Index Key	0001462120
Trading Symbol	LOB
Current Fiscal Year End Date	--12-31
Entity Filer Category	Large Accelerated Filer
Document Type	10-Q
Document Period End Date	Jun. 30, 2019
Document Fiscal Year Focus	2019
Document Fiscal Period Focus	Q2
Amendment Flag	false
Entity Emerging Growth Company	false
Entity Small Business	false
Entity Current Reporting Status	Yes
Entity Shell Company	false
Entity File Number	001-37497
Entity Tax Identification Number	264596286
Entity Address, Address Line One	1741 Tiburon Drive
Entity Address, City or Town	Wilmington
Entity Address, State or Province	North Carolina
Entity Address, Postal Zip Code	28403
City Area Code	910
Local Phone Number	790-5867
Entity Voting Common Stock
Document Information [Line Items]
Entity Common Stock, Shares Outstanding (in shares)		35,590,365
Entity Nonvoting Common Stock
Document Information [Line Items]
Entity Common Stock, Shares Outstanding (in shares)		4,643,530

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Jun. 30, 2019	Dec. 31, 2018
Assets
Cash and due from banks	$ 115,292	$ 316,823
Federal funds sold	68,153
Certificates of deposit with other banks	7,250	7,250
Investment securities available-for-sale	576,275	380,490
Loans held for sale	857,837	687,393
Loans and leases held for investment	2,225,473	1,843,419
Allowance for loan and lease losses	(38,048)	(32,434)
Net loans and leases	2,187,425	1,810,985
Premises and equipment, net	281,126	262,524
Foreclosed assets	6,044	1,094
Servicing assets	41,687	47,641
Operating lease right-of-use assets	1,996
Other assets	131,216	156,249
Total assets	4,274,301	3,670,449
Deposits:
Noninterest-bearing	55,416	53,993
Interest-bearing	3,666,181	3,095,590
Total deposits	3,721,597	3,149,583
Short term borrowings	1,345	1,441
Long term borrowings	16	16
Operating lease liabilities	2,162
Other liabilities	30,195	25,849
Total liabilities	3,755,315	3,176,889
Shareholders’ equity
Retained earnings	171,954	167,124
Accumulated other comprehensive income (loss)	12,877	(1,677)
Total shareholders’ equity	518,986	493,560
Total liabilities and shareholders’ equity	4,274,301	3,670,449
Preferred Stock Undefined
Shareholders’ equity
Preferred stock, no par value, 1,000,000 authorized, none issued or outstanding at June 30, 2019 and December 31, 2018
Class A Common Stock
Shareholders’ equity
Common stock	284,987	278,945
Class B Common Stock
Shareholders’ equity
Common stock	$ 49,168	$ 49,168

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Parenthetical) - $ / shares	Jun. 30, 2019	Dec. 31, 2018
Preferred Stock Undefined
Preferred stock, par value
Preferred stock authorized (in shares)	1,000,000	1,000,000
Preferred stock issued (in shares)	0	0
Preferred stock outstanding (in shares)	0	0
Class A Common Stock
Common stock, par value
Common stock authorized (in shares)	100,000,000	100,000,000
Common stock issued (in shares)	35,577,386	35,512,262
Common stock outstanding (in shares)	35,577,386	35,512,262
Class B Common Stock
Common stock, par value
Common stock authorized (in shares)	10,000,000	10,000,000
Common stock issued (in shares)	4,643,530	4,643,530
Common stock outstanding (in shares)	4,643,530	4,643,530

Condensed Consolidated Statemen

Condensed Consolidated Statements of Income - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2019	Jun. 30, 2018	Jun. 30, 2019	Jun. 30, 2018
Interest income
Loans and fees on loans	$ 49,914	$ 36,267	$ 94,880	$ 68,958
Investment securities, taxable	4,116	2,530	7,433	3,647
Other interest earning assets	1,108	2,179	2,747	3,394
Total interest income	55,138	40,976	105,060	75,999
Interest expense
Deposits	21,203	13,927	40,520	24,345
Borrowings		1		130
Total interest expense	21,203	13,928	40,520	24,475
Net interest income	33,935	27,048	64,540	51,524
Provision for loan and lease losses	3,463	2,087	6,205	6,479
Net interest income after provision for loan and lease losses	30,472	24,961	58,335	45,045
Noninterest income
Loan servicing revenue	7,063	6,965	14,473	13,863
Loan servicing asset revaluation	(403)	(3,670)	(2,649)	(8,758)
Net gains on sales of loans	6,015	23,061	10,213	47,479
Equity method investments income (loss)	(1,736)	(673)	(3,750)	(1,037)
Gain on sale of investment securities available-for-sale			5
Lease income	2,369	1,920	4,694	3,528
Construction supervision fee income	386	597	1,165	1,376
Title insurance income		996		2,296
Other noninterest income	1,007	1,417	3,577	2,622
Total noninterest income	14,701	30,613	27,728	61,369
Noninterest expense
Salaries and employee benefits	21,990	22,146	43,845	42,355
Travel expense	1,541	2,041	2,741	3,884
Professional services expense	1,621	1,119	3,803	2,417
Advertising and marketing expense	1,665	1,868	3,029	3,530
Occupancy expense	1,848	1,882	3,457	3,739
Data processing expense	1,947	2,906	4,346	5,743
Equipment expense	4,239	3,368	7,564	6,445
Other loan origination and maintenance expense	1,708	1,414	3,347	2,743
Renewable energy tax credit investment impairment	602		602
FDIC insurance	699	1,010	1,334	1,582
Title insurance closing services expense		372		798
Other expense	1,716	2,704	3,709	5,666
Total noninterest expense	39,576	40,830	77,777	78,902
Income before taxes	5,597	14,744	8,286	27,512
Income tax expense	662	491	979	806
Net income	$ 4,935	$ 14,253	$ 7,307	$ 26,706
Basic earnings per share	$ 0.12	$ 0.36	$ 0.18	$ 0.67
Diluted earnings per share	$ 0.12	$ 0.34	$ 0.18	$ 0.64

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Comprehensive Income - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2019	Jun. 30, 2018	Jun. 30, 2019	Jun. 30, 2018
Statement Of Income And Comprehensive Income [Abstract]
Net income	$ 4,935	$ 14,253	$ 7,307	$ 26,706
Other comprehensive income (loss) before tax:
Net unrealized gain (loss) on investment securities arising during the period	15,637	(1,965)	19,155	(4,920)
Reclassification adjustment for gain on sale of securities available-for-sale included in net income			(5)
Other comprehensive income (loss) before tax	15,637	(1,965)	19,150	(4,920)
Income tax (expense) benefit	(3,753)	471	(4,596)	1,181
Other comprehensive income (loss), net of tax	11,884	(1,494)	14,554	(3,739)
Total comprehensive income	$ 16,819	$ 12,759	$ 21,861	$ 22,967

Condensed Consolidated Statem_3

Condensed Consolidated Statements of Changes in Shareholders' Equity - USD ($) $ in Thousands	Total	Common stock	Common stockClass A Common Stock	Common stockClass B Common Stock	Retained earnings	Accumulated other comprehensive income (loss)
Beginning balance at Dec. 31, 2017	$ 436,933	$ 317,725			$ 120,241	$ (1,033)
Beginning balance (in shares) at Dec. 31, 2017			35,252,053	4,643,530
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	26,706				26,706
Other comprehensive income (loss)	(3,739)					(3,739)
Issuance of restricted stock	0
Issuance of restricted stock (in shares)			39,133
Withholding cash issued in lieu of restricted stock issuance	(495)	(495)
Employee stock purchase program	165	165
Employee stock purchase program (in shares)			7,022
Stock option exercises	$ 1,252	1,252
Stock option exercises (in shares)	144,671		144,671
Stock option based compensation expense	$ 809	809
Restricted stock expense	3,755	3,755
Reclassification of accumulated other comprehensive income due to tax rate change	0				244	(244)
Cash dividends	(2,400)				(2,400)
Ending balance at Jun. 30, 2018	462,986	323,211			144,791	(5,016)
Ending balance (in shares) at Jun. 30, 2018			35,442,879	4,643,530
Beginning balance at Mar. 31, 2018	448,836	320,619			131,739	(3,522)
Beginning balance (in shares) at Mar. 31, 2018			35,330,618	4,643,530
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	14,253				14,253
Other comprehensive income (loss)	(1,494)					(1,494)
Issuance of restricted stock	0
Issuance of restricted stock (in shares)			21,844
Withholding cash issued in lieu of restricted stock issuance	(184)	(184)
Stock option exercises	561	561
Stock option exercises (in shares)			90,417
Stock option based compensation expense	346	346
Restricted stock expense	1,869	1,869
Cash dividends	(1,201)				(1,201)
Ending balance at Jun. 30, 2018	462,986	323,211			144,791	(5,016)
Ending balance (in shares) at Jun. 30, 2018			35,442,879	4,643,530
Beginning balance at Dec. 31, 2018	493,560	328,113			167,124	(1,677)
Beginning balance (in shares) at Dec. 31, 2018			35,512,262	4,643,530
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	7,307				7,307
Other comprehensive income (loss)	14,554					14,554
Issuance of restricted stock	0
Issuance of restricted stock (in shares)			21,486
Withholding cash issued in lieu of restricted stock issuance	(86)	(86)
Employee stock purchase program	182	182
Employee stock purchase program (in shares)			14,059
Stock option exercises	$ 172	172
Stock option exercises (in shares)	30,634		29,579
Stock option based compensation expense	$ 870	870
Restricted stock expense	4,904	4,904
Cash dividends	(2,411)				(2,411)
Ending balance at Jun. 30, 2019	518,986	334,155			171,954	12,877
Ending balance (in shares) at Jun. 30, 2019			35,577,386	4,643,530
Beginning balance at Mar. 31, 2019	500,380	331,162			168,225	993
Beginning balance (in shares) at Mar. 31, 2019			35,531,549	4,643,530
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	4,935				4,935
Other comprehensive income (loss)	11,884					11,884
Issuance of restricted stock	0
Issuance of restricted stock (in shares)			19,346
Withholding cash issued in lieu of restricted stock issuance	(81)	(81)
Stock option exercises	158	158
Stock option exercises (in shares)			26,491
Stock option based compensation expense	400	400
Restricted stock expense	2,516	2,516
Cash dividends	(1,206)				(1,206)
Ending balance at Jun. 30, 2019	518,986	$ 334,155			171,954	$ 12,877
Ending balance (in shares) at Jun. 30, 2019			35,577,386	4,643,530
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Cumulative effect of accounting change for Accounting Standards Update 2016-02 | Accounting Standards Update 2016-02 [Member]	$ (66)				$ (66)

Condensed Consolidated Statem_4

Condensed Consolidated Statements of Changes in Shareholders' Equity (Parenthetical) - $ / shares	3 Months Ended		6 Months Ended
	Jun. 30, 2019	Jun. 30, 2018	Jun. 30, 2019	Jun. 30, 2018
Statement Of Stockholders Equity [Abstract]
Cash dividends per share	$ 0.03	$ 0.03	$ 0.06	$ 0.06

Condensed Consolidated Statem_5

Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2019	Jun. 30, 2018
Cash flows from operating activities
Net income	$ 7,307	$ 26,706
Adjustments to reconcile net income to net cash used by operating activities:
Depreciation and amortization	9,101	7,823
Provision for loan and lease losses	6,205	6,479
Amortization of premium on securities, net of accretion	254	353
Change in discount on unguaranteed loans	(3,431)	3,501
Deferred tax (benefit) expense	(417)	807
Originations of loans held for sale	(455,456)	(621,290)
Proceeds from sales of loans held for sale	168,981	613,911
Net gains on sale of loans held for sale	(10,213)	(47,479)
Net loss on sale of foreclosed assets	4	1
Net decrease (increase) in servicing assets	5,954	(391)
Gain on sale of securities available-for-sale	(5)
Net gain on disposal of long-lived asset	(357)
Net loss on disposal of property and equipment	109
Renewable energy tax credit investment impairment	602
Stock option based compensation expense	870	809
Restricted stock expense	4,904	3,755
Stock based compensation expense tax (shortfall) benefit	(76)	24
Business combination contingent consideration fair value adjustment		(260)
Changes in assets and liabilities:
Lease right-of-use assets and liabilities, net	102
Other assets	13,704	(7,445)
Other liabilities	154	909
Net cash used by operating activities	(251,704)	(11,787)
Cash flows from investing activities
Purchases of securities available-for-sale	(205,829)	(316,588)
Proceeds from sales, maturities, calls, and principal paydown of securities available-for-sale	28,945	19,727
Proceeds from SBA reimbursement/sale of foreclosed assets	393	212
Maturities of certificates of deposits with other banks		750
Loan and lease originations and principal collections, net	(258,028)	(217,743)
Proceeds from sale of long-lived asset	10,895
Purchases of premises and equipment, net	(27,823)	(61,217)
Net cash used by investing activities	(451,447)	(574,859)
Cash flows from financing activities
Net increase in deposits	572,014	708,973
Proceeds from long term borrowings		18
Repayment of long term borrowings	(2)	(23,197)
Repayment of short term borrowings	(96)
Stock option exercises	172	1,252
Employee stock purchase program	182	165
Withholding cash issued in lieu of restricted stock	(86)	(495)
Shareholder dividend distributions	(2,411)	(2,400)
Net cash provided by financing activities	569,773	684,316
Net (decrease) increase in cash and cash equivalents	(133,378)	97,670
Cash and cash equivalents, beginning	316,823	295,271
Cash and cash equivalents, ending	183,445	392,941
Supplemental disclosures of cash flow information
Interest paid	39,391	24,308
Income tax received	(12,439)	(542)
Supplemental disclosures of noncash operating, investing, and financing activities
Unrealized holding gains (losses) on available-for-sale securities, net of taxes	14,554	(3,739)
Transfers from loans and leases to foreclosed real estate and other repossessions	5,058	346
Net transfers from SBA receivable to foreclosed real estate	289	311
Right-of-use assets obtained in exchange for lessee operating lease liabilities	2,241
Transfer of loans held for sale to loans and leases held for investment	146,305	19,774
Transfer of loans and leases held for investment to loans held for sale	$ 23,321	$ 51,614

Basis of Presentation

Basis of Presentation	6 Months Ended
	Jun. 30, 2019
Organization Consolidation And Presentation Of Financial Statements [Abstract]
Basis of Presentation	Note 1. Basis of Presentation Nature of Operations Live Oak Bancshares, Inc. (the “Company” or “LOB”) is a bank holding company headquartered in Wilmington, North Carolina incorporated under the laws of North Carolina in December 2008. The Company conducts business operations primarily through its commercial bank subsidiary, Live Oak Banking Company (the “Bank”). The Bank was organized and incorporated under the laws of the State of North Carolina on February 25, 2008 and commenced operations on May 12, 2008. The Bank specializes in providing lending services to small businesses nationwide. The Bank identifies and grows lending to credit-worthy borrowers both within specific industries, also called verticals, through expertise within those industries, and more broadly to select borrowers outside of those industries. A significant portion of the loans originated by the Bank are guaranteed by the Small Business Administration (“SBA”) under the 7(a) Loan Program and the U.S. Department of Agriculture ("USDA") Rural Energy for America Program ("REAP"), Business & Industry ("B&I") a nd Water & Waste Disposal (“WEP”) In 2010, the Bank formed Live Oak Number One, Inc., a wholly-owned subsidiary, to hold properties foreclosed on by the Bank. In addition to the Bank, the Company owns Live Oak Grove, LLC, opened in September 2015 for the purpose of providing Company employees and business visitors an on-site restaurant location; Government Loan Solutions, Inc. (“GLS”), a management and technology consulting firm that specializes in the settlement, accounting, and securitization processes for government guaranteed loans, including loans originated under the SBA 7(a) loan program and USDA-guaranteed loans; and 504 Fund Advisors, LLC (“504FA”), formed to serve as the investment adviser to the 504 Fund, a closed-end mutual fund organized to invest in SBA section 504 loans. As of May 1, 2019, 504FA exited as advisor for the 504 Fund. In August 2016, the Company formed Live Oak Ventures, Inc. (formerly known as “Canapi, Inc.”) for the purpose of investing in businesses that align with the Company's strategic initiative to be a leader in financial technology. In November 2016, the Company formed Live Oak Clean Energy Financing LLC (“LOCEF”) for the purpose of providing financing to entities for renewable energy applications. During the first quarter of 2019, LOCEF became a wholly-owned subsidiary of the Bank. On February 1, 2017, the Company completed its acquisition of Reltco Inc. and National Assurance Title, Inc. (collectively referred to as "Reltco"), two nationwide title agencies under common control based in Tampa, Florida. Effective August 1, 2018, Reltco was sold. In June 2018, the Bank formed Live Oak Private Wealth, LLC for the purpose of providing high-net-worth individuals and families with strategic wealth and investment management services. In September 2018, the Company formed Canapi Advisors, LLC for the purpose of providing investment advisory services to a series of new funds focused on providing venture capital to new and emerging financial service technology companies. The Company generates revenue primarily from net interest income and the origination and sale of government guaranteed loans. Income from the retention of loans is comprised of interest income. Income from the sale of loans is comprised of loan servicing revenue and revaluation of related servicing assets along with net gains on sales of loans. Offsetting these revenues are the cost of funding sources, provision for loan and lease losses, any costs related to foreclosed assets and other operating costs such as salaries and employee benefits, travel, professional services, advertising and marketing and tax expense. General In the opinion of management, all adjustments necessary for a fair presentation of the financial position and results of operations for the periods presented have been included, and all intercompany transactions have been eliminated in consolidation. Results of operations for the six months ended June 30, 2019 are not necessarily indicative of the results of operations that may be expected for the year ending December 31, 2019. The consolidated balance sheet as of December 31, 2018 has been derived from the audited consolidated financial statements contained in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2018, filed with the Securities Exchange Commission on February 27, 2019 (SEC File No. 001-37497) (the "2018 Annual Report"). A summary description of the significant accounting policies followed by the Company is set forth in Note 1 of the Notes to Consolidated Financial Statements in the Company’s 2018 Annual Report. These unaudited interim condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and footnotes in the Company's 2018 Annual Report. The preparation of financial statements in conformity with United States generally accepted accounting principles, or GAAP, requires management to make estimates and assumptions that affect reported amounts of assets and liabilities and the reported amounts of revenues and expenses during the reporting period. Actual results could differ significantly from those estimates. Amounts in all tables in the Notes to Unaudited Condensed Consolidated Financial Statements have been presented in thousands, except percentage, time period, stock option, share and per share data or where otherwise indicated. Business Segments Management has determined that the Company has one significant operating segment, which is providing a lending platform for small businesses nationwide. In determining the appropriateness of segment definition, the Company considers the materiality of a potential segment, the components of the business about which financial information is available, and components for which management regularly evaluates relative to resource allocation and performance assessment. Reclassifications Certain reclassifications have been made to the prior period’s consolidated financial statements to place them on a comparable basis with the current year. Net income and shareholders’ equity previously reported were not affected by these reclassifications. Accounting Change On January 1, 2019, the Company adopted Accounting Standards Update ("ASU") No. 2016-02 “Leases (Topic 842),” (“ASU 2016-02”) and all subsequent ASUs that modified Topic 842. The Company elected to apply certain practical expedients provided under ASU 2016-02 whereby the Company will not reassess (i) whether any expired or existing contracts are or contain leases, (ii) the lease classification for any expired or existing leases and (iii) initial direct costs for any existing leases. The Company has also applied the practical expedient to use hindsight in determining the lease term and in assessing impairment of the right-of-use assets. The Company does not apply the recognition and measurement requirements to any short-term leases (as defined by ASU 2016-02). The Company accounts for lease and non-lease components separately because such amounts are readily determinable under the lease contracts. The Company utilized the modified-retrospective transition approach prescribed by ASU 2018-11, “Leases (Topic 842) Targeted Improvements The Company determines if an arrangement is or contains a lease at inception. If it is determined to be or contain a lease, then the lease is classified as an operating or finance lease. Right-of-use ("ROU") assets represent the Company's right to use an underlying asset for the lease term. Lease liabilities represent the Company's obligation to make lease payments arising from the lease. ROU assets and liabilities are measured on commencement date based on the present value of the lease payments over the lease term, discounted using the discount rate for the lease at commencement. The discount rate shall be the rate implicit in the lease, however, if that is not readily determinable, the Company will use its incremental borrowing rate. The ROU asset also includes any lease payments made before the commencement date and initial direct costs and excludes any lease incentives received. The lease terms may include options to extend or terminate the lease when it is reasonably certain that the option will be exercised. Lease expense for lease payments is recognized on a straight-line basis over the lease term. Operating leases are included in operating lease right-of-use assets and operating lease liabilities in the consolidated balance sheets. Finance leases are included in other assets and long term borrowings in the consolidated balance sheets. Lease expense for operating leases and finance leases is included in occupancy expense in the consolidated statements of income and interest expense for finance leases is included in other interest expense in the consolidated statements of income.

Recent Accounting Pronouncement

Recent Accounting Pronouncements	6 Months Ended
	Jun. 30, 2019
Accounting Policies [Abstract]
Recent Accounting Pronouncements	Note 2. Recent Accounting Pronouncements In June 2016, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2016-13, “Financial Instruments – Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments” (“ASU 2016-13”). This new guidance replaces the incurred loss impairment methodology in current standards with an expected credit loss methodology and requires consideration of a broader range of information to determine credit loss estimates. ASU 2016-13 requires the measurement of all expected credit losses for financial assets held at the reporting date based on historical experience, current conditions, and reasonable and supportable forecasts and requires enhanced disclosures related to the significant estimates and judgments used in estimating credit losses, as well as the credit quality and underwriting standards of an organization’s portfolio. In addition, ASU 2016-13 amends the accounting for credit losses on available-for-sale debt securities and purchased financial assets with credit deterioration. ASU 2016-13 will be effective for the Company on January 1, 2020. The Company is currently evaluating the potential impact of ASU 2016-13 on the consolidated financial statements. In that regard, a cross-functional working group has been formed, under the direction of the Company's Chief Financial Officer and Chief Credit Officer. The working group is comprised of individuals from various functional areas including credit, risk management, finance and information technology, among others. Implementation efforts continue with model development, ongoing system requirements evaluation and the identification of data and resource needs, among other things. The Company has also engaged a third-party vendor solution to assist in the application of ASU 2016-13. While the Company is currently unable to reasonably estimate the impact of adopting ASU 2016-13, the impact of adoption is expected to be significantly influenced by the composition, characteristics and quality of loan and securities portfolios as well as the prevailing economic conditions and forecasts as of the adoption date. In June 2018, the FASB issued ASU No. 2018-07, “Compensation - Stock Compensation (Topic 718) Improvements to Nonemployee Share-Based Payment Accounting” (“ASU 2018-07”). ASU 2018-07 amends Accounting Standard Codification 718 to largely align accounting for share-based payment awards issued to employees and nonemployees. Under the new guidance, existing employee guidance will generally apply to nonemployee share-based transactions, except for specific guidance on inputs into option pricing models and the attribution of cost. The Company adopted the standard on January 1, 2019 with no material effect on its consolidated financial statements. In March 2019, the FASB issued ASU 2019-01, “Leases (Topic 842): Codification Improvements” (“ASU 2019-01”). ASU 2019-01 provides updates to Topic 842 including: (i) guidance on how to determine fair value of leased items for lessors who are not dealers or manufacturers, (ii) cash flow presentation for lessors of sales-type and direct financing leases and (iii) clarifies that certain transition disclosures. The amendments are effective for the Company on January 1, 2020. In April 2019, the FASB issued ASU No. 2019-04, “Codification Improvements to Topic 326, Financial Instruments-Credit Losses, Topic 815, Derivatives and Hedging, and Topic 825, Financial Instruments” (“ASU 2019-04”). ASU 2019-04 provides clarification and minor improvements related to ASU 2016-01 “Financial Instruments - Overall (Subtopic 825-10): Recognition and Measurement of Financial Assets and Financial Liabilities,” “Derivatives and Hedging (Topic 815) - Targeted Improvements to Accounting for Hedging Activities.” In May 2019, the FASB issued ASU No. 2019-05, “Financial Instruments – Credit Losses (Topic 326): Targeted Transition Relief” (“ASU 2019-05”). ASU 2019-05 allows entities an option to irrevocably elect the fair value option for eligible instruments upon adoption of Topic 326. The amendments are effective for the Company on January 1, 2020. See discussion of ASU 2016-13 above for impact to the consolidated financial statements.

Earnings Per Share

Earnings Per Share	6 Months Ended
	Jun. 30, 2019
Earnings Per Share [Abstract]
Earnings Per Share	Note 3. Earnings Per Share Basic and diluted earnings per share are computed based on the weighted average number of shares outstanding during each period. Diluted earnings per share reflects the potential dilution that could occur, upon the exercise of stock options or upon the vesting of restricted stock grants, any of which would result in the issuance of common stock that would then be shared in the net income of the Company. Three Months Ended June 30, Six Months Ended June 30, 2019 2018 2019 2018 Basic earnings per share: Net income available to common shareholders $ 4,935 $ 14,253 $ 7,307 $ 26,706 Weighted-average basic shares outstanding 40,196,662 40,027,336 40,178,491 39,977,336 Basic earnings per share $ 0.12 $ 0.36 $ 0.18 $ 0.67 Diluted earnings per share: Net income available to common shareholders, for diluted earnings per share $ 4,935 $ 14,253 $ 7,307 $ 26,706 Total weighted-average basic shares outstanding 40,196,662 40,027,336 40,178,491 39,977,336 Add effect of dilutive stock options and restricted stock grants 801,879 1,592,311 801,879 1,538,997 Total weighted-average diluted shares outstanding 40,998,541 41,619,647 40,980,370 41,516,333 Diluted earnings per share $ 0.12 $ 0.34 $ 0.18 $ 0.64 Anti-dilutive shares 1,578,197 — 1,578,197 9,102

Investment Securities

Investment Securities	6 Months Ended
	Jun. 30, 2019
Investments Debt And Equity Securities [Abstract]
Investment Securities	Note 4. Investment Securities The carrying amount of investment securities and their approximate fair values are reflected in the following table: June 30, 2019 Amortized Cost Unrealized Gains Unrealized Losses Fair Value US treasury securities $ 4,979 $ 36 $ — $ 5,015 US government agencies 48,303 613 11 48,905 Mortgage-backed securities 497,529 16,479 659 513,349 Municipal bonds 8,521 492 7 9,006 Total $ 559,332 $ 17,620 $ 677 $ 576,275 December 31, 2018 US treasury securities $ 4,969 $ — $ 3 $ 4,966 US government agencies 31,121 48 225 30,944 Mortgage-backed securities 345,606 1,340 3,365 343,581 Municipal bond 1,000 — 1 999 Total $ 382,696 $ 1,388 $ 3,594 $ 380,490 There were no sales of securities during the three months ended June 30, 2019 and 2018. During the six months ended June 30, 2019, $900 thousand of one municipal bond was sold resulting in a net gain of $5 thousand. There were no sales of securities during the six months ended June 30, 2018. The following tables show gross unrealized losses and fair value, aggregated by investment category and length of time that the individual securities have been in a continuous unrealized loss position. Less Than 12 Months 12 Months or More Total June 30, 2019 Fair Value Unrealized Losses Fair Value Unrealized Losses Fair Value Unrealized Losses US government agencies $ — $ — $ 6,471 $ 11 $ 6,471 $ 11 Mortgage-backed securities — — 44,567 659 44,567 659 Municipal bonds 93 7 — — 93 7 Total $ 93 $ 7 $ 51,038 $ 670 $ 51,131 $ 677 Less Than 12 Months 12 Months or More Total December 31, 2018 Fair Value Unrealized Losses Fair Value Unrealized Losses Fair Value Unrealized Losses US treasury securities $ 4,966 $ 3 $ — $ — $ 4,966 $ 3 US government agencies — — 16,268 225 16,268 225 Mortgage-backed securities 164,836 1,177 51,371 2,188 216,207 3,365 Municipal bond 999 1 — — 999 1 Total $ 170,801 $ 1,181 $ 67,639 $ 2,413 $ 238,440 $ 3,594 At June 30, 2019, there were twenty-five mortgage-backed securities and three US government agencies in unrealized loss positions for greater than 12 months and one municipal bond in unrealized loss positions for less than 12 months. Unrealized losses at December 31, 2018 were comprised of thirty-one These unrealized losses are primarily the result of volatility in the market and are related to market interest rates. Since none of the unrealized losses relate to marketability of the securities or the issuer’s ability to honor redemption obligations and the Company has the intent and ability to hold the securities for a sufficient period of time to recover unrealized losses, none of the securities are deemed to be other than temporarily impaired. All mortgage-backed securities in the Company’s portfolio at June 30, 2019 and December 31, 2018 were backed by U.S. government sponsored enterprises (“GSEs”). The following is a summary of investment securities by maturity: June 30, 2019 Amortized cost Fair value US treasury securities One to five years $ 4,979 $ 5,015 Total 4,979 5,015 US government agencies Within one year 6,483 6,471 One to five years 29,909 30,345 Five to ten years 11,911 12,089 Total 48,303 48,905 Mortgage-backed securities One to five years 2,743 2,760 Five to ten years 150,463 156,698 After 10 years 344,323 353,891 Total 497,529 513,349 Municipal bonds After 10 years 8,521 9,006 Total 8,521 9,006 Total $ 559,332 $ 576,275 The table above reflects contractual maturities. Actual results will differ as the loans underlying the mortgage-backed securities may repay sooner than scheduled. There were no investment securities pledged at June 30, 2019. At December 31, 2018, investment securities with a fair market value of $100 thousand was pledged to the Ohio State Treasurer to allow the Company's trust department to conduct business in the State of Ohio and $2.5 million were pledged to the Company's trust department for uninsured trust assets held by the trust department.

Loans and Leases Held for Inves

Loans and Leases Held for Investment and Allowance for Loan and Lease Losses	6 Months Ended
	Jun. 30, 2019
Receivables [Abstract]
Loans and Leases Held for Investment and Allowance for Loan and Lease Losses	Note 5. Loans and Leases Held for Investment and Allowance for Loan and Lease Losses Loan and Lease Portfolio Segments The following describes the risk characteristics relevant to each of the portfolio segments. Each loan and lease category is assigned a risk grade during the origination and closing process based on criteria described later in this section. Commercial and Industrial Commercial and industrial loans (C&I) receive similar underwriting treatment as commercial real estate loans in that the repayment source is analyzed to determine its ability to meet cash flow coverage requirements as set forth by Bank policies. Repayment of the Bank’s C&I loans generally comes from the generation of cash flow as the result of the borrower’s business operations. This business cycle itself brings a certain level of risk to the portfolio. In some instances, these loans may carry a higher degree of risk due to a variety of reasons – illiquid collateral, specialized equipment, highly depreciable assets, uncollectable accounts receivable, revolving balances, or simply being unsecured. As a result of these characteristics, the SBA guarantee on these loans is an important factor in mitigating risk. Construction and Development Construction and development loans are for the purpose of acquisition and development of land to be improved through the construction of commercial buildings. Such loans are usually paid off through the conversion to permanent financing for the long-term benefit of the borrower’s ongoing operations. At the completion of the project, if the loan is converted to permanent financing or if scheduled loan amortization begins, it is then reclassified to the “Commercial Real Estate” segment. Underwriting of construction and development loans typically includes analysis of not only the borrower’s financial condition and ability to meet the required debt obligations, but also the general market conditions associated with the area and type of project being funded. Commercial Real Estate Commercial real estate loans are extensions of credit secured by owner occupied and non-owner occupied collateral. Underwriting generally involves intensive analysis of the financial strength of the borrower and guarantor, liquidation value of the subject collateral, the associated unguaranteed exposure, and any available secondary sources of repayment, with the greatest emphasis given to a borrower’s capacity to meet cash flow coverage requirements as set forth by Bank policies. Such repayment of commercial real estate loans is commonly derived from the successful ongoing operations of the business occupying the property. These typically include small businesses and professional practices. Commercial Land Commercial land loans are extensions of credit secured by farmland. Such loans are often for land improvements related to agricultural endeavors that may include construction of new specialized facilities. These loans are usually repaid through the conversion to permanent financing, or if scheduled loans amortization begins, for the long-term benefit of the borrower’s ongoing operations. Underwriting generally involves intensive analysis of the financial strength of the borrower and guarantor, liquidation value of the subject collateral, the associated unguaranteed exposure, and any available secondary sources of repayment, with the greatest emphasis given to a borrower’s capacity to meet cash flow coverage requirements as set forth by Bank policies. Each of the loan types referenced in the sections above is further segmented into verticals in which the Bank chooses to operate. The Bank chooses to finance businesses operating in specific industries because of certain similarities. The similarities range from historical default and loss characteristics to business operations. However, there are differences that create the necessity to underwrite these loans according to varying criteria and guidelines. When underwriting a loan, the Bank considers numerous factors such as cash flow coverage, the credit scores of the guarantors, revenue growth, practice ownership experience and debt service capacity. Minimum guidelines have been set with regard to these various factors and deviations from those guidelines require compensating strengths when considering a proposed loan. Loans and leases consist of the following: June 30, 2019 December 31, 2018 Commercial & Industrial Agriculture $ 6,305 $ 6,400 Funeral Home & Cemetery 22,709 17,378 Healthcare 46,344 51,082 Independent Pharmacies 110,956 108,783 Registered Investment Advisors 92,901 94,338 Veterinary Industry 47,744 45,604 Other Industries 402,962 295,163 Total 729,921 618,748 Construction & Development Agriculture 40,258 43,454 Funeral Home & Cemetery 10,840 9,874 Healthcare 92,296 81,619 Independent Pharmacies 1,193 2,149 Registered Investment Advisors 2,138 1,232 Veterinary Industry 22,694 14,094 Other Industries 155,313 96,482 Total 324,732 248,904 Commercial Real Estate Agriculture 49,532 53,085 Funeral Home & Cemetery 86,830 71,344 Healthcare 221,195 188,531 Independent Pharmacies 26,877 20,597 Registered Investment Advisors 8,152 7,905 Veterinary Industry 135,470 136,721 Other Industries 354,321 260,847 Total 882,377 739,030 Commercial Land Agriculture 288,467 243,798 Total 288,467 243,798 Total Loans 2,225,497 1,850,480 Net Deferred Costs 9,767 5,960 Discount on SBA 7(a) Unguaranteed (9,791 ) (13,021 ) Loans, Net of Unearned $ 2,225,473 $ 1,843,419 1 Total loans and leases include $498.8 million and $305.4 million of U.S. government guaranteed loans as of June 30, 2019 and December 31, 2018, respectively. 2 The Company measures the carrying value of the retained portion of loans sold at fair value under ASC Subtopic 825-10. The value of these retained loan balances is discounted based on the estimates derived from comparable unguaranteed loan sales. Credit Risk Profile The Bank uses internal loan and lease reviews to assess the performance of individual loans and leases by industry segment. An independent review of the loan and lease portfolio is performed annually by an external firm. The goal of the Bank’s annual review of select borrowers' financial performance is to validate the adequacy of the risk grade assigned. The Bank uses a grading system to rank the quality of each loan and lease. The grade is periodically evaluated and adjusted as performance dictates. Loan and lease grades 1 through 4 are passing grades and grade 5 is special mention. Collectively, grades 6 through 8 represent classified loans and leases in the Bank’s portfolio. The following guidelines govern the assignment of these risk grades: Exceptional (1 Rated): These loans and leases are of the highest quality, with strong, well-documented sources of repayment. These loans and leases will typically have multiple demonstrated sources of repayment with no significant identifiable risk to collection, exhibit well-qualified management, and have liquid financial statements relative to both direct and indirect obligations. Quality (2 Rated): These loans and leases are of very high credit quality, with strong, well-documented sources of repayment. These loans and leases exhibit very strong, well defined primary and secondary sources of repayment, with no significant identifiable risk of collection and have internally generated cash flow that more than adequately covers current maturities of long-term debt. Satisfactory (3 rated): These loans and leases exhibit satisfactory credit risk and have excellent sources of repayment, with no significant identifiable risk of collection. These loans and leases have documented historical cash flow that meets or exceeds required minimum Bank guidelines, or that can be supplemented with verifiable cash flow from other sources. They have adequate secondary sources to liquidate the debt, including combinations of liquidity, liquidation of collateral, or liquidation value to the net worth of the borrower or guarantor. Acceptable (4 rated): These loans and leases show signs of weakness in either adequate sources of repayment or collateral but have demonstrated mitigating factors that minimize the risk of delinquency or loss. These loans and leases may have unproved, insufficient or marginal primary sources of repayment that appear sufficient to service the debt at this time. Repayment weaknesses may be due to minor operational issues, financial trends, or reliance on projected performance. They may also contain marginal or unproven secondary sources to liquidate the debt, including combinations of liquidation of collateral and liquidation value to the net worth of the borrower or guarantor. Special mention (5 rated): These loans and leases show signs of weaknesses in either adequate sources of repayment or collateral. These loans and leases may contain underwriting guideline tolerances and/or exceptions with no mitigating factors; and/or instances where adverse economic conditions develop subsequent to origination that do not jeopardize liquidation of the debt but substantially increase the level of risk. Substandard (6 rated): Loans and leases graded Substandard are inadequately protected by current sound net worth, paying capacity of the obligor, or pledged collateral. Loans and leases classified as Substandard must have a well-defined weakness or weaknesses that jeopardize the liquidation of the debt; are characterized by the distinct possibility that the Bank will sustain some loss if the deficiencies are not corrected. These loans and leases are consistently not meeting the repayment schedule. Doubtful (7 rated): Loans and leases graded Doubtful have all the weaknesses inherent in those classified as Substandard, plus the added characteristic that the weaknesses make collection or liquidation in full on the basis of currently existing facts, conditions, and values highly questionable and improbable. The ability of the borrower to service the debt is extremely weak, overdue status is constant, the debt has been placed on non-accrual status, and no definite repayment schedule exists. Once the loss position is determined, the amount is charged off. Loss (8 rated): Loss rated loans and leases are considered uncollectible and of such little value that their continuance as assets is not warranted. This classification does not mean that the asset has absolutely no recovery or salvage value, but rather that it is not practical or desirable to defer writing off this credit even though partial recovery may be affected in the future. The following tables summarize the risk grades of each category: Risk Grades 1 - 4 Risk Grade 5 Risk Grades 6 - 8 Total 1 June 30, 2019 Commercial & Industrial Agriculture $ 5,760 $ 545 $ — $ 6,305 Funeral Home & Cemetery 20,811 1,898 — 22,709 Healthcare 34,936 2,888 8,520 46,344 Independent Pharmacies 99,284 6,502 5,170 110,956 Registered Investment Advisors 88,782 2,050 2,069 92,901 Veterinary Industry 44,419 1,016 2,309 47,744 Other Industries 382,016 15,437 5,509 402,962 Total 676,008 30,336 23,577 729,921 Construction & Development Agriculture 40,258 — — 40,258 Funeral Home & Cemetery 10,840 — — 10,840 Healthcare 88,885 3,411 — 92,296 Independent Pharmacies 1,193 — — 1,193 Registered Investment Advisors 2,138 — — 2,138 Veterinary Industry 22,694 — — 22,694 Other Industries 142,116 13,197 — 155,313 Total 308,124 16,608 — 324,732 Commercial Real Estate Agriculture 46,841 466 2,225 49,532 Funeral Home & Cemetery 79,149 5,720 1,961 86,830 Healthcare 191,816 8,377 21,002 221,195 Independent Pharmacies 17,303 2,411 7,163 26,877 Registered Investment Advisors 8,114 38 — 8,152 Veterinary Industry 119,320 3,362 12,788 135,470 Other Industries 336,073 8,914 9,334 354,321 Total 798,616 29,288 54,473 882,377 Commercial Land Agriculture 263,961 10,749 13,757 288,467 Total 263,961 10,749 13,757 288,467 Total $ 2,046,709 $ 86,981 $ 91,807 $ 2,225,497 Risk Grades 1 - 4 Risk Grade 5 Risk Grades 6 - 8 Total 1 December 31, 2018 Commercial & Industrial Agriculture $ 6,187 $ 213 $ — $ 6,400 Funeral Home & Cemetery 17,085 287 6 17,378 Healthcare 38,908 2,502 9,672 51,082 Independent Pharmacies 93,976 5,734 9,073 108,783 Registered Investment Advisors 88,614 2,381 3,343 94,338 Veterinary Industry 42,175 1,190 2,239 45,604 Other Industries 272,771 18,463 3,929 295,163 Total 559,716 30,770 28,262 618,748 Construction & Development Agriculture 43,454 — — 43,454 Funeral Home & Cemetery 9,874 — — 9,874 Healthcare 79,814 1,805 — 81,619 Independent Pharmacies 2,149 — — 2,149 Registered Investment Advisors 1,232 — — 1,232 Veterinary Industry 14,094 — — 14,094 Other Industries 96,482 — — 96,482 Total 247,099 1,805 — 248,904 Commercial Real Estate Agriculture 52,518 567 — 53,085 Funeral Home & Cemetery 64,487 3,711 3,146 71,344 Healthcare 161,026 7,696 19,809 188,531 Independent Pharmacies 12,509 2,495 5,593 20,597 Registered Investment Advisors 7,780 125 — 7,905 Veterinary Industry 117,879 4,205 14,637 136,721 Other Industries 255,651 5,196 — 260,847 Total 671,850 23,995 43,185 739,030 Commercial Land Agriculture 223,826 8,914 11,058 243,798 Total 223,826 8,914 11,058 243,798 Total $ 1,702,491 $ 65,484 $ 82,505 $ 1,850,480 1 Total loans and leases include $498.8 million of U.S. government guaranteed loans as of June 30, 2019, segregated by risk grade as follows: Risk Grades 1 – 4 = $410.8 million, Risk Grade 5 = $24.6 million, Risk Grades 6 – 8 = $63.4 million. As of December 31, 2018, total loans and leases include $305.4 million of U.S. government guaranteed loans, segregated by risk grade as follows: Risk Grades 1 – 4 = $236.1 million, Risk Grade 5 = $10.1 million, Risk Grades 6 – 8 = $59.2 million. Past Due Loans and Leases Loans and leases are considered past due if the required principal and interest payments have not been received as of the date such payments were due. Loans and leases less than 30 days past due and accruing are included within current loans and leases shown below. The following tables show an age analysis of past due loans and leases as of the dates presented. Less Than 30 Days Past Due & Not Accruing 30-89 Days Past Due & Accruing 30-89 Days Past Due & Not Accruing Greater Than 90 Days Past Due Total Not Accruing & Past Due Loans Current Loans Total Loans Loans 90 Days or More Past Due & Still Accruing June 30, 2019 Commercial & Industrial Agriculture $ — $ — $ — $ — $ — $ 6,305 $ 6,305 $ — Funeral Home & Cemetery — — — — — 22,709 22,709 — Healthcare 906 — 623 5,498 7,027 39,317 46,344 — Independent Pharmacies — — — 5,170 5,170 105,786 110,956 — Registered Investment Advisors 1,201 — 399 209 1,809 91,092 92,901 — Veterinary Industry — — 576 1,031 1,607 46,137 47,744 — Other Industries 557 1,192 2,804 2,148 6,701 396,261 402,962 — Total 2,664 1,192 4,402 14,056 22,314 707,607 729,921 — Construction & Development Agriculture — — — — — 40,258 40,258 — Funeral Home & Cemetery — — — — — 10,840 10,840 — Healthcare — — — — — 92,296 92,296 — Independent Pharmacies — — — — — 1,193 1,193 — Registered Investment Advisors — — — — — 2,138 2,138 — Veterinary Industry — — — — — 22,694 22,694 — Other Industries — — — — — 155,313 155,313 — Total — — — — — 324,732 324,732 — Commercial Real Estate Agriculture — — — 2,226 2,226 47,306 49,532 — Funeral Home & Cemetery 137 — — 1,824 1,961 84,869 86,830 — Healthcare — 1,034 — 7,076 8,110 213,085 221,195 — Independent Pharmacies — — — 5,831 5,831 21,046 26,877 — Registered Investment Advisors — — — — — 8,152 8,152 — Veterinary Industry 634 — 3,682 3,023 7,339 128,131 135,470 — Other Industries — — — 6,568 6,568 347,753 354,321 — Total 771 1,034 3,682 26,548 32,035 850,342 882,377 — Commercial Land Agriculture 10,010 714 3,340 — 14,064 274,403 288,467 — Total 10,010 714 3,340 — 14,064 274,403 288,467 — Total 1 $ 13,445 $ 2,940 $ 11,424 $ 40,604 $ 68,413 $ 2,157,084 $ 2,225,497 $ — Less Than 30 Days Past Due & Not Accruing 30-89 Days Past Due & Accruing 30-89 Days Past Due & Not Accruing Greater Than 90 Days Past Due Total Not Accruing & Past Due Loans Current Loans Total Loans Loans 90 Days or More Past Due & Still Accruing December 31, 2018 Commercial & Industrial Agriculture $ — $ — $ — $ — $ — $ 6,400 $ 6,400 $ — Funeral Home & Cemetery — — — — — 17,378 17,378 — Healthcare 41 1,027 665 6,821 8,554 42,528 51,082 — Independent Pharmacies 1,399 29 — 7,570 8,998 99,785 108,783 — Registered Investment Advisors — 232 320 2,741 3,293 91,045 94,338 — Veterinary Industry — — 600 906 1,506 44,098 45,604 — Other Industries 2,669 166 — 504 3,339 291,824 295,163 — Total 4,109 1,454 1,585 18,542 25,690 593,058 618,748 — Construction & Development Agriculture — — — — — 43,454 43,454 — Funeral Home & Cemetery — — — — — 9,874 9,874 — Healthcare — — — — — 81,619 81,619 — Independent Pharmacies — — — — — 2,149 2,149 — Registered Investment Advisors — — — — — 1,232 1,232 — Veterinary Industry — — — — — 14,094 14,094 — Other Industries — — — — — 96,482 96,482 — Total — — — — — 248,904 248,904 — Commercial Real Estate Agriculture — — — — — 53,085 53,085 — Funeral Home & Cemetery 248 — — 2,762 3,010 68,334 71,344 — Healthcare 42 1,668 — 7,417 9,127 179,404 188,531 — Independent Pharmacies — 3,400 — 2,193 5,593 15,004 20,597 — Registered Investment Advisors — — — — — 7,905 7,905 — Veterinary Industry 1,644 3,757 2,899 5,191 13,491 123,230 136,721 — Other Industries — 10,743 — — 10,743 250,104 260,847 — Total 1,934 19,568 2,899 17,563 41,964 697,066 739,030 — Commercial Land Agriculture 6,277 — — 4,781 11,058 232,740 243,798 — Total 6,277 — — 4,781 11,058 232,740 243,798 — Total 1 $ 12,320 $ 21,022 $ 4,484 $ 40,886 $ 78,712 $ 1,771,768 $ 1,850,480 $ — 1 Total loans and leases include $498.8 million of U.S. government guaranteed loans as of June 30, 2019, of which $30.5 million is greater than 90 days past due, $9.0 million is 30-89 days past due and $459.3 million is included in current loans and leases as presented above. As of December 31, 2018, total loans and leases include $305.4 million of U.S. government guaranteed loans, of which $33.4 million is greater than 90 days past due, $9.0 million is 30-89 days past due and $263.0 million is included in current loans and leases as presented above. Nonaccrual Loans and Leases Loans and leases that become 90 days delinquent, or in cases where there is evidence that the borrower’s ability to make the required payments is impaired, are placed in nonaccrual status and interest accrual is discontinued. If interest on nonaccrual loans and leases had been accrued in accordance with the original terms, interest income would have increased by approximately $1.1 million and $588 thousand for the three months ended June 30, 2019 and 2018, respectively, and for the six months ended June 30, 2019 and 2018 interest income would have increased approximately $2.2 million and $1.0 million, respectively. All nonaccrual loans and leases are included in the held for investment portfolio. Nonaccrual loans and leases as of June 30, 2019 and December 31, 2018 are as follows: June 30, 2019 Loan Balance Guaranteed Balance Unguaranteed Exposure Commercial & Industrial Healthcare $ 7,027 $ 6,097 $ 930 Independent Pharmacies 5,170 4,105 1,065 Registered Investment Advisors 1,809 1,409 400 Veterinary Industry 1,607 1,458 149 Other Industries 5,509 3,806 1,703 Total 21,122 16,875 4,247 Commercial Real Estate Agriculture 2,226 1,669 557 Funeral Home & Cemetery 1,961 1,368 593 Healthcare 7,076 4,708 2,368 Independent Pharmacies 5,831 5,084 747 Veterinary Industry 7,339 6,157 1,182 Other Industries 6,568 3,747 2,821 Total 31,001 22,733 8,268 Commercial Land Agriculture 13,350 7,513 5,837 Total 13,350 7,513 5,837 Total $ 65,473 $ 47,121 $ 18,352 December 31, 2018 Loan Balance Guaranteed Balance Unguaranteed Exposure Commercial & Industrial Healthcare $ 7,527 $ 6,517 $ 1,010 Independent Pharmacies 8,969 7,896 1,073 Registered Investment Advisors 3,061 2,427 634 Veterinary Industry 1,506 1,361 145 Other Industries 3,173 2,147 1,026 Total 24,236 20,348 3,888 Commercial Real Estate Funeral Home & Cemetery 3,010 2,260 750 Healthcare 7,459 4,963 2,496 Independent Pharmacies 2,193 1,863 330 Veterinary Industry 9,734 8,271 1,463 Total 22,396 17,357 5,039 Commercial Land Agriculture 11,058 5,497 5,561 Total 11,058 5,497 5,561 Total $ 57,690 $ 43,202 $ 14,488 Allowance for Loan and Lease Loss Methodology The methodology and the estimation process for calculating the Allowance for Loan and Lease Losses (“ALLL”) is described below: Estimated credit losses should meet the criteria for accrual of a loss contingency, i.e., a provision to the ALLL, set forth in GAAP. The Company’s methodology for determining the ALLL is based on the requirements of GAAP, the Interagency Policy Statement on the Allowance for Loan and Lease Losses and other regulatory and accounting pronouncements. The ALLL is determined by the sum of three separate components: (i) the impaired loan and lease component, which addresses specific reserves for impaired loans and leases; (ii) the general reserve component, which addresses reserves for pools of homogeneous loans and leases; and (iii) an unallocated reserve component (if any) based on management’s judgment and experience. The loan and lease pools and impaired loans and leases are mutually exclusive; any loan or lease that is impaired is excluded from its homogenous pool for purposes of that pool’s reserve calculation, regardless of the level of impairment. The ALLL policy for pooled loans and leases is governed in accordance with banking regulatory guidance for homogenous pools of non-impaired loans and leases that have similar risk characteristics. The Company follows a consistent and structured approach for assessing the need for reserves within each individual loan and lease pool. Loans and leases are considered impaired when, based on current information and events, it is probable that the creditor will be unable to collect all interest and principal payments due according to the originally contracted, or reasonably modified, terms of the loan or lease agreement. The Company has determined that loans and leases that meet the criteria defined below must be reviewed quarterly to determine if they are impaired. • All commercial loans and leases classified substandard or worse. • Any other delinquent loan or lease that is in a nonaccrual status, or any loan or lease that is delinquent 90 days or more and still accruing interest. • Any loan or lease which has been modified such that it meets the definition of a Troubled Debt Restructuring (TDR). The Company’s policy for impaired loan and lease accounting subjects all loans and leases to impairment recognition; however, loan and lease relationships with unguaranteed credit exposure of less than $100,000 are generally not evaluated on an individual basis for impairment and instead are evaluated collectively using a methodology based on historical specific reserves on similar sized loans and leases. Any loan or lease not meeting the above criteria and determined to be impaired is subjected to an impairment analysis, which is a calculation of the probable loss on the loan or lease. This portion is the loan's or lease’s “impairment,” and is established as a specific reserve against the loan or lease, or charged against the ALLL. Individual specific reserve amounts imply probability of loss and may not be carried in the reserve indefinitely. When the amount of the actual loss becomes reasonably quantifiable, the amount of the loss is charged off against the ALLL, whether or not all liquidation and recovery efforts have been completed. If the total amount of the individual specific reserve that will eventually be charged off cannot yet be sufficiently quantified but some portion of the impairment can be viewed as a confirmed loss, then the confirmed loss portion should be charged off against the ALLL and the individual specific reserve reduced by a corresponding amount. For impaired loans or leases, the reserve amount is calculated on a loan or lease-specific basis. The Company utilizes two methods of analyzing impaired loans and leases not guaranteed by the SBA: • The Fair Market Value of Collateral method utilizes the value at which the collateral could be sold considering the appraised value, appraisal discount rate, prior liens and selling costs. The amount of the reserve is the deficit of the estimated collateral value compared to the loan or lease balance. • The Present Value of Future Cash Flows method takes into account the amount and timing of cash flows and the effective interest rate used to discount the cash flows. The following table details activity in the allowance for loan and lease losses by portfolio segment allowance for the periods presented: Three Months Ended Construction & Development Commercial Real Estate Commercial & Industrial Commercial Land Total June 30, 2019 Beginning Balance $ 2,236 $ 10,623 $ 16,543 $ 5,709 $ 35,111 Charge offs — (1 ) (416 ) (178 ) (595 ) Recoveries — 13 56 — 69 Provision 688 1,954 724 97 3,463 Ending Balance $ 2,924 $ 12,589 $ 16,907 $ 5,628 $ 38,048 June 30, 2018 Beginning Balance $ 2,428 $ 11,244 $ 12,201 $ 2,177 $ 28,050 Charge offs — (419 ) (549 ) — (968 ) Recoveries — 29 152 — 181 Provision (201 ) 554 1,573 161 2,087 Ending Balance $ 2,227 $ 11,408 $ 13,377 $ 2,338 $ 29,350 Six Months Ended Construction & Development Commercial Real Estate Commercial & Industrial Commercial Land Total June 30, 2019 Beginning Balance $ 2,042 $ 11,044 $ 14,562 $ 4,786 $ 32,434 Charge offs — (1 ) (638 ) (178 ) (817 ) Recoveries — 23 198 5 226 Provision 882 1,523 2,785 1,015 6,205 Ending Balance $ 2,924 $ 12,589 $ 16,907 $ 5,628 $ 38,048 June 30, 2018 Beginning Balance $ 2,030 $ 9,180 $ 10,751 $ 2,229 $ 24,190 Charge offs — (419 ) (1,221 ) — (1,640 ) Recoveries — 33 288 — 321 Provision 197 2,614 3,559 109 6,479 Ending Balance $ 2,227 $ 11,408 $ 13,377 $ 2,338 $ 29,350 The following tables detail the recorded allowance for loan and lease losses and the investment in loans and leases related to each portfolio segment, disaggregated on the basis of impairment evaluation methodology: June 30, 2019 Construction & Development Commercial Real Estate Commercial & Industrial Commercial Land Total Allowance for loan and lease losses: Loans and leases individually evaluated for impairment $ — $ 3,610 $ 3,128 $ 4,721 $ 11,459 Loans and leases collectively evaluated for impairment 2,924 8,979 13,779 907 26,589 Total allowance for loan and lease losses $ 2,924 $ 12,589 $ 16,907 $ 5,628 $ 38,048 Loans and leases receivable 1 Loans and leases individually evaluated for impairment $ — $ 57,444 $ 24,473 $ 35,192 $ 117,109 Loans and leases collectively evaluated for impairment 324,732 824,933 705,448 253,275 2,108,388 Total loans and leases receivable $ 324,732 $ 882,377 $ 729,921 $ 288,467 $ 2,225,497 December 31, 2018 Construction & Development Commercial Real Estate Commercial & Industrial Commercial Land Total Allowance for loan and lease losses: Loans and leases individually evaluated for impairment $ 118 $ 2,424 $ 2,598 $ 3,951 $ 9,091 Loans and leases collectively evaluated for impairment 1,924 8,620 11,964 835 23,343 Total allowance for loan and lease losses $ 2,042 $ 11,044 $ 14,562 $ 4,786 $ 32,434 Loans and leases receivable 1 Loans and leases individually evaluated for impairment $ 5,027 $ 46,731 $ 28,659 $ 21,997 $ 102,414 Loans and leases collectively evaluated for impairment 243,877 692,299 590,089 221,801 1,748,066 Total loans and leases receivable $ 248,904 $ 739,030 $ 618,748 $ 243,798 $ 1,850,480 1 Loans and leases receivable includes $498.8 million of U.S. government guaranteed loans as of June 30, 2019, of which $79.3 million are impaired. As of December 31, 2018, loans and leases receivable includes $305.4 million of U.S. government guaranteed loans, of which $72.4 million are considered impaired. Loans and leases classified as impaired as of the dates presented are summarized in the following tables. June 30, 2019 Recorded Investment Guaranteed Balance Unguaranteed Exposure Commercial & Industrial Agriculture $ 7 $ — $ 7 Healthcare 9,096 6,530 2,566 Independent Pharmacies 5,457 4,105 1,352 Registered Investment Advisors 2,076 1,409 667 Veterinary Industry 2,357 1,876 481 Other Industries 5,480 3,806 1,674 Total 24,473 17,726 6,747 Commercial Real Estate Agriculture 2,226 1,669 557 Funeral Home & Cemetery 1,958 1,368 590 Healthcare 22,879 14,206 8,673 Independent Pharmacies 7,168 6,082 1,086 Veterinary Industry 13,846 9,466 4,380 Other Industries 9,367 5,821 3,546 Total 57,444 38,612 18,832 Commercial Land Agriculture 35,192 22,980 12,212 Total 35,192 22,980 12,212 Total $ 117,109 $ 79,318 $ 37,791 December 31, 2018 Recorded Investment Guaranteed Balance Unguaranteed Exposure Commercial & Industrial Agriculture $ 7 $ — $ 7 Funeral Home & Cemetery 6 — 6 Healthcare 9,668 7,229 2,439 Independent Pharmacies 9,356 7,896 1,460 Registered Investment Advisors 3,347 2,427 920 Veterinary Industry 2,326 1,819 507 Other Industries 3,949 2,304 1,645 Total 28,659 21,675 6,984 Construction & Development Agriculture 5,027 3,704 1,323 Total 5,027 3,704 1,323 Commercial Real Estate Agriculture 1,798 1,299 499 Funeral Home & Cemetery 3,143 2,261 882 Healthcare 20,442 14,559 5,883 Independent Pharmacies 5,633 4,079 1,554 Veterinary Industry 15,715 11,613 4,102 Total 46,731 33,811 12,920 Commercial Land Agriculture 21,997 13,177 8,820 Total 21,997 13,177 8,820 Total $ 102,414 $ 72,367 $ 30,047 The following table presents evaluated balances of loans and leases classified as impaired at the dates presented that carried an associated reserve as compared to those with no reserve. The recorded investment includes accrued interest and net deferred loan and lease fees or costs. June 30, 2019 Recorded Investment With a Recorded Allowance With No Recorded Allowance Total Unpaid Principal Balance Related Allowance Recorded Commercial & Industrial Agriculture $ 7 $ — $ 7 $ 6 $ 7 Funeral Home & Cemetery — — — — — Healthcare 9,039 57 9,096 9,827 870 Independent Pharmacies 5,161 296 5,457 5,763 833 Registered Investment Advisors 2,076 — 2,076 2,138 432 Veterinary Industry 2,180 177 2,357 2,667 57 Other Industries 5,480 — 5,480 5,655 929 Total 23,943 530 24,473 26,056 3,128 Commercial Real Estate Agriculture 2,226 — 2,226 2,226 13 Funeral Home & Cemetery 1,821 137 1,958 1,961 87 Healthcare 20,754 2,125 22,879 22,873 1,266 Independent Pharmacies 7,168 — 7,168 7,453 43 Veterinary Industry 13,146 700 13,846 14,650 1,277 Other Industries 9,367 — 9,367 9,334 924 Total 54,482 2,962 57,444 58,497 3,610 Commercial Land Agriculture 35,192 — 35,192 34,988 4,721 Total 35,192 — 35,192 34,988 4,721 Total Impaired Loans and Leases $ 113,617 $ 3,492 $ 117,109 $ 119,541 $ 11,459 December 31, 2018 Recorded Investment With a Recorded Allowance With No Recorded Allowance Total Unpaid Principal Balance Related Allowance Recorded Commercial & Industrial Agriculture $ — $ 7 $ 7 $ 6 $ — Funeral Home & Cemetery — 6 6 6 — Healthcare 9,604 64 9,668 10,432 827 Independent Pharmacies 9,032 324 9,356 10,564 478 Registered Investment Advisors 3,347 — 3,347 3,839 811 Veterinary Industry 2,160 166 2,326 2,593 65 Other Industries 3,496 453 3,949 4,097 417 Total 27,639 1,020 28,659 31,537 2,598 Construction & Development Agriculture 5,027 — 5,027 4,939 118 Total 5,027 — 5,027 4,939 118 Commercial Real Estate Agriculture 1,798 — 1,798 1,732 93 Funeral Home & Cemetery 2,859 284 3,143 3,281 30 Healthcare 20,211 231 20,442 20,461 1,145 Independent Pharmacies 5,184 449 5,633 5,884 220 Veterinary Industry 15,606 109 15,715 16,677 936 Total 45,658 1,073 46,731 48,035 2,424 Commercial Land Agriculture 21,997 — 21,997 22,147 3,951 Total 21,997 — 21,997 22,147 3,951 Total Impaired Loans and Leases $ 100,321 $ 2,093 $ 102,414 $ 106,658 $ 9,091 The following table presents the average recorded investment of impaired loans and leases for each period presented and interest income recognized during the period in which the loans and leases were considered impaired. Three Months Ended June 30, 2019 Three Months Ended June 30, 2018 Average Balance Interest Income Recognized Average Balance Interest Income Recognized Commercial & Industrial Agriculture $ 6 $ — $ — $ — Funeral Home & Cemetery — — 7 — Healthcare 9,280 34 5,094 19 Independent Pharmacies 5,459 5 7,978 7 Registered Investment Advisors 2,083 5 2,818 12 Veterinary Industry 2,394 13 2,930 18 Other Industries 5,904 7 1,373 5 Total 25,126 64 20,200 61 Construction & Development Agriculture — — 2,526 — Healthcare — — 1,799 28 Total — — 4,325 28 Commercial Real Estate Agriculture 2,228 — — — Funeral Home & Cemetery 1,967 — 3,122 27 Healthcare 23,057 259 12,852 64 Independent Pharmacies 7,198 25

Leases

Leases	6 Months Ended
	Jun. 30, 2019
Leases [Abstract]
Leases	Note 6. Leases Lessor Equipment Leasing The Company purchases new equipment for the purpose of leasing such equipment to customers within its verticals. Equipment purchased to fulfill commitments to commercial renewable energy projects is rented out under operating leases while leases of equipment outside of the renewable energy vertical are generally direct financing leases. Accordingly, leased assets under operating leases are included in premises and equipment while leased assets under direct financing leases are included in loans and leases held for investment. Direct Financing Leases Interest income on direct financing leases is recognized when earned. Unearned interest is recognized over the lease term on a basis which results in a constant rate of return on the unrecovered lease investment. The term of each lease is generally 3-7 years which is consistent with the useful life of the equipment with no residual value. The gross lease payments receivable and the net investment included in accounts receivable for such leases are as follows: June 30, 2019 December 31, 2018 Gross direct finance lease payments receivable $ 15,587 $ 12,541 Less – unearned interest (3,063 ) (2,635 ) Net investment in direct financing leases $ 12,524 $ 9,906 Future minimum lease payments under finance leases are as follows: As of June 30, 2019 Amount 2019 $ 1,544 2020 3,061 2021 3,007 2022 2,744 2023 2,286 Thereafter 2,945 Total $ 15,587 Interest income of $267 thousand and $73 thousand was recognized in the three months ended June 30, 2019 and 2018, respectively. Interest income of $501 thousand and $120 thousand was recognized in the six months ended June 30, 2019 and 2018, respectively. Operating Leases The term of each operating lease is generally 10 to 15 years. The Company retains ownership of the equipment and associated tax benefits such as investment tax credits and accelerated depreciation. At the end of the lease term, the lessee has the option to renew the lease for two additional terms or purchase the equipment at the then current fair market value. Rental revenue from operating leases is recognized on a straight-line basis over the term of the lease. Rental equipment is recorded at cost and depreciated to an estimated residual value on a straight-line basis over the estimated useful life. The useful lives generally range from 20 to 25 years and residual values generally range from 20% to 50%, however, they are subject to periodic evaluation. Changes in useful lives or residual values will impact depreciation expense and any gain or loss from the sale of used equipment. The estimated useful lives and residual values of the Company's leasing equipment are based on industry disposal experience and the Company's expectations for future sale prices. If the Company decides to sell or otherwise dispose of rental equipment, it is carried at the lower of cost or fair value less costs to sell or dispose. Repair and maintenance costs that do not extend the lives of the rental equipment are charged to direct operating expenses at the time the costs are incurred. As of June 30, 2019 and December 31, 2018, the Company had a net investment of $147.4 million and $148.8 million, respectively, in assets included in premises and equipment that are subject to operating leases. Of the net investment, the gross balance of the assets was $162.6 million and $159.2 million and accumulated depreciation was $ 15.2 Lease income of $2.4 million and $1.9 million was recognized in the three months ended June 30, 2019 and 2018, respectively. Lease income of $4.7 million and $3.5 million was recognized in the six months ended June 30, 2019 and 2018, respectively. A maturity analysis of future minimum lease payments under non-cancelable operating leases is as follows: As of June 30, 2019 Amount 2019 $ 3,889 2020 8,883 2021 8,930 2022 8,924 2023 8,956 Thereafter 48,267 Total $ 87,849 Lessee Lease Arrangements The Company has operating leases for real property, land, copiers and other equipment. These leases have remaining lease terms of 1 year to 27 years, some of which include options to extend the leases for up to 20 years, and some of which include options to terminate the leases. The Company has concluded that it is reasonably certain it will exercise the options to extend for only one lease, which was therefore recognized as part of the ROU asset and lease liability. The Company has a finance lease for fitness equipment and it has a remaining lease term of approximately 3.4 years. There are no options to extend or terminate this lease. The components of lease expense are as follows: Three Months Ended June 30, 2019 Six Months Ended June 30, 2019 Operating lease cost $ 169 $ 326 Short-term lease cost 166 375 Finance lease cost: Amortization of right-of-use assets 1 2 Interest expense on lease liabilities — — Sublease income (9 ) (18 ) Total net lease cost $ 327 $ 685 Supplemental disclosure for the consolidated balance sheet related to finance leases is as follows: June 30, 2019 Finance lease right-of-use asset $ 16 Finance lease liability 16 The weighted average remaining lease term and weighted average discount rate for leases are as follows: As of June 30, 2019 Weighted average remaining lease term (years) Operating leases 15.30 Finance lease 3.42 Weighted average discount rate Operating leases 3.50 % Finance lease 3.10 % A maturity analysis of operating and finance lease liabilities is as follows: As of June 30, 2019 Operating Leases Finance Leases 2019 $ 343 $ 3 2020 504 5 2021 297 5 2022 275 4 2023 143 — Thereafter 1,285 — Total lease payments 2,847 17 Less: imputed interest (685 ) (1 ) Total lease liabilities $ 2,162 $ 16

Servicing Assets

Servicing Assets	6 Months Ended
	Jun. 30, 2019
Transfers And Servicing [Abstract]
Servicing Assets	Note 7. Servicing Assets Loans serviced for others are not included in the accompanying balance sheet. The unpaid principal balances of loans serviced for others requiring recognition of a servicing asset were $2.39 billion and $2.63 billion at June 30, 2019 and December 31, 2018, respectively. The unpaid principal balance for all loans serviced for others was $3.05 billion and $3.22 billion at June 30, 2019 and December 31, 2018, respectively. The following summarizes the activity pertaining to servicing rights: Three Months Ended June 30, Six Months Ended June 30, 2019 2018 2019 2018 Balance at beginning of period $ 44,324 $ 53,120 $ 47,641 $ 52,298 Additions, net 608 4,202 1,331 9,076 Fair value changes: Due to changes in valuation inputs or assumptions 260 (552 ) (489 ) (553 ) Decay due to increases in principal paydowns or runoff (3,505 ) (4,081 ) (6,796 ) (8,132 ) Balance at end of period $ 41,687 $ 52,689 $ 41,687 $ 52,689 The fair value of servicing rights was determined using a weighted average discount rate of 13.4% on June 30, 2019 and 13.0% on June 30, 2018. The fair value of servicing rights was determined using a weighted average prepayment speed of 14.1% on June 30, 2019 and 9.6% on June 30, 2018, depending on the stratification of the specific right. Changes to fair value are reported in loan servicing asset revaluation within the consolidated statements of income. The fair value of servicing rights is highly sensitive to changes in underlying assumptions. Changes in prepayment speed assumptions have the most significant impact on the fair value of servicing rights. Generally, as interest rates rise on variable rate loans, loan prepayments increase due to an increase in refinance activity, which results in a decrease in the fair value of servicing assets. Measurement of fair value is limited to the conditions existing and the assumptions used as of a particular point in time, and those assumptions may not be appropriate if they are applied at a different time.

Borrowings

Borrowings	6 Months Ended
	Jun. 30, 2019
Debt Disclosure [Abstract]
Borrowings	Note 8. Borrowings Total outstanding short and long term borrowings consisted of the following: June 30, 2019 December 31, 2018 Short term borrowings On September 18, 2014, the Company entered into a note payable revolving line of credit of $8.1 million with an unaffiliated commercial bank. On April 18, 2017, the Company renewed and increased the revolving line of credit to $25 million. The note was unsecured and accrued interest at Prime minus 0.50% for a term of 24 months. Payments were interest only with all principal and accrued interest due on April 30, 2019. The terms of this loan required the Company to maintain minimum capital, liquidity and Texas ratios. This line of credit was paid in full on August 25, 2017. This line of credit matured on April 30, 2019 and there is no available credit at June 30, 2019. $ — $ — On February 23, 2015, the Company transferred two related party loans to an unaffiliated commercial bank in exchange for $4.7 million. The exchange price equated to the unpaid principal balance plus accrued but uncollected interest at the time of transfer. The terms of the transfer agreement with the unaffiliated commercial bank identified the transaction as a secured borrowing for accounting purposes. One of the loans with an outstanding balance of $1.3 million was paid in full on August 17, 2018. Interest accrues at prime plus 1% with monthly principal and interest payments over a term of 60 months. The interest rate at June 30, 2019 is 6.50%. The maturity date is October 5, 2019. The pledged collateral is classified in other assets with a fair value of $1.3 million at June 30, 2019. The underlying loan carries a risk grade of 3 and is current with no delinquency. 1,345 1,441 On October 20, 2017, the Company entered into a revolving line of credit of $20 million with an unaffiliated commercial bank. On October 2, 2018, the Company renewed the revolving $20 million line of credit. The note is unsecured and accrues interest at LIBOR plus 1.750% for a term of 12 months. Payments are interest only with all principal and accrued interest due on October 18, 2019. The terms of this loan require the Company to maintain minimum capital and debt service coverage ratios. No advances have been made to this line of credit and there is $20 million of available credit at June 30, 2019. — — Total short term borrowings $ 1,345 $ 1,441 June 30, 2019 December 31, 2018 Long term borrowings In October 2017, the Company entered into a capital lease of $19 thousand with an unaffiliated equipment lease company, secured by fitness equipment which is included in other assets on the consolidated balance sheet. Payments are principal and interest due monthly starting December 15, 2017 over a term of 60 months. At the end of the lease term there is a $1.00 bargain purchase option. As of January 1, 2019, this borrowing was revised in accordance with ASU 2016-02. $ 16 $ 16 Total long term borrowings $ 16 $ 16 The Company may purchase federal funds through unsecured federal funds lines of credit with various correspondent banks, which totaled $72.5 million as of June 30, 2019 and December 31, 2018. These lines are intended for short-term borrowings and are subject to restrictions limiting the frequency and terms of advances. These lines of credit are payable on demand and bear interest based upon the daily federal funds rate. The Company had no outstanding balances on the lines of credit as of June 30, 2019 and December 31, 2018. The Company has entered into a repurchase agreement with a third party for $ 5.0 million as of June 30, 2019 and December 31, 2018 . At the time the Company enters into a transaction with the third party, the Company must transfer securities or other assets against the funds received. The terms of the agreement are set at market conditions at the time the Company enters into such transaction. The Company had no outstanding balance on the repurchase agreement as of June 30, 2019 and December 31, 2018 . On June 18, 2018, the Company entered into a borrowing agreement with the Federal Home Loan Bank of Atlanta. These borrowings must be secured with eligible collateral approved by the Federal Home Loan Bank of Atlanta. At June 30, 2019 and December 31, 2018, the Company had approximately $1.01 billion and $849.1 million, respectively, in borrowing capacity available under these agreements. There is no collateral pledged and no advances outstanding as of June 30, 2019 and December 31, 2018. The Company may borrow funds through the Federal Reserve Bank’s discount window. These borrowings are secured by a blanket floating lien on qualifying loans with a balance of $412.9 million and $395.2 million as of June 30, 2019 and December 31, 2018, respectively. At June 30, 2019 and December 31, 2018, the Company had approximately $234.9 million and $218.0 million, respectively, in borrowing capacity available under these arrangements with no outstanding balance as of June 30, 2019 and December 31, 2018.

Income Taxes

Income Taxes	6 Months Ended
	Jun. 30, 2019
Income Tax Disclosure [Abstract]
Income Taxes	Note 9. Income Taxes The Company's effective tax rate is lower than the U.S. statutory rate primarily because of the anticipated effect of investment tax credits during 2019. The Company's effective tax rate in the future will depend on the actual investment tax credits earned as a part of its financing renewable energy applications.

Fair Value of Financial Instrum

Fair Value of Financial Instruments	6 Months Ended
	Jun. 30, 2019
Fair Value Disclosures [Abstract]
Fair Value of Financial Instruments	Note 10. Fair Value of Financial Instruments Fair Value Hierarchy There are three levels of inputs in the fair value hierarchy that may be used to measure fair value. Financial instruments are considered Level 1 when valuation can be based on quoted prices in active markets for identical assets or liabilities. Level 2 financial instruments are valued using quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or models using inputs that are observable or can be corroborated by observable market data of substantially the full term of the assets or liabilities. Financial instruments are considered Level 3 when their values are determined using pricing models, discounted cash flow methodologies or similar techniques and at least one significant model assumption or input is unobservable and when determination of the fair value requires significant management judgment or estimation. Financial Instruments Measured at Fair Value The following sections provide a description of the valuation methodologies used for instruments measured at fair value, as well as the general classification of such instruments pursuant to the fair value hierarchy: Investment securities: Where quoted prices are available in an active market, securities are classified within Level 1 of the valuation hierarchy. Level 1 securities would include highly liquid government bonds, mortgage products and exchange traded equities. If quoted market prices are not available, then fair values are estimated by using pricing models, quoted prices of securities with similar characteristics, discounted cash flow or at net asset value per share. Level 2 securities would include U.S. government agency securities, mortgage-backed securities, obligations of states and political subdivisions and certain corporate, asset backed mutual fund and other securities. In certain cases where there is limited activity or less transparency around inputs to the valuation, securities are classified within Level 3 of the valuation hierarchy. Impaired loans : Impairment of a loan is based on the fair value of the collateral of the loan for collateral-dependent loans. Fair value of the loan’s collateral, when the loan is dependent on collateral, is determined by appraisals or independent valuation which is then adjusted for the cost related to liquidation of the collateral. For non-collateral dependent loans, impairment is determined by the present value of expected future cash flows. Impaired loans classified as Level 3 are based on management’s judgment and estimation. Servicing assets: Servicing rights do not trade in an active, open market with readily observable prices. While sales of servicing rights do occur, the precise terms and conditions typically are not readily available. Accordingly, the Company estimates the fair value of servicing rights using discounted cash flow models incorporating numerous assumptions from the perspective of a market participant including servicing income, servicing costs, market discount rates and prepayment speeds. Due to the nature of the valuation inputs, servicing rights are classified within Level 3 of the valuation hierarchy. Foreclosed assets: Foreclosed real estate is adjusted to fair value less selling costs upon transfer of the loans to foreclosed real estate. Subsequently, foreclosed real estate is carried at the lower of carrying value or fair value less selling costs. Fair value is based upon independent market prices, appraised values of the collateral or management’s estimation of the value of the collateral. Given the lack of observable market prices for identical properties and market discounts applied to appraised values, the Company generally classifies foreclosed assets as nonrecurring Level 3. Mutual fund: The following mutual fund is registered with the Securities and Exchange Commission as a closed-end, non-diversified management investment company and operates as an interval fund. The fund primarily invests in the unguaranteed portion of SBA504 First Lien Loans secured by owner-occupied commercial real estate. This investment is valued using quoted prices in markets that are not active and is classified as Level 2 within the valuation hierarchy. Equity warrant assets: Fair value measurements of equity warrant assets of private companies are priced based on a Black-Scholes option pricing model to estimate the asset value by using stated strike prices, option expiration dates, risk-free interest rates and option volatility assumptions. Option volatility assumptions used in the Black-Scholes model are based on public companies that operate in similar industries as the companies in our private company portfolio. Option expiration dates are modified to account for estimates to actual life relative to stated expiration. Values are further adjusted for a general lack of liquidity due to the private nature of the associated underlying company. The Company classifies equity warrant assets within Level 3 of the valuation hierarchy. Recurring Fair Value The tables below present the recorded amount of assets and liabilities measured at fair value on a recurring basis. June 30, 2019 Total Level 1 Level 2 Level 3 Investment securities available-for-sale US treasury securities $ 5,015 $ — $ 5,015 $ — US government agencies 48,905 — 48,905 — Mortgage-backed securities 513,349 — 513,349 — Municipal bonds 1 9,006 — 8,913 93 Servicing assets 2 41,687 — — 41,687 Mutual fund 2,175 — 2,175 — Equity warrant assets 3 720 — — 720 Total assets at fair value $ 620,857 $ — $ 578,357 $ 42,500 December 31, 2018 Total Level 1 Level 2 Level 3 Investment securities available-for-sale US treasury securities $ 4,966 $ — $ 4,966 $ — US government agencies 30,944 — 30,944 — Mortgage-backed securities 343,581 — 343,581 — Municipal bond 1 999 — — 999 Servicing assets 2 47,641 — — 47,641 Mutual fund 2,099 — 2,099 — Equity warrant assets 3 527 — — 527 Total assets at fair value $ 430,757 $ — $ 381,590 $ 49,167 1 During the six months ended June 30, 2019, the Company sold $900 thousand of a municipal bond to a third party and recorded a fair value adjustment loss of $7 thousand. During the three months ended June 30, 2019, the Company recorded no fair value adjustment. 2 See Note 7 for a rollforward of recurring Level 3 fair values for servicing assets. 3 During the six months ended June 30, 2019, the Company recorded net gains on derivative instruments of $193 thousand. During the three months ended June 30, 2019, the Company recorded net losses on derivative instruments of $62 thousand. During the six months ended June 30, 2018, the Company entered into equity warrant assets with a fair value of $399 thousand at the time of issuance. There was no activity for the derivative instruments during the three months ended June 30, 2018. Non-recurring Fair Value The tables below present the recorded amount of assets and liabilities measured at fair value on a non-recurring basis. June 30, 2019 Total Level 1 Level 2 Level 3 Impaired loans $ 102,158 $ — $ — $ 102,158 Foreclosed assets 6,044 — — 6,044 Total assets at fair value $ 108,202 $ — $ — $ 108,202 December 31, 2018 Total Level 1 Level 2 Level 3 Impaired loans $ 91,230 $ — $ — $ 91,230 Foreclosed assets 1,094 — — 1,094 Total assets at fair value $ 92,324 $ — $ — $ 92,324 Level 3 Analysis For Level 3 assets and liabilities measured at fair value on a recurring or non-recurring basis as of June 30, 2019 and December 31, 2018 the significant unobservable inputs used in the fair value measurements were as follows: June 30, 2019 Level 3 Assets with Significant Unobservable Inputs Fair Value Valuation Technique Significant Unobservable Inputs Range Municipal bond $ 93 Discounted expected cash flows Discount rate Prepayment speed 4.76% 5.00% Impaired loans $ 102,158 Discounted appraisals Discounted expected cash flows Appraisal adjustments (1) Interest rate & repayment term 0% to 48% Weighted average discount rate 6.77% Foreclosed assets $ 6,044 Discounted appraisals Appraisal adjustments (1) 9% to 37% Equity warrant assets $ 720 Black-Scholes option pricing model Volatility Risk-free interest rate Marketability discount Remaining life 20.90% 2.03% 20.00% 8 - 9 years December 31, 2018 Level 3 Assets with Significant Unobservable Inputs Fair Value Valuation Technique Significant Unobservable Inputs Range Municipal bond $ 999 Discounted expected cash flows Discount rate Prepayment speed 5.14% 5.00% Impaired loans $ 91,230 Discounted appraisals Discounted expected cash flows Appraisal adjustments (1) Interest rate & repayment term 8% to 48% Weighted average discount rate 6.58% Foreclosed assets $ 1,094 Discounted appraisals Appraisal adjustments (1) 9% to 37% Equity warrant assets $ 527 Black-Scholes option pricing model Volatility Risk-free interest rate Marketability discount Remaining life 20.40% 2.69% 20.00% 9 - 10 years (1) Appraisals may be adjusted by management for customized discounting criteria, estimated sales costs, and proprietary qualitative adjustments. Estimated Fair Value of Other Financial Instruments GAAP also requires disclosure of the fair value of financial instruments carried at book value on the consolidated balance sheets. The carrying amounts and estimated fair values of the Company’s financial instruments are as follows: June 30, 2019 Carrying Amount Quoted Price In Active Markets for Identical Assets /Liabilities (Level 1) Significant Other Observable Inputs (Level 2) Significant Unobservable Inputs (Level 3) Total Fair Value Financial assets Cash and due from banks $ 115,292 $ 115,292 $ — $ — $ 115,292 Federal funds sold 68,153 68,153 — — 68,153 Certificates of deposit with other banks 7,250 7,604 — — 7,604 Investment securities, available-for-sale 576,275 — 576,182 93 576,275 Loans held for sale 857,837 — — 881,747 881,747 Loans and leases, net of allowance for loan and lease losses 2,187,425 — — 2,182,023 2,182,023 Servicing assets 41,687 — — 41,687 41,687 Accrued interest receivable 19,791 19,791 — — 19,791 Mutual fund 2,175 — 2,175 — 2,175 Equity warrant assets 720 — — 720 720 Financial liabilities Deposits 3,721,597 — 3,734,139 — 3,734,139 Accrued interest payable 1,990 1,990 — — 1,990 Short term borrowings 1,345 — — 1,347 1,347 Long term borrowings 16 — — 16 16 December 31, 2018 Carrying Amount Quoted Price In Active Markets for Identical Assets /Liabilities (Level 1) Significant Other Observable Inputs (Level 2) Significant Unobservable Inputs (Level 3) Total Fair Value Financial assets Cash and due from banks $ 316,823 $ 316,823 $ — $ — $ 316,823 Certificates of deposit with other banks 7,250 7,442 — — 7,442 Investment securities, available-for-sale 380,490 — 379,491 999 380,490 Loans held for sale 687,393 — — 695,154 695,154 Loans and leases, net of allowance for loan and lease losses 1,810,985 — — 1,807,528 1,807,528 Servicing assets 47,641 — — 47,641 47,641 Accrued interest receivable 15,895 15,895 — — 15,895 Mutual fund 2,099 — 2,099 — 2,099 Equity warrant assets 527 — — 527 527 Financial liabilities Deposits 3,149,583 — 3,117,941 — 3,117,941 Accrued interest payable 861 861 — — 861 Short term borrowings 1,441 — — 1,441 1,441 Long term borrowings 16 — — 16 16

Commitments and Contingencies

Commitments and Contingencies	6 Months Ended
	Jun. 30, 2019
Leases [Abstract]
Commitments and Contingencies	Note 11. Commitments and Contingencies Litigation In the normal course of business the Company is involved in various legal proceedings. Management believes that the outcome of such proceedings will not materially affect the financial position, results of operations or cash flows of the Company. Financial Instruments with Off-balance-sheet Risk The Company is party to financial instruments with off-balance-sheet risk in the normal course of business to meet the financing needs of its customers. These financial instruments include commitments to extend credit and standby letters of credit. These instruments involve, to varying degrees, credit risk in excess of the amount recognized in the balance sheet. The Company’s exposure to credit loss in the event of nonperformance by the other party to the financial instrument for commitments to extend credit and standby letters of credit is represented by the contractual amount of those instruments. The Company uses the same credit policies in making commitments and conditional obligations as for on-balance-sheet instruments. A summary of the Company’s commitments is as follows: June 30, 2019 December 31, 2018 Commitments to extend credit $ 1,641,814 $ 1,435,024 Standby letters of credit 12,285 2,150 Airplane purchase agreement commitments — 10,450 Total unfunded off-balance-sheet credit risk $ 1,654,099 $ 1,447,624 Commitments to extend credit are agreements to lend to a customer as long as there is no violation of any condition established in the contract. Commitments generally have fixed expiration dates or other termination clauses and may require payment of a fee. Since many of the commitments are expected to expire without being drawn upon, the total commitment amounts do not necessarily represent future cash requirements. The Company evaluates each customer’s creditworthiness on a case-by-case basis. The amount of collateral obtained, if deemed necessary by the Company upon extension of credit, is based on management’s credit evaluation of the party. Collateral held varies, but may include accounts receivable, inventory, property and equipment, residential real estate and income-producing commercial properties. In 2012, the Company began issuing commitment letters after approval of the loan by the Credit Department. Commitment letters generally expire ninety days after issuance. Standby letters of credit are conditional commitments issued by the Company to guarantee the performance of a customer to a third party. Those guarantees are primarily issued to support public and private borrowing arrangements. The credit risk involved in issuing letters of credit is essentially the same as that involved in extending loan facilities to customers. Collateral held varies as specified above and is required in instances which the Company deems necessary. As of June 30, 2019 and December 31, 2018, the Company had unfunded commitments to provide capital contributions for on-balance-sheet investments in the amount of $1.6 million and $2.8 million, respectively. Concentrations of Credit Risk Although the Company is not subject to any geographic concentrations, a substantial amount of the Company’s loans, leases, and commitments to extend credit have been granted to customers in the agriculture, healthcare and veterinary verticals. The concentrations of credit by type of loan are set forth in Note 5. The distribution of commitments to extend credit approximates the distribution of loans outstanding. The Company does not have a significant number of credits to any single borrower or group of related borrowers whereby their retained unguaranteed exposure exceeds $7.5 million, except for 16 relationships that have a retained unguaranteed exposure of $193.0 million of which $137.0 million of the unguaranteed exposure has been disbursed. Additionally, the Company has future minimum lease payments due under non-cancelable operating leases totaling $87.8 million, of which $63.7 million is due from four relationships. The Company from time-to-time may have cash and cash equivalents on deposit with financial institutions that exceed federally-insured limits.

Stock Plans

Stock Plans	6 Months Ended
	Jun. 30, 2019
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]
Stock Plans	Note 12. Stock Plans On March 20, 2015, the Company adopted the 2015 Omnibus Stock Incentive Plan which replaced the previously existing Amended Incentive Stock Option Plan and Nonstatutory Stock Option Plan. Subsequently on May 24, 2016, the 2015 Omnibus Stock Incentive Plan was amended to authorize awards covering a maximum of 7,000,000 common voting shares and has an expiration date of March 20, 2025. On May 15, 2018, the Amended and Restated 2015 Omnibus Stock Incentive Plan was amended to authorize awards covering a maximum of 8,750,000 common voting shares. Options or restricted shares granted under the Amended and Restated 2015 Omnibus Stock Incentive Plan (the "Plan") expire no more than 10 years from the date of grant. Exercise prices under the Plan are set by the Board of Directors at the date of grant, but shall not be less than 100% of fair market value of the related stock at the date of the grant. Options vest over a minimum of three years from the date of the grant. Restricted stock grants vest in equal installments ranging from immediate vesting to over a seven year period from the date of the grant. Market Restricted Stock Units also have a restriction based on the passage of time and non-market-related performance criteria, but also have a restriction based on market price criteria related to the Company’s share price closing at or above a specified price defined at time of grant. Stock Options Compensation cost relating to share-based payment transactions are recognized in the financial statements with measurement based upon the fair value of the equity or liability instruments issued. For the three months ended June 30, 2019 and 2018, the Company recognized $400 thousand and $347 thousand in compensation expense for stock options, respectively. For the six months ended June 30, 2019 and 2018, the Company recognized $838 thousand and $780 thousand in compensation expense for stock options, respectively. Stock option activity under the Plan during the six month periods ended June 30, 2019 and 2018, is summarized below. Shares Weighted Average Exercise Price Weighted Average Remaining Contractual Term Aggregate Intrinsic Value Outstanding at December 31, 2018 2,656,855 $ 11.27 Exercised 30,634 6.16 Forfeited 32,042 9.34 Granted — — Outstanding at June 30, 2019 2,594,179 $ 11.35 5.52 years $ 15,457,477 Exercisable at June 30, 2019 954,353 $ 10.24 5.30 years $ 6,721,334 Shares Weighted Average Exercise Price Weighted Average Remaining Contractual Terms Aggregate Intrinsic Value Outstanding at December 31, 2017 3,058,459 $ 11.30 Exercised 144,671 8.66 Forfeited 134,623 14.11 Granted — — Outstanding at June 30, 2018 2,779,165 $ 11.30 6.54 years $ 53,786,948 Exercisable at June 30, 2018 727,697 $ 9.83 6.27 years $ 15,148,795 The following is a summary of non-vested stock option activity for the Company for the six months ended June 30, 2019 and 2018. Shares Weighted Average Grant Date Fair Value Non-vested at December 31, 2018 1,839,830 $ 4.60 Granted — — Vested (167,962 ) 2.85 Forfeited (32,042 ) 9.34 Non-vested at June 30, 2019 1,639,826 12.00 Shares Weighted Average Grant Date Fair Value Non-vested at December 31, 2017 2,364,999 $ 4.65 Granted — — Vested (178,908 ) 2.95 Forfeited (134,623 ) 6.26 Non-vested at June 30, 2018 2,051,468 4.79 The total intrinsic value of options exercised at June 30, 2019 and 2018, was $326 thousand and $2.9 million, respectively. At June 30, 2019, unrecognized compensation costs relating to stock options amounted to $5.1 million which will be recognized over a weighted average period of 3.1 years. The weighted average fair value of each stock option grant is estimated on the date of grant using the Black-Scholes option-pricing model. The expected volatility is based on historical volatility. The risk-free interest rates for periods within the contractual life of the awards are based on the U.S. Treasury yield curve in effect at the time of the grant. The expected life is based on historical exercise experience. The dividend yield assumption is based on the Company’s history and expectation of dividend payouts. There were no stock options granted during the three and six months ended June 30, 2019 and 2018. Restricted Stock Restricted stock awards are authorized in the form of restricted stock awards or units ("RSU"s) and restricted stock awards or units with a market price condition ("Market RSU"s). RSUs have a restriction based on the passage of time and may also have a restriction based on a non-market-related performance criteria. The fair value of the RSUs is based on the closing price on the date of the grant. Market RSUs also have a restriction based on the passage of time and non-market-related performance criteria, but also have a restriction based on market price criteria related to the Company’s share price closing at or above a specified price ranging from $34.00 to $55.00 per share for at least twenty (20) consecutive trading days at any time prior to expiration date. The amount of Market RSUs earned will not exceed 100% of the Market RSUs awarded. The fair value of the Market RSUs and the implied service period is calculated using the Monte Carlo simulation method. RSU stock activity under the Plan during the six months of 201 9 is summarized below. Shares Weighted Average Grant Date Fair Value Non-vested at December 31, 2018 388,187 $ 23.85 Granted 69,621 16.02 Vested (26,714 ) 28.33 Forfeited (4,918 ) 23.96 Non-vested at June 30, 2019 426,176 22.29 For the three months ended June 30, 2019 and 2018, the Company recognized $556 thousand and $921 thousand in compensation expense for RSUs, respectively. For the six months ended June 30, 2019 and 2018, the Company recognized $1.1 million and $1.8 million in compensation expense for RSUs, respectively. At June 30, 2019, unrecognized compensation costs relating to RSUs amounted to $8.2 million which will be recognized over a weighted average period of 4.7 years. Market RSU stock activity under the Plan during the first three months of 2019 is summarized below. Shares Weighted Average Grant Date Fair Value Non-vested at December 31, 2018 2,709,202 $ 9.87 Granted 500,000 8.81 Vested — — Forfeited (22,347 ) 9.28 Non-vested at June 30, 2019 3,186,855 8.45 The compensation expense for Market RSUs is measured based on their grant date fair value as calculated using the Monte Carlo simulation and is recognized on a straight-line basis over the average vesting period. The Monte Carlo simulation used 100,000 simulation paths to assess the expected date of achieving the market price criteria. Related to the 500,000 Market RSUs granted on February 11, 2019, the share price simulation was based on the Cox, Ross & Rubinstein option pricing methodology for a period of 10.0 years. The implied term of the restricted stock ranges from 4.5 to 5.8 years. The Monte Carlo Simulation used various assumptions that included a risk free rate of return of 2.62%, expected volatility of 37.6% and a dividend yield of 0.78%. On February 11, 2019, 75,000 Market RSUs granted on May 14, 2018 to one employee were modified to lengthen the vesting term from 7 to 10 years and change the target stock price from $48.00 to a range of $35.00 to $48.00 per share for at least twenty (20) consecutive trading days. Additionally, 410,000 Market RSUs granted on August 10, 2018 to eleven employees were modified to lengthen the vesting term from 7 to 10 years and change the amount of Market RSUs that vest at various target stock prices to 20% per tier. As a result of modification, the Company recognized additional compensation expense of $166 thousand and $234 thousand for the three and six months periods ended June 30, 2019, respectively. For the three months ended June 30, 2019 and 2018, the Company recognized $2.0 million and $947 thousand in compensation expense for Market RSUs, respectively. For the six months ended June 30, 2019 and 2018, the Company recognized $3.8 million and $1.9 million in compensation expense for Market RSUs, respectively. At June 30, 2019, unrecognized compensation costs relating to Market RSUs amounted to $19.1 million which will be recognized over a weighted average period of 3.3 years. Employee Stock Purchase Plan The Company adopted an Employee Stock Purchase Plan on October 8, 2014. On May 24, 2016, the plan was amended and the Amended and Restated Employee Stock Purchase Plan (the "ESPP") became effective within the meaning of Section 423 of the Internal Revenue Code of 1986, as amended. Under the ESPP, eligible employees are able to purchase available shares with post-tax dollars as of the grant date. In order for employees to be eligible to participate in the ESPP they must be employed or on an authorized leave of absence from the Company or any subsidiary immediately prior to the grant date. ESPP stock purchases cannot exceed $25 thousand in fair market value per employee per calendar year. Options to purchase shares under the ESPP are granted at a 15% discount to fair market value. There was no expense recognized in relation to the ESPP for the three months ended June 30, 2019 and 2018. For the six months ended June 30, 2019 and 2018, the Company recognized $32 thousand and $29 thousand in expense, respectively.

Basis of Presentation (Policies

Basis of Presentation (Policies)	6 Months Ended
	Jun. 30, 2019
Organization Consolidation And Presentation Of Financial Statements [Abstract]
General	General In the opinion of management, all adjustments necessary for a fair presentation of the financial position and results of operations for the periods presented have been included, and all intercompany transactions have been eliminated in consolidation. Results of operations for the six months ended June 30, 2019 are not necessarily indicative of the results of operations that may be expected for the year ending December 31, 2019. The consolidated balance sheet as of December 31, 2018 has been derived from the audited consolidated financial statements contained in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2018, filed with the Securities Exchange Commission on February 27, 2019 (SEC File No. 001-37497) (the "2018 Annual Report"). A summary description of the significant accounting policies followed by the Company is set forth in Note 1 of the Notes to Consolidated Financial Statements in the Company’s 2018 Annual Report. These unaudited interim condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and footnotes in the Company's 2018 Annual Report. The preparation of financial statements in conformity with United States generally accepted accounting principles, or GAAP, requires management to make estimates and assumptions that affect reported amounts of assets and liabilities and the reported amounts of revenues and expenses during the reporting period. Actual results could differ significantly from those estimates. Amounts in all tables in the Notes to Unaudited Condensed Consolidated Financial Statements have been presented in thousands, except percentage, time period, stock option, share and per share data or where otherwise indicated.
Business Segments	Business Segments Management has determined that the Company has one significant operating segment, which is providing a lending platform for small businesses nationwide. In determining the appropriateness of segment definition, the Company considers the materiality of a potential segment, the components of the business about which financial information is available, and components for which management regularly evaluates relative to resource allocation and performance assessment.
Reclassifications	Reclassifications Certain reclassifications have been made to the prior period’s consolidated financial statements to place them on a comparable basis with the current year. Net income and shareholders’ equity previously reported were not affected by these reclassifications.
Accounting Change	Accounting Change On January 1, 2019, the Company adopted Accounting Standards Update ("ASU") No. 2016-02 “Leases (Topic 842),” (“ASU 2016-02”) and all subsequent ASUs that modified Topic 842. The Company elected to apply certain practical expedients provided under ASU 2016-02 whereby the Company will not reassess (i) whether any expired or existing contracts are or contain leases, (ii) the lease classification for any expired or existing leases and (iii) initial direct costs for any existing leases. The Company has also applied the practical expedient to use hindsight in determining the lease term and in assessing impairment of the right-of-use assets. The Company does not apply the recognition and measurement requirements to any short-term leases (as defined by ASU 2016-02). The Company accounts for lease and non-lease components separately because such amounts are readily determinable under the lease contracts. The Company utilized the modified-retrospective transition approach prescribed by ASU 2018-11, “Leases (Topic 842) Targeted Improvements The Company determines if an arrangement is or contains a lease at inception. If it is determined to be or contain a lease, then the lease is classified as an operating or finance lease. Right-of-use ("ROU") assets represent the Company's right to use an underlying asset for the lease term. Lease liabilities represent the Company's obligation to make lease payments arising from the lease. ROU assets and liabilities are measured on commencement date based on the present value of the lease payments over the lease term, discounted using the discount rate for the lease at commencement. The discount rate shall be the rate implicit in the lease, however, if that is not readily determinable, the Company will use its incremental borrowing rate. The ROU asset also includes any lease payments made before the commencement date and initial direct costs and excludes any lease incentives received. The lease terms may include options to extend or terminate the lease when it is reasonably certain that the option will be exercised. Lease expense for lease payments is recognized on a straight-line basis over the lease term. Operating leases are included in operating lease right-of-use assets and operating lease liabilities in the consolidated balance sheets. Finance leases are included in other assets and long term borrowings in the consolidated balance sheets. Lease expense for operating leases and finance leases is included in occupancy expense in the consolidated statements of income and interest expense for finance leases is included in other interest expense in the consolidated statements of income.

Earnings Per Share (Tables)

Earnings Per Share (Tables)	6 Months Ended
	Jun. 30, 2019
Earnings Per Share [Abstract]
Computation of Basic and Diluted Earnings Per Share	Basic and diluted earnings per share are computed based on the weighted average number of shares outstanding during each period. Diluted earnings per share reflects the potential dilution that could occur, upon the exercise of stock options or upon the vesting of restricted stock grants, any of which would result in the issuance of common stock that would then be shared in the net income of the Company. Three Months Ended June 30, Six Months Ended June 30, 2019 2018 2019 2018 Basic earnings per share: Net income available to common shareholders $ 4,935 $ 14,253 $ 7,307 $ 26,706 Weighted-average basic shares outstanding 40,196,662 40,027,336 40,178,491 39,977,336 Basic earnings per share $ 0.12 $ 0.36 $ 0.18 $ 0.67 Diluted earnings per share: Net income available to common shareholders, for diluted earnings per share $ 4,935 $ 14,253 $ 7,307 $ 26,706 Total weighted-average basic shares outstanding 40,196,662 40,027,336 40,178,491 39,977,336 Add effect of dilutive stock options and restricted stock grants 801,879 1,592,311 801,879 1,538,997 Total weighted-average diluted shares outstanding 40,998,541 41,619,647 40,980,370 41,516,333 Diluted earnings per share $ 0.12 $ 0.34 $ 0.18 $ 0.64 Anti-dilutive shares 1,578,197 — 1,578,197 9,102

Investment Securities (Tables)

Investment Securities (Tables)	6 Months Ended
	Jun. 30, 2019
Investments Debt And Equity Securities [Abstract]
Summary of Carrying Amount and Fair Value of Securities	The carrying amount of investment securities and their approximate fair values are reflected in the following table: June 30, 2019 Amortized Cost Unrealized Gains Unrealized Losses Fair Value US treasury securities $ 4,979 $ 36 $ — $ 5,015 US government agencies 48,303 613 11 48,905 Mortgage-backed securities 497,529 16,479 659 513,349 Municipal bonds 8,521 492 7 9,006 Total $ 559,332 $ 17,620 $ 677 $ 576,275 December 31, 2018 US treasury securities $ 4,969 $ — $ 3 $ 4,966 US government agencies 31,121 48 225 30,944 Mortgage-backed securities 345,606 1,340 3,365 343,581 Municipal bond 1,000 — 1 999 Total $ 382,696 $ 1,388 $ 3,594 $ 380,490
Gross Unrealized Losses and Fair Value of Securities in a Continuous Unrealized Loss Position	The following tables show gross unrealized losses and fair value, aggregated by investment category and length of time that the individual securities have been in a continuous unrealized loss position. Less Than 12 Months 12 Months or More Total June 30, 2019 Fair Value Unrealized Losses Fair Value Unrealized Losses Fair Value Unrealized Losses US government agencies $ — $ — $ 6,471 $ 11 $ 6,471 $ 11 Mortgage-backed securities — — 44,567 659 44,567 659 Municipal bonds 93 7 — — 93 7 Total $ 93 $ 7 $ 51,038 $ 670 $ 51,131 $ 677 Less Than 12 Months 12 Months or More Total December 31, 2018 Fair Value Unrealized Losses Fair Value Unrealized Losses Fair Value Unrealized Losses US treasury securities $ 4,966 $ 3 $ — $ — $ 4,966 $ 3 US government agencies — — 16,268 225 16,268 225 Mortgage-backed securities 164,836 1,177 51,371 2,188 216,207 3,365 Municipal bond 999 1 — — 999 1 Total $ 170,801 $ 1,181 $ 67,639 $ 2,413 $ 238,440 $ 3,594
Summary of Investment Securities by Maturity	The following is a summary of investment securities by maturity: June 30, 2019 Amortized cost Fair value US treasury securities One to five years $ 4,979 $ 5,015 Total 4,979 5,015 US government agencies Within one year 6,483 6,471 One to five years 29,909 30,345 Five to ten years 11,911 12,089 Total 48,303 48,905 Mortgage-backed securities One to five years 2,743 2,760 Five to ten years 150,463 156,698 After 10 years 344,323 353,891 Total 497,529 513,349 Municipal bonds After 10 years 8,521 9,006 Total 8,521 9,006 Total $ 559,332 $ 576,275

Loans and Leases Held for Inv_2

Loans and Leases Held for Investment and Allowance for Loan and Lease Losses (Tables)	6 Months Ended
	Jun. 30, 2019
Receivables [Abstract]
Composition of Loans and Leases	Loans and leases consist of the following: June 30, 2019 December 31, 2018 Commercial & Industrial Agriculture $ 6,305 $ 6,400 Funeral Home & Cemetery 22,709 17,378 Healthcare 46,344 51,082 Independent Pharmacies 110,956 108,783 Registered Investment Advisors 92,901 94,338 Veterinary Industry 47,744 45,604 Other Industries 402,962 295,163 Total 729,921 618,748 Construction & Development Agriculture 40,258 43,454 Funeral Home & Cemetery 10,840 9,874 Healthcare 92,296 81,619 Independent Pharmacies 1,193 2,149 Registered Investment Advisors 2,138 1,232 Veterinary Industry 22,694 14,094 Other Industries 155,313 96,482 Total 324,732 248,904 Commercial Real Estate Agriculture 49,532 53,085 Funeral Home & Cemetery 86,830 71,344 Healthcare 221,195 188,531 Independent Pharmacies 26,877 20,597 Registered Investment Advisors 8,152 7,905 Veterinary Industry 135,470 136,721 Other Industries 354,321 260,847 Total 882,377 739,030 Commercial Land Agriculture 288,467 243,798 Total 288,467 243,798 Total Loans 2,225,497 1,850,480 Net Deferred Costs 9,767 5,960 Discount on SBA 7(a) Unguaranteed (9,791 ) (13,021 ) Loans, Net of Unearned $ 2,225,473 $ 1,843,419 1 Total loans and leases include $498.8 million and $305.4 million of U.S. government guaranteed loans as of June 30, 2019 and December 31, 2018, respectively. 2 The Company measures the carrying value of the retained portion of loans sold at fair value under ASC Subtopic 825-10. The value of these retained loan balances is discounted based on the estimates derived from comparable unguaranteed loan sales.
Summary of Risk Grades of Each Category of Loans	The following tables summarize the risk grades of each category: Risk Grades 1 - 4 Risk Grade 5 Risk Grades 6 - 8 Total 1 June 30, 2019 Commercial & Industrial Agriculture $ 5,760 $ 545 $ — $ 6,305 Funeral Home & Cemetery 20,811 1,898 — 22,709 Healthcare 34,936 2,888 8,520 46,344 Independent Pharmacies 99,284 6,502 5,170 110,956 Registered Investment Advisors 88,782 2,050 2,069 92,901 Veterinary Industry 44,419 1,016 2,309 47,744 Other Industries 382,016 15,437 5,509 402,962 Total 676,008 30,336 23,577 729,921 Construction & Development Agriculture 40,258 — — 40,258 Funeral Home & Cemetery 10,840 — — 10,840 Healthcare 88,885 3,411 — 92,296 Independent Pharmacies 1,193 — — 1,193 Registered Investment Advisors 2,138 — — 2,138 Veterinary Industry 22,694 — — 22,694 Other Industries 142,116 13,197 — 155,313 Total 308,124 16,608 — 324,732 Commercial Real Estate Agriculture 46,841 466 2,225 49,532 Funeral Home & Cemetery 79,149 5,720 1,961 86,830 Healthcare 191,816 8,377 21,002 221,195 Independent Pharmacies 17,303 2,411 7,163 26,877 Registered Investment Advisors 8,114 38 — 8,152 Veterinary Industry 119,320 3,362 12,788 135,470 Other Industries 336,073 8,914 9,334 354,321 Total 798,616 29,288 54,473 882,377 Commercial Land Agriculture 263,961 10,749 13,757 288,467 Total 263,961 10,749 13,757 288,467 Total $ 2,046,709 $ 86,981 $ 91,807 $ 2,225,497 Risk Grades 1 - 4 Risk Grade 5 Risk Grades 6 - 8 Total 1 December 31, 2018 Commercial & Industrial Agriculture $ 6,187 $ 213 $ — $ 6,400 Funeral Home & Cemetery 17,085 287 6 17,378 Healthcare 38,908 2,502 9,672 51,082 Independent Pharmacies 93,976 5,734 9,073 108,783 Registered Investment Advisors 88,614 2,381 3,343 94,338 Veterinary Industry 42,175 1,190 2,239 45,604 Other Industries 272,771 18,463 3,929 295,163 Total 559,716 30,770 28,262 618,748 Construction & Development Agriculture 43,454 — — 43,454 Funeral Home & Cemetery 9,874 — — 9,874 Healthcare 79,814 1,805 — 81,619 Independent Pharmacies 2,149 — — 2,149 Registered Investment Advisors 1,232 — — 1,232 Veterinary Industry 14,094 — — 14,094 Other Industries 96,482 — — 96,482 Total 247,099 1,805 — 248,904 Commercial Real Estate Agriculture 52,518 567 — 53,085 Funeral Home & Cemetery 64,487 3,711 3,146 71,344 Healthcare 161,026 7,696 19,809 188,531 Independent Pharmacies 12,509 2,495 5,593 20,597 Registered Investment Advisors 7,780 125 — 7,905 Veterinary Industry 117,879 4,205 14,637 136,721 Other Industries 255,651 5,196 — 260,847 Total 671,850 23,995 43,185 739,030 Commercial Land Agriculture 223,826 8,914 11,058 243,798 Total 223,826 8,914 11,058 243,798 Total $ 1,702,491 $ 65,484 $ 82,505 $ 1,850,480 1 Total loans and leases include $498.8 million of U.S. government guaranteed loans as of June 30, 2019, segregated by risk grade as follows: Risk Grades 1 – 4 = $410.8 million, Risk Grade 5 = $24.6 million, Risk Grades 6 – 8 = $63.4 million. As of December 31, 2018, total loans and leases include $305.4 million of U.S. government guaranteed loans, segregated by risk grade as follows: Risk Grades 1 – 4 = $236.1 million, Risk Grade 5 = $10.1 million, Risk Grades 6 – 8 = $59.2 million.
Age Analysis of Past Due Loans and Leases	The following tables show an age analysis of past due loans and leases as of the dates presented. Less Than 30 Days Past Due & Not Accruing 30-89 Days Past Due & Accruing 30-89 Days Past Due & Not Accruing Greater Than 90 Days Past Due Total Not Accruing & Past Due Loans Current Loans Total Loans Loans 90 Days or More Past Due & Still Accruing June 30, 2019 Commercial & Industrial Agriculture $ — $ — $ — $ — $ — $ 6,305 $ 6,305 $ — Funeral Home & Cemetery — — — — — 22,709 22,709 — Healthcare 906 — 623 5,498 7,027 39,317 46,344 — Independent Pharmacies — — — 5,170 5,170 105,786 110,956 — Registered Investment Advisors 1,201 — 399 209 1,809 91,092 92,901 — Veterinary Industry — — 576 1,031 1,607 46,137 47,744 — Other Industries 557 1,192 2,804 2,148 6,701 396,261 402,962 — Total 2,664 1,192 4,402 14,056 22,314 707,607 729,921 — Construction & Development Agriculture — — — — — 40,258 40,258 — Funeral Home & Cemetery — — — — — 10,840 10,840 — Healthcare — — — — — 92,296 92,296 — Independent Pharmacies — — — — — 1,193 1,193 — Registered Investment Advisors — — — — — 2,138 2,138 — Veterinary Industry — — — — — 22,694 22,694 — Other Industries — — — — — 155,313 155,313 — Total — — — — — 324,732 324,732 — Commercial Real Estate Agriculture — — — 2,226 2,226 47,306 49,532 — Funeral Home & Cemetery 137 — — 1,824 1,961 84,869 86,830 — Healthcare — 1,034 — 7,076 8,110 213,085 221,195 — Independent Pharmacies — — — 5,831 5,831 21,046 26,877 — Registered Investment Advisors — — — — — 8,152 8,152 — Veterinary Industry 634 — 3,682 3,023 7,339 128,131 135,470 — Other Industries — — — 6,568 6,568 347,753 354,321 — Total 771 1,034 3,682 26,548 32,035 850,342 882,377 — Commercial Land Agriculture 10,010 714 3,340 — 14,064 274,403 288,467 — Total 10,010 714 3,340 — 14,064 274,403 288,467 — Total 1 $ 13,445 $ 2,940 $ 11,424 $ 40,604 $ 68,413 $ 2,157,084 $ 2,225,497 $ — Less Than 30 Days Past Due & Not Accruing 30-89 Days Past Due & Accruing 30-89 Days Past Due & Not Accruing Greater Than 90 Days Past Due Total Not Accruing & Past Due Loans Current Loans Total Loans Loans 90 Days or More Past Due & Still Accruing December 31, 2018 Commercial & Industrial Agriculture $ — $ — $ — $ — $ — $ 6,400 $ 6,400 $ — Funeral Home & Cemetery — — — — — 17,378 17,378 — Healthcare 41 1,027 665 6,821 8,554 42,528 51,082 — Independent Pharmacies 1,399 29 — 7,570 8,998 99,785 108,783 — Registered Investment Advisors — 232 320 2,741 3,293 91,045 94,338 — Veterinary Industry — — 600 906 1,506 44,098 45,604 — Other Industries 2,669 166 — 504 3,339 291,824 295,163 — Total 4,109 1,454 1,585 18,542 25,690 593,058 618,748 — Construction & Development Agriculture — — — — — 43,454 43,454 — Funeral Home & Cemetery — — — — — 9,874 9,874 — Healthcare — — — — — 81,619 81,619 — Independent Pharmacies — — — — — 2,149 2,149 — Registered Investment Advisors — — — — — 1,232 1,232 — Veterinary Industry — — — — — 14,094 14,094 — Other Industries — — — — — 96,482 96,482 — Total — — — — — 248,904 248,904 — Commercial Real Estate Agriculture — — — — — 53,085 53,085 — Funeral Home & Cemetery 248 — — 2,762 3,010 68,334 71,344 — Healthcare 42 1,668 — 7,417 9,127 179,404 188,531 — Independent Pharmacies — 3,400 — 2,193 5,593 15,004 20,597 — Registered Investment Advisors — — — — — 7,905 7,905 — Veterinary Industry 1,644 3,757 2,899 5,191 13,491 123,230 136,721 — Other Industries — 10,743 — — 10,743 250,104 260,847 — Total 1,934 19,568 2,899 17,563 41,964 697,066 739,030 — Commercial Land Agriculture 6,277 — — 4,781 11,058 232,740 243,798 — Total 6,277 — — 4,781 11,058 232,740 243,798 — Total 1 $ 12,320 $ 21,022 $ 4,484 $ 40,886 $ 78,712 $ 1,771,768 $ 1,850,480 $ — 1 Total loans and leases include $498.8 million of U.S. government guaranteed loans as of June 30, 2019, of which $30.5 million is greater than 90 days past due, $9.0 million is 30-89 days past due and $459.3 million is included in current loans and leases as presented above. As of December 31, 2018, total loans and leases include $305.4 million of U.S. government guaranteed loans, of which $33.4 million is greater than 90 days past due, $9.0 million is 30-89 days past due and $263.0 million is included in current loans and leases as presented above.
Nonaccrual Loans and Leases	Nonaccrual loans and leases as of June 30, 2019 and December 31, 2018 are as follows: June 30, 2019 Loan Balance Guaranteed Balance Unguaranteed Exposure Commercial & Industrial Healthcare $ 7,027 $ 6,097 $ 930 Independent Pharmacies 5,170 4,105 1,065 Registered Investment Advisors 1,809 1,409 400 Veterinary Industry 1,607 1,458 149 Other Industries 5,509 3,806 1,703 Total 21,122 16,875 4,247 Commercial Real Estate Agriculture 2,226 1,669 557 Funeral Home & Cemetery 1,961 1,368 593 Healthcare 7,076 4,708 2,368 Independent Pharmacies 5,831 5,084 747 Veterinary Industry 7,339 6,157 1,182 Other Industries 6,568 3,747 2,821 Total 31,001 22,733 8,268 Commercial Land Agriculture 13,350 7,513 5,837 Total 13,350 7,513 5,837 Total $ 65,473 $ 47,121 $ 18,352 December 31, 2018 Loan Balance Guaranteed Balance Unguaranteed Exposure Commercial & Industrial Healthcare $ 7,527 $ 6,517 $ 1,010 Independent Pharmacies 8,969 7,896 1,073 Registered Investment Advisors 3,061 2,427 634 Veterinary Industry 1,506 1,361 145 Other Industries 3,173 2,147 1,026 Total 24,236 20,348 3,888 Commercial Real Estate Funeral Home & Cemetery 3,010 2,260 750 Healthcare 7,459 4,963 2,496 Independent Pharmacies 2,193 1,863 330 Veterinary Industry 9,734 8,271 1,463 Total 22,396 17,357 5,039 Commercial Land Agriculture 11,058 5,497 5,561 Total 11,058 5,497 5,561 Total $ 57,690 $ 43,202 $ 14,488
Activity in the Allowance for Loan and Lease Losses by Portfolio Segment	The following table details activity in the allowance for loan and lease losses by portfolio segment allowance for the periods presented: Three Months Ended Construction & Development Commercial Real Estate Commercial & Industrial Commercial Land Total June 30, 2019 Beginning Balance $ 2,236 $ 10,623 $ 16,543 $ 5,709 $ 35,111 Charge offs — (1 ) (416 ) (178 ) (595 ) Recoveries — 13 56 — 69 Provision 688 1,954 724 97 3,463 Ending Balance $ 2,924 $ 12,589 $ 16,907 $ 5,628 $ 38,048 June 30, 2018 Beginning Balance $ 2,428 $ 11,244 $ 12,201 $ 2,177 $ 28,050 Charge offs — (419 ) (549 ) — (968 ) Recoveries — 29 152 — 181 Provision (201 ) 554 1,573 161 2,087 Ending Balance $ 2,227 $ 11,408 $ 13,377 $ 2,338 $ 29,350 Six Months Ended Construction & Development Commercial Real Estate Commercial & Industrial Commercial Land Total June 30, 2019 Beginning Balance $ 2,042 $ 11,044 $ 14,562 $ 4,786 $ 32,434 Charge offs — (1 ) (638 ) (178 ) (817 ) Recoveries — 23 198 5 226 Provision 882 1,523 2,785 1,015 6,205 Ending Balance $ 2,924 $ 12,589 $ 16,907 $ 5,628 $ 38,048 June 30, 2018 Beginning Balance $ 2,030 $ 9,180 $ 10,751 $ 2,229 $ 24,190 Charge offs — (419 ) (1,221 ) — (1,640 ) Recoveries — 33 288 — 321 Provision 197 2,614 3,559 109 6,479 Ending Balance $ 2,227 $ 11,408 $ 13,377 $ 2,338 $ 29,350 The following tables detail the recorded allowance for loan and lease losses and the investment in loans and leases related to each portfolio segment, disaggregated on the basis of impairment evaluation methodology: June 30, 2019 Construction & Development Commercial Real Estate Commercial & Industrial Commercial Land Total Allowance for loan and lease losses: Loans and leases individually evaluated for impairment $ — $ 3,610 $ 3,128 $ 4,721 $ 11,459 Loans and leases collectively evaluated for impairment 2,924 8,979 13,779 907 26,589 Total allowance for loan and lease losses $ 2,924 $ 12,589 $ 16,907 $ 5,628 $ 38,048 Loans and leases receivable 1 Loans and leases individually evaluated for impairment $ — $ 57,444 $ 24,473 $ 35,192 $ 117,109 Loans and leases collectively evaluated for impairment 324,732 824,933 705,448 253,275 2,108,388 Total loans and leases receivable $ 324,732 $ 882,377 $ 729,921 $ 288,467 $ 2,225,497 December 31, 2018 Construction & Development Commercial Real Estate Commercial & Industrial Commercial Land Total Allowance for loan and lease losses: Loans and leases individually evaluated for impairment $ 118 $ 2,424 $ 2,598 $ 3,951 $ 9,091 Loans and leases collectively evaluated for impairment 1,924 8,620 11,964 835 23,343 Total allowance for loan and lease losses $ 2,042 $ 11,044 $ 14,562 $ 4,786 $ 32,434 Loans and leases receivable 1 Loans and leases individually evaluated for impairment $ 5,027 $ 46,731 $ 28,659 $ 21,997 $ 102,414 Loans and leases collectively evaluated for impairment 243,877 692,299 590,089 221,801 1,748,066 Total loans and leases receivable $ 248,904 $ 739,030 $ 618,748 $ 243,798 $ 1,850,480 1 Loans and leases receivable includes $498.8 million of U.S. government guaranteed loans as of June 30, 2019, of which $79.3 million are impaired. As of December 31, 2018, loans and leases receivable includes $305.4 million of U.S. government guaranteed loans, of which $72.4 million are considered impaired.
Impaired Loans and Leases	Loans and leases classified as impaired as of the dates presented are summarized in the following tables. June 30, 2019 Recorded Investment Guaranteed Balance Unguaranteed Exposure Commercial & Industrial Agriculture $ 7 $ — $ 7 Healthcare 9,096 6,530 2,566 Independent Pharmacies 5,457 4,105 1,352 Registered Investment Advisors 2,076 1,409 667 Veterinary Industry 2,357 1,876 481 Other Industries 5,480 3,806 1,674 Total 24,473 17,726 6,747 Commercial Real Estate Agriculture 2,226 1,669 557 Funeral Home & Cemetery 1,958 1,368 590 Healthcare 22,879 14,206 8,673 Independent Pharmacies 7,168 6,082 1,086 Veterinary Industry 13,846 9,466 4,380 Other Industries 9,367 5,821 3,546 Total 57,444 38,612 18,832 Commercial Land Agriculture 35,192 22,980 12,212 Total 35,192 22,980 12,212 Total $ 117,109 $ 79,318 $ 37,791 December 31, 2018 Recorded Investment Guaranteed Balance Unguaranteed Exposure Commercial & Industrial Agriculture $ 7 $ — $ 7 Funeral Home & Cemetery 6 — 6 Healthcare 9,668 7,229 2,439 Independent Pharmacies 9,356 7,896 1,460 Registered Investment Advisors 3,347 2,427 920 Veterinary Industry 2,326 1,819 507 Other Industries 3,949 2,304 1,645 Total 28,659 21,675 6,984 Construction & Development Agriculture 5,027 3,704 1,323 Total 5,027 3,704 1,323 Commercial Real Estate Agriculture 1,798 1,299 499 Funeral Home & Cemetery 3,143 2,261 882 Healthcare 20,442 14,559 5,883 Independent Pharmacies 5,633 4,079 1,554 Veterinary Industry 15,715 11,613 4,102 Total 46,731 33,811 12,920 Commercial Land Agriculture 21,997 13,177 8,820 Total 21,997 13,177 8,820 Total $ 102,414 $ 72,367 $ 30,047 The following table presents evaluated balances of loans and leases classified as impaired at the dates presented that carried an associated reserve as compared to those with no reserve. The recorded investment includes accrued interest and net deferred loan and lease fees or costs. June 30, 2019 Recorded Investment With a Recorded Allowance With No Recorded Allowance Total Unpaid Principal Balance Related Allowance Recorded Commercial & Industrial Agriculture $ 7 $ — $ 7 $ 6 $ 7 Funeral Home & Cemetery — — — — — Healthcare 9,039 57 9,096 9,827 870 Independent Pharmacies 5,161 296 5,457 5,763 833 Registered Investment Advisors 2,076 — 2,076 2,138 432 Veterinary Industry 2,180 177 2,357 2,667 57 Other Industries 5,480 — 5,480 5,655 929 Total 23,943 530 24,473 26,056 3,128 Commercial Real Estate Agriculture 2,226 — 2,226 2,226 13 Funeral Home & Cemetery 1,821 137 1,958 1,961 87 Healthcare 20,754 2,125 22,879 22,873 1,266 Independent Pharmacies 7,168 — 7,168 7,453 43 Veterinary Industry 13,146 700 13,846 14,650 1,277 Other Industries 9,367 — 9,367 9,334 924 Total 54,482 2,962 57,444 58,497 3,610 Commercial Land Agriculture 35,192 — 35,192 34,988 4,721 Total 35,192 — 35,192 34,988 4,721 Total Impaired Loans and Leases $ 113,617 $ 3,492 $ 117,109 $ 119,541 $ 11,459 December 31, 2018 Recorded Investment With a Recorded Allowance With No Recorded Allowance Total Unpaid Principal Balance Related Allowance Recorded Commercial & Industrial Agriculture $ — $ 7 $ 7 $ 6 $ — Funeral Home & Cemetery — 6 6 6 — Healthcare 9,604 64 9,668 10,432 827 Independent Pharmacies 9,032 324 9,356 10,564 478 Registered Investment Advisors 3,347 — 3,347 3,839 811 Veterinary Industry 2,160 166 2,326 2,593 65 Other Industries 3,496 453 3,949 4,097 417 Total 27,639 1,020 28,659 31,537 2,598 Construction & Development Agriculture 5,027 — 5,027 4,939 118 Total 5,027 — 5,027 4,939 118 Commercial Real Estate Agriculture 1,798 — 1,798 1,732 93 Funeral Home & Cemetery 2,859 284 3,143 3,281 30 Healthcare 20,211 231 20,442 20,461 1,145 Independent Pharmacies 5,184 449 5,633 5,884 220 Veterinary Industry 15,606 109 15,715 16,677 936 Total 45,658 1,073 46,731 48,035 2,424 Commercial Land Agriculture 21,997 — 21,997 22,147 3,951 Total 21,997 — 21,997 22,147 3,951 Total Impaired Loans and Leases $ 100,321 $ 2,093 $ 102,414 $ 106,658 $ 9,091 The following table presents the average recorded investment of impaired loans and leases for each period presented and interest income recognized during the period in which the loans and leases were considered impaired. Three Months Ended June 30, 2019 Three Months Ended June 30, 2018 Average Balance Interest Income Recognized Average Balance Interest Income Recognized Commercial & Industrial Agriculture $ 6 $ — $ — $ — Funeral Home & Cemetery — — 7 — Healthcare 9,280 34 5,094 19 Independent Pharmacies 5,459 5 7,978 7 Registered Investment Advisors 2,083 5 2,818 12 Veterinary Industry 2,394 13 2,930 18 Other Industries 5,904 7 1,373 5 Total 25,126 64 20,200 61 Construction & Development Agriculture — — 2,526 — Healthcare — — 1,799 28 Total — — 4,325 28 Commercial Real Estate Agriculture 2,228 — — — Funeral Home & Cemetery 1,967 — 3,122 27 Healthcare 23,057 259 12,852 64 Independent Pharmacies 7,198 25 2,836 1 Veterinary Industry 13,984 105 16,135 98 Other Industries 9,357 52 — — Total 57,791 441 34,945 190 Commercial Land Agriculture 32,435 280 5,138 25 Total 32,435 280 5,138 25 Total $ 115,352 $ 785 $ 64,608 $ 304 Six Months Ended June 30, 2019 Six Months Ended June 30, 2018 Average Balance Interest Income Recognized Average Balance Interest Income Recognized Commercial & Industrial Agriculture $ 6 $ — $ — $ — Funeral Home & Cemetery — — 7 — Healthcare 9,421 65 5,188 31 Independent Pharmacies 5,385 15 8,038 27 Registered Investment Advisors 2,103 10 2,825 24 Veterinary Industry 2,417 27 2,917 38 Other Industries 5,745 24 1,373 5 Total 25,077 141 20,348 125 Construction & Development Agriculture — — 2,509 5 Healthcare — — 1,579 51 Total — — 4,088 56 Commercial Real Estate Agriculture 2,228 — — — Funeral Home & Cemetery 1,974 2 3,133 64 Healthcare 23,198 487 12,486 80 Independent Pharmacies 6,663 67 2,836 1 Veterinary Industry 14,412 206 16,159 235 Other Industries 9,357 61 — — Total 57,832 823 34,614 380 Commercial Land Agriculture 31,825 518 5,138 25 Total 31,825 518 5,138 25 Total $ 114,734 $ 1,482 $ 64,188 $ 586
Troubled Debt Restructurings on Financing Receivables	The following tables represent the types of TDRs that were made during the periods presented: Six Months Ended June 30, 2019 Six Months Ended June 30, 2018 All Restructurings All Restructurings Number of Loans Pre- modification Recorded Investment Post- modification Recorded Investment Number of Loans Pre- modification Recorded Investment Post- modification Recorded Investment Interest Only Construction and Development Healthcare — $ — $ — 1 $ 612 $ 612 Total Interest Only — — — 1 612 612 Extended Amortization Commercial Land Agriculture 1 3,489 3,489 — — — Total Extend Amortization 1 3,489 3,489 — — — Payment Deferral Commercial & Industrial Healthcare 1 144 144 — — — Commercial Real Estate Healthcare 1 1,853 1,853 — — — Total Payment Deferral 2 1,997 1,997 — — — Total 3 $ 5,486 $ 5,486 1 $ 612 $ 612

Leases (Tables)

Leases (Tables)	6 Months Ended
	Jun. 30, 2019
Leases [Abstract]
Net Lease Investment	The gross lease payments receivable and the net investment included in accounts receivable for such leases are as follows: June 30, 2019 December 31, 2018 Gross direct finance lease payments receivable $ 15,587 $ 12,541 Less – unearned interest (3,063 ) (2,635 ) Net investment in direct financing leases $ 12,524 $ 9,906
Future Minimum Capital Lease Payments	Future minimum lease payments under finance leases are as follows: As of June 30, 2019 Amount 2019 $ 1,544 2020 3,061 2021 3,007 2022 2,744 2023 2,286 Thereafter 2,945 Total $ 15,587
Maturity Analysis of Future Minimum Operating Lease Payments	A maturity analysis of future minimum lease payments under non-cancelable operating leases is as follows: As of June 30, 2019 Amount 2019 $ 3,889 2020 8,883 2021 8,930 2022 8,924 2023 8,956 Thereafter 48,267 Total $ 87,849
Summary of Components of Lease Expense	The components of lease expense are as follows: Three Months Ended June 30, 2019 Six Months Ended June 30, 2019 Operating lease cost $ 169 $ 326 Short-term lease cost 166 375 Finance lease cost: Amortization of right-of-use assets 1 2 Interest expense on lease liabilities — — Sublease income (9 ) (18 ) Total net lease cost $ 327 $ 685
Summary of Consolidated Balance Sheet Related to Finance Leases	Supplemental disclosure for the consolidated balance sheet related to finance leases is as follows: June 30, 2019 Finance lease right-of-use asset $ 16 Finance lease liability 16
Summary of Weighted Average Remaining Lease Term and Weighted Average Discount Rate for Leases	The weighted average remaining lease term and weighted average discount rate for leases are as follows: As of June 30, 2019 Weighted average remaining lease term (years) Operating leases 15.30 Finance lease 3.42 Weighted average discount rate Operating leases 3.50 % Finance lease 3.10 %
Summary of Operating and Finance Lease Liabilities	A maturity analysis of operating and finance lease liabilities is as follows: As of June 30, 2019 Operating Leases Finance Leases 2019 $ 343 $ 3 2020 504 5 2021 297 5 2022 275 4 2023 143 — Thereafter 1,285 — Total lease payments 2,847 17 Less: imputed interest (685 ) (1 ) Total lease liabilities $ 2,162 $ 16

Servicing Assets (Tables)

Servicing Assets (Tables)	6 Months Ended
	Jun. 30, 2019
Transfers And Servicing [Abstract]
Summary of Activity Pertaining to Servicing Rights	The following summarizes the activity pertaining to servicing rights: Three Months Ended June 30, Six Months Ended June 30, 2019 2018 2019 2018 Balance at beginning of period $ 44,324 $ 53,120 $ 47,641 $ 52,298 Additions, net 608 4,202 1,331 9,076 Fair value changes: Due to changes in valuation inputs or assumptions 260 (552 ) (489 ) (553 ) Decay due to increases in principal paydowns or runoff (3,505 ) (4,081 ) (6,796 ) (8,132 ) Balance at end of period $ 41,687 $ 52,689 $ 41,687 $ 52,689

Borrowings (Tables)

Borrowings (Tables)	6 Months Ended
	Jun. 30, 2019
Debt Disclosure [Abstract]
Total Outstanding Short and Long-Term Borrowings	Total outstanding short and long term borrowings consisted of the following: June 30, 2019 December 31, 2018 Short term borrowings On September 18, 2014, the Company entered into a note payable revolving line of credit of $8.1 million with an unaffiliated commercial bank. On April 18, 2017, the Company renewed and increased the revolving line of credit to $25 million. The note was unsecured and accrued interest at Prime minus 0.50% for a term of 24 months. Payments were interest only with all principal and accrued interest due on April 30, 2019. The terms of this loan required the Company to maintain minimum capital, liquidity and Texas ratios. This line of credit was paid in full on August 25, 2017. This line of credit matured on April 30, 2019 and there is no available credit at June 30, 2019. $ — $ — On February 23, 2015, the Company transferred two related party loans to an unaffiliated commercial bank in exchange for $4.7 million. The exchange price equated to the unpaid principal balance plus accrued but uncollected interest at the time of transfer. The terms of the transfer agreement with the unaffiliated commercial bank identified the transaction as a secured borrowing for accounting purposes. One of the loans with an outstanding balance of $1.3 million was paid in full on August 17, 2018. Interest accrues at prime plus 1% with monthly principal and interest payments over a term of 60 months. The interest rate at June 30, 2019 is 6.50%. The maturity date is October 5, 2019. The pledged collateral is classified in other assets with a fair value of $1.3 million at June 30, 2019. The underlying loan carries a risk grade of 3 and is current with no delinquency. 1,345 1,441 On October 20, 2017, the Company entered into a revolving line of credit of $20 million with an unaffiliated commercial bank. On October 2, 2018, the Company renewed the revolving $20 million line of credit. The note is unsecured and accrues interest at LIBOR plus 1.750% for a term of 12 months. Payments are interest only with all principal and accrued interest due on October 18, 2019. The terms of this loan require the Company to maintain minimum capital and debt service coverage ratios. No advances have been made to this line of credit and there is $20 million of available credit at June 30, 2019. — — Total short term borrowings $ 1,345 $ 1,441 June 30, 2019 December 31, 2018 Long term borrowings In October 2017, the Company entered into a capital lease of $19 thousand with an unaffiliated equipment lease company, secured by fitness equipment which is included in other assets on the consolidated balance sheet. Payments are principal and interest due monthly starting December 15, 2017 over a term of 60 months. At the end of the lease term there is a $1.00 bargain purchase option. As of January 1, 2019, this borrowing was revised in accordance with ASU 2016-02. $ 16 $ 16 Total long term borrowings $ 16 $ 16

Fair Value of Financial Instr_2

Fair Value of Financial Instruments (Tables)	6 Months Ended
	Jun. 30, 2019
Fair Value Disclosures [Abstract]
Record Amount of Assets and Liabilities Measured at Fair Value on a Recurring Basis	The tables below present the recorded amount of assets and liabilities measured at fair value on a recurring basis. June 30, 2019 Total Level 1 Level 2 Level 3 Investment securities available-for-sale US treasury securities $ 5,015 $ — $ 5,015 $ — US government agencies 48,905 — 48,905 — Mortgage-backed securities 513,349 — 513,349 — Municipal bonds 1 9,006 — 8,913 93 Servicing assets 2 41,687 — — 41,687 Mutual fund 2,175 — 2,175 — Equity warrant assets 3 720 — — 720 Total assets at fair value $ 620,857 $ — $ 578,357 $ 42,500 December 31, 2018 Total Level 1 Level 2 Level 3 Investment securities available-for-sale US treasury securities $ 4,966 $ — $ 4,966 $ — US government agencies 30,944 — 30,944 — Mortgage-backed securities 343,581 — 343,581 — Municipal bond 1 999 — — 999 Servicing assets 2 47,641 — — 47,641 Mutual fund 2,099 — 2,099 — Equity warrant assets 3 527 — — 527 Total assets at fair value $ 430,757 $ — $ 381,590 $ 49,167 1 During the six months ended June 30, 2019, the Company sold $900 thousand of a municipal bond to a third party and recorded a fair value adjustment loss of $7 thousand. During the three months ended June 30, 2019, the Company recorded no fair value adjustment. 2 See Note 7 for a rollforward of recurring Level 3 fair values for servicing assets. 3 During the six months ended June 30, 2019, the Company recorded net gains on derivative instruments of $193 thousand. During the three months ended June 30, 2019, the Company recorded net losses on derivative instruments of $62 thousand. During the six months ended June 30, 2018, the Company entered into equity warrant assets with a fair value of $399 thousand at the time of issuance. There was no activity for the derivative instruments during the three months ended June 30, 2018.
Recorded Amount of Assets and Liabilities Measured at Fair Value on a Non-Recurring Basis	Non-recurring Fair Value The tables below present the recorded amount of assets and liabilities measured at fair value on a non-recurring basis. June 30, 2019 Total Level 1 Level 2 Level 3 Impaired loans $ 102,158 $ — $ — $ 102,158 Foreclosed assets 6,044 — — 6,044 Total assets at fair value $ 108,202 $ — $ — $ 108,202 December 31, 2018 Total Level 1 Level 2 Level 3 Impaired loans $ 91,230 $ — $ — $ 91,230 Foreclosed assets 1,094 — — 1,094 Total assets at fair value $ 92,324 $ — $ — $ 92,324
Analysis of Level 3 Valuation Techniques	For Level 3 assets and liabilities measured at fair value on a recurring or non-recurring basis as of June 30, 2019 and December 31, 2018 the significant unobservable inputs used in the fair value measurements were as follows: June 30, 2019 Level 3 Assets with Significant Unobservable Inputs Fair Value Valuation Technique Significant Unobservable Inputs Range Municipal bond $ 93 Discounted expected cash flows Discount rate Prepayment speed 4.76% 5.00% Impaired loans $ 102,158 Discounted appraisals Discounted expected cash flows Appraisal adjustments (1) Interest rate & repayment term 0% to 48% Weighted average discount rate 6.77% Foreclosed assets $ 6,044 Discounted appraisals Appraisal adjustments (1) 9% to 37% Equity warrant assets $ 720 Black-Scholes option pricing model Volatility Risk-free interest rate Marketability discount Remaining life 20.90% 2.03% 20.00% 8 - 9 years December 31, 2018 Level 3 Assets with Significant Unobservable Inputs Fair Value Valuation Technique Significant Unobservable Inputs Range Municipal bond $ 999 Discounted expected cash flows Discount rate Prepayment speed 5.14% 5.00% Impaired loans $ 91,230 Discounted appraisals Discounted expected cash flows Appraisal adjustments (1) Interest rate & repayment term 8% to 48% Weighted average discount rate 6.58% Foreclosed assets $ 1,094 Discounted appraisals Appraisal adjustments (1) 9% to 37% Equity warrant assets $ 527 Black-Scholes option pricing model Volatility Risk-free interest rate Marketability discount Remaining life 20.40% 2.69% 20.00% 9 - 10 years (1) Appraisals may be adjusted by management for customized discounting criteria, estimated sales costs, and proprietary qualitative adjustments.
Carrying Amount and Estimated Fair Value of Financial Instruments	The carrying amounts and estimated fair values of the Company’s financial instruments are as follows: June 30, 2019 Carrying Amount Quoted Price In Active Markets for Identical Assets /Liabilities (Level 1) Significant Other Observable Inputs (Level 2) Significant Unobservable Inputs (Level 3) Total Fair Value Financial assets Cash and due from banks $ 115,292 $ 115,292 $ — $ — $ 115,292 Federal funds sold 68,153 68,153 — — 68,153 Certificates of deposit with other banks 7,250 7,604 — — 7,604 Investment securities, available-for-sale 576,275 — 576,182 93 576,275 Loans held for sale 857,837 — — 881,747 881,747 Loans and leases, net of allowance for loan and lease losses 2,187,425 — — 2,182,023 2,182,023 Servicing assets 41,687 — — 41,687 41,687 Accrued interest receivable 19,791 19,791 — — 19,791 Mutual fund 2,175 — 2,175 — 2,175 Equity warrant assets 720 — — 720 720 Financial liabilities Deposits 3,721,597 — 3,734,139 — 3,734,139 Accrued interest payable 1,990 1,990 — — 1,990 Short term borrowings 1,345 — — 1,347 1,347 Long term borrowings 16 — — 16 16 December 31, 2018 Carrying Amount Quoted Price In Active Markets for Identical Assets /Liabilities (Level 1) Significant Other Observable Inputs (Level 2) Significant Unobservable Inputs (Level 3) Total Fair Value Financial assets Cash and due from banks $ 316,823 $ 316,823 $ — $ — $ 316,823 Certificates of deposit with other banks 7,250 7,442 — — 7,442 Investment securities, available-for-sale 380,490 — 379,491 999 380,490 Loans held for sale 687,393 — — 695,154 695,154 Loans and leases, net of allowance for loan and lease losses 1,810,985 — — 1,807,528 1,807,528 Servicing assets 47,641 — — 47,641 47,641 Accrued interest receivable 15,895 15,895 — — 15,895 Mutual fund 2,099 — 2,099 — 2,099 Equity warrant assets 527 — — 527 527 Financial liabilities Deposits 3,149,583 — 3,117,941 — 3,117,941 Accrued interest payable 861 861 — — 861 Short term borrowings 1,441 — — 1,441 1,441 Long term borrowings 16 — — 16 16

Commitments and Contingencies (

Commitments and Contingencies (Tables)	6 Months Ended
	Jun. 30, 2019
Commitments And Contingencies Disclosure [Abstract]
Summary of Commitments	A summary of the Company’s commitments is as follows: June 30, 2019 December 31, 2018 Commitments to extend credit $ 1,641,814 $ 1,435,024 Standby letters of credit 12,285 2,150 Airplane purchase agreement commitments — 10,450 Total unfunded off-balance-sheet credit risk $ 1,654,099 $ 1,447,624

Stock Plans (Tables)

Stock Plans (Tables)	6 Months Ended
	Jun. 30, 2019
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]
Stock Option Activity	Stock option activity under the Plan during the six month periods ended June 30, 2019 and 2018, is summarized below. Shares Weighted Average Exercise Price Weighted Average Remaining Contractual Term Aggregate Intrinsic Value Outstanding at December 31, 2018 2,656,855 $ 11.27 Exercised 30,634 6.16 Forfeited 32,042 9.34 Granted — — Outstanding at June 30, 2019 2,594,179 $ 11.35 5.52 years $ 15,457,477 Exercisable at June 30, 2019 954,353 $ 10.24 5.30 years $ 6,721,334 Shares Weighted Average Exercise Price Weighted Average Remaining Contractual Terms Aggregate Intrinsic Value Outstanding at December 31, 2017 3,058,459 $ 11.30 Exercised 144,671 8.66 Forfeited 134,623 14.11 Granted — — Outstanding at June 30, 2018 2,779,165 $ 11.30 6.54 years $ 53,786,948 Exercisable at June 30, 2018 727,697 $ 9.83 6.27 years $ 15,148,795
Summary of Non-vested Stock Option Activity	The following is a summary of non-vested stock option activity for the Company for the six months ended June 30, 2019 and 2018. Shares Weighted Average Grant Date Fair Value Non-vested at December 31, 2018 1,839,830 $ 4.60 Granted — — Vested (167,962 ) 2.85 Forfeited (32,042 ) 9.34 Non-vested at June 30, 2019 1,639,826 12.00 Shares Weighted Average Grant Date Fair Value Non-vested at December 31, 2017 2,364,999 $ 4.65 Granted — — Vested (178,908 ) 2.95 Forfeited (134,623 ) 6.26 Non-vested at June 30, 2018 2,051,468 4.79
Restricted Stock Unit Activity	RSU stock activity under the Plan during the six months of 201 9 is summarized below. Shares Weighted Average Grant Date Fair Value Non-vested at December 31, 2018 388,187 $ 23.85 Granted 69,621 16.02 Vested (26,714 ) 28.33 Forfeited (4,918 ) 23.96 Non-vested at June 30, 2019 426,176 22.29 Market RSU stock activity under the Plan during the first three months of 2019 is summarized below. Shares Weighted Average Grant Date Fair Value Non-vested at December 31, 2018 2,709,202 $ 9.87 Granted 500,000 8.81 Vested — — Forfeited (22,347 ) 9.28 Non-vested at June 30, 2019 3,186,855 8.45

Basis of Presentation - Narrati

Basis of Presentation - Narrative (Details) - USD ($) $ in Thousands	Jan. 01, 2019	Jun. 30, 2019
Schedule Of Equity Method Investments [Line Items]
Operating lease right-of-use assets		$ 1,996
Operating lease liabilities		2,162
Right-of-use assets		16
Financing lease obligations		$ 16
Accounting Standards Update 2016-02 [Member]
Schedule Of Equity Method Investments [Line Items]
Operating lease right-of-use assets	$ 2,200
Operating lease liabilities	2,400
Cumulative effect adjustment to retained earnings	(66)
Right-of-use assets	18
Financing lease obligations	$ 18

Earnings Per Share - Computatio

Earnings Per Share - Computation of Basic and Diluted Earnings Per Share (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2019	Jun. 30, 2018	Jun. 30, 2019	Jun. 30, 2018
Basic earnings per share:
Net income available to common shareholders	$ 4,935	$ 14,253	$ 7,307	$ 26,706
Weighted-average basic shares outstanding	40,196,662	40,027,336	40,178,491	39,977,336
Basic earnings per share	$ 0.12	$ 0.36	$ 0.18	$ 0.67
Diluted earnings per share:
Net income available to common shareholders, for diluted earnings per share	$ 4,935	$ 14,253	$ 7,307	$ 26,706
Weighted-average basic shares outstanding	40,196,662	40,027,336	40,178,491	39,977,336
Add effect of dilutive stock options and restricted stock grants	801,879	1,592,311	801,879	1,538,997
Total weighted-average diluted shares outstanding	40,998,541	41,619,647	40,980,370	41,516,333
Diluted earnings per share	$ 0.12	$ 0.34	$ 0.18	$ 0.64
Anti-dilutive shares	1,578,197		1,578,197	9,102

Investment Securities - Carryin

Investment Securities - Carrying Amount and Fair Value of Investment Securities (Details) - USD ($) $ in Thousands	Jun. 30, 2019	Dec. 31, 2018
Schedule Of Available For Sale Securities [Line Items]
Amortized Cost	$ 559,332	$ 382,696
Unrealized Gains	17,620	1,388
Unrealized Losses	677	3,594
Investment securities available-for-sale	576,275	380,490
US Treasury Securities
Schedule Of Available For Sale Securities [Line Items]
Amortized Cost	4,979	4,969
Unrealized Gains	36
Unrealized Losses		3
Investment securities available-for-sale	5,015	4,966
US government agencies
Schedule Of Available For Sale Securities [Line Items]
Amortized Cost	48,303	31,121
Unrealized Gains	613	48
Unrealized Losses	11	225
Investment securities available-for-sale	48,905	30,944
Mortgage-backed securities
Schedule Of Available For Sale Securities [Line Items]
Amortized Cost	497,529	345,606
Unrealized Gains	16,479	1,340
Unrealized Losses	659	3,365
Investment securities available-for-sale	513,349	343,581
Municipal bonds
Schedule Of Available For Sale Securities [Line Items]
Amortized Cost	8,521	1,000
Unrealized Gains	492
Unrealized Losses	7	1
Investment securities available-for-sale	$ 9,006	$ 999

Investment Securities - Narrati

Investment Securities - Narrative (Details) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2019Security	Jun. 30, 2018Security	Jun. 30, 2019USD ($)Security	Jun. 30, 2018Security	Dec. 31, 2018USD ($)Security
Schedule Of Available For Sale Securities [Line Items]
Number of municipal bond sold	0	0		0
Gain on sale of investment securities available-for-sale | $			$ 5
Other than temporary impairment losses | $			$ 0
Collateral Pledged | Ohio State Treasurer
Schedule Of Available For Sale Securities [Line Items]
Debt securities, available-for-sale, restricted | $					$ 100
Collateral Pledged | Trust Department
Schedule Of Available For Sale Securities [Line Items]
Debt securities, available-for-sale, restricted | $					$ 2,500
Mortgage-backed securities
Schedule Of Available For Sale Securities [Line Items]
Number of securities in unrealized loss portions for longer than 12 months	25		25		31
Number of securities in unrealized loss positions for less than 12 months					25
US government agencies
Schedule Of Available For Sale Securities [Line Items]
Number of securities in unrealized loss portions for longer than 12 months	3		3		6
Municipal bonds
Schedule Of Available For Sale Securities [Line Items]
Number of securities in unrealized loss positions for less than 12 months	1		1		1
US Treasury Securities
Schedule Of Available For Sale Securities [Line Items]
Number of securities in unrealized loss positions for less than 12 months					1
Municipal bonds
Schedule Of Available For Sale Securities [Line Items]
Number of municipal bond sold			1
Proceeds from sale of municipal bond | $			$ 900
Gain on sale of investment securities available-for-sale | $			$ 5

Investment Securities - Gross U

Investment Securities - Gross Unrealized Losses and Fair Value of Securities in a Continuous Unrealized Loss Position (Details) - USD ($) $ in Thousands	Jun. 30, 2019	Dec. 31, 2018
Schedule Of Available For Sale Securities [Line Items]
Securities in unrealized loss position, Less Than 12 Months, Fair Value	$ 93	$ 170,801
Securities in unrealized loss position, Less Than 12 Months, Unrealized Losses	7	1,181
Securities in unrealized loss position, 12 Months or More, Fair Value	51,038	67,639
Securities in unrealized loss position, 12 Months or More, Unrealized Losses	670	2,413
Securities in unrealized loss position, Total, Fair Value	51,131	238,440
Securities in unrealized loss position, Total, Unrealized Losses	677	3,594
US Treasury Securities
Schedule Of Available For Sale Securities [Line Items]
Securities in unrealized loss position, Less Than 12 Months, Fair Value		4,966
Securities in unrealized loss position, Less Than 12 Months, Unrealized Losses		3
Securities in unrealized loss position, Total, Fair Value		4,966
Securities in unrealized loss position, Total, Unrealized Losses		3
US government agencies
Schedule Of Available For Sale Securities [Line Items]
Securities in unrealized loss position, 12 Months or More, Fair Value	6,471	16,268
Securities in unrealized loss position, 12 Months or More, Unrealized Losses	11	225
Securities in unrealized loss position, Total, Fair Value	6,471	16,268
Securities in unrealized loss position, Total, Unrealized Losses	11	225
Mortgage-backed securities
Schedule Of Available For Sale Securities [Line Items]
Securities in unrealized loss position, Less Than 12 Months, Fair Value		164,836
Securities in unrealized loss position, Less Than 12 Months, Unrealized Losses		1,177
Securities in unrealized loss position, 12 Months or More, Fair Value	44,567	51,371
Securities in unrealized loss position, 12 Months or More, Unrealized Losses	659	2,188
Securities in unrealized loss position, Total, Fair Value	44,567	216,207
Securities in unrealized loss position, Total, Unrealized Losses	659	3,365
Municipal bonds
Schedule Of Available For Sale Securities [Line Items]
Securities in unrealized loss position, Less Than 12 Months, Fair Value	93	999
Securities in unrealized loss position, Less Than 12 Months, Unrealized Losses	7	1
Securities in unrealized loss position, Total, Fair Value	93	999
Securities in unrealized loss position, Total, Unrealized Losses	$ 7	$ 1

Investment Securities - Summary

Investment Securities - Summary of Investment Securities by Maturity (Details) - USD ($) $ in Thousands	Jun. 30, 2019	Dec. 31, 2018
Debt Securities, Available-for-sale, Maturity, Amortized Cost, Rolling Maturity [Abstract]
Amortized Cost	$ 559,332	$ 382,696
Debt Securities, Available-for-sale, Maturity, Fair Value, Rolling Maturity [Abstract]
Total, Fair value	576,275	380,490
US Treasury Securities
Debt Securities, Available-for-sale, Maturity, Amortized Cost, Rolling Maturity [Abstract]
One to five years, Amortized cost	4,979
Amortized Cost	4,979	4,969
Debt Securities, Available-for-sale, Maturity, Fair Value, Rolling Maturity [Abstract]
One to five years, Fair value	5,015
Total, Fair value	5,015	4,966
US government agencies
Debt Securities, Available-for-sale, Maturity, Amortized Cost, Rolling Maturity [Abstract]
Within one year, Amortized cost	6,483
One to five years, Amortized cost	29,909
Five to ten years, Amortized cost	11,911
Amortized Cost	48,303	31,121
Debt Securities, Available-for-sale, Maturity, Fair Value, Rolling Maturity [Abstract]
Within one year, Fair value	6,471
One to five years, Fair value	30,345
Five to ten years, Fair value	12,089
Total, Fair value	48,905	30,944
Mortgage-backed securities
Debt Securities, Available-for-sale, Maturity, Amortized Cost, Rolling Maturity [Abstract]
One to five years, Amortized cost	2,743
Five to ten years, Amortized cost	150,463
After 10 years, Amortized cost	344,323
Amortized Cost	497,529	345,606
Debt Securities, Available-for-sale, Maturity, Fair Value, Rolling Maturity [Abstract]
One to five years, Fair value	2,760
Five to ten years, Fair value	156,698
After 10 years, Fair value	353,891
Total, Fair value	513,349	343,581
Municipal bonds
Debt Securities, Available-for-sale, Maturity, Amortized Cost, Rolling Maturity [Abstract]
After 10 years, Amortized cost	8,521
Amortized Cost	8,521	1,000
Debt Securities, Available-for-sale, Maturity, Fair Value, Rolling Maturity [Abstract]
After 10 years, Fair value	9,006
Total, Fair value	$ 9,006	$ 999

Loans and Leases Held for Inv_3

Loans and Leases Held for Investment and Allowance for Loan and Lease Losses - Composition of Loans and Leases (Details) - USD ($) $ in Thousands	Jun. 30, 2019	Dec. 31, 2018
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans and Leases	$ 2,225,497	$ 1,850,480
Net Deferred Costs	9,767	5,960
Discount on SBA 7(a) Unguaranteed	(9,791)	(13,021)
Loans, Net of Unearned	2,225,473	1,843,419
Commercial & Industrial
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans and Leases	729,921	618,748
Construction & Development
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans and Leases	324,732	248,904
Commercial Real Estate
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans and Leases	882,377	739,030
Commercial Land
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans and Leases	288,467	243,798
Agriculture | Commercial & Industrial
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans and Leases	6,305	6,400
Agriculture | Construction & Development
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans and Leases	40,258	43,454
Agriculture | Commercial Real Estate
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans and Leases	49,532	53,085
Agriculture | Commercial Land
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans and Leases	288,467	243,798
Funeral Home & Cemetery | Commercial & Industrial
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans and Leases	22,709	17,378
Funeral Home & Cemetery | Construction & Development
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans and Leases	10,840	9,874
Funeral Home & Cemetery | Commercial Real Estate
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans and Leases	86,830	71,344
Healthcare | Commercial & Industrial
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans and Leases	46,344	51,082
Healthcare | Construction & Development
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans and Leases	92,296	81,619
Healthcare | Commercial Real Estate
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans and Leases	221,195	188,531
Independent Pharmacies | Commercial & Industrial
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans and Leases	110,956	108,783
Independent Pharmacies | Construction & Development
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans and Leases	1,193	2,149
Independent Pharmacies | Commercial Real Estate
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans and Leases	26,877	20,597
Registered Investment Advisors | Commercial & Industrial
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans and Leases	92,901	94,338
Registered Investment Advisors | Construction & Development
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans and Leases	2,138	1,232
Registered Investment Advisors | Commercial Real Estate
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans and Leases	8,152	7,905
Veterinary Industry | Commercial & Industrial
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans and Leases	47,744	45,604
Veterinary Industry | Construction & Development
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans and Leases	22,694	14,094
Veterinary Industry | Commercial Real Estate
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans and Leases	135,470	136,721
Other Industries | Commercial & Industrial
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans and Leases	402,962	295,163
Other Industries | Construction & Development
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans and Leases	155,313	96,482
Other Industries | Commercial Real Estate
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans and Leases	$ 354,321	$ 260,847

Loans and Leases Held for Inv_4

Loans and Leases Held for Investment and Allowance for Loan and Lease Losses - Composition of Loans and Leases (Parenthetical) (Details) - USD ($) $ in Thousands	Jun. 30, 2019	Dec. 31, 2018
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans and Leases	$ 2,225,497	$ 1,850,480
Loans Insured or Guaranteed by US Government Authorities
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans and Leases	$ 498,800	$ 305,400

Loans and Leases Held for Inv_5

Loans and Leases Held for Investment and Allowance for Loan and Lease Losses - Summary of Risk Grades of Each Category of Loans (Details) - USD ($) $ in Thousands	Jun. 30, 2019	Dec. 31, 2018
Financing Receivable, Recorded Investment [Line Items]
Total loans and leases	$ 2,225,497	$ 1,850,480
Commercial & Industrial
Financing Receivable, Recorded Investment [Line Items]
Total loans and leases	729,921	618,748
Construction & Development
Financing Receivable, Recorded Investment [Line Items]
Total loans and leases	324,732	248,904
Commercial Real Estate
Financing Receivable, Recorded Investment [Line Items]
Total loans and leases	882,377	739,030
Commercial Land
Financing Receivable, Recorded Investment [Line Items]
Total loans and leases	288,467	243,798
Healthcare | Commercial & Industrial
Financing Receivable, Recorded Investment [Line Items]
Total loans and leases	46,344	51,082
Healthcare | Construction & Development
Financing Receivable, Recorded Investment [Line Items]
Total loans and leases	92,296	81,619
Healthcare | Commercial Real Estate
Financing Receivable, Recorded Investment [Line Items]
Total loans and leases	221,195	188,531
Risk Grades 1 - 4
Financing Receivable, Recorded Investment [Line Items]
Total loans and leases	2,046,709	1,702,491
Risk Grades 1 - 4 | Commercial & Industrial
Financing Receivable, Recorded Investment [Line Items]
Total loans and leases	676,008	559,716
Risk Grades 1 - 4 | Construction & Development
Financing Receivable, Recorded Investment [Line Items]
Total loans and leases	308,124	247,099
Risk Grades 1 - 4 | Commercial Real Estate
Financing Receivable, Recorded Investment [Line Items]
Total loans and leases	798,616	671,850
Risk Grades 1 - 4 | Commercial Land
Financing Receivable, Recorded Investment [Line Items]
Total loans and leases	263,961	223,826
Risk Grades 1 - 4 | Healthcare | Commercial & Industrial
Financing Receivable, Recorded Investment [Line Items]
Total loans and leases	34,936	38,908
Risk Grades 1 - 4 | Healthcare | Construction & Development
Financing Receivable, Recorded Investment [Line Items]
Total loans and leases	88,885	79,814
Risk Grades 1 - 4 | Healthcare | Commercial Real Estate
Financing Receivable, Recorded Investment [Line Items]
Total loans and leases	191,816	161,026
Risk Grade 5
Financing Receivable, Recorded Investment [Line Items]
Total loans and leases	86,981	65,484
Risk Grade 5 | Commercial & Industrial
Financing Receivable, Recorded Investment [Line Items]
Total loans and leases	30,336	30,770
Risk Grade 5 | Construction & Development
Financing Receivable, Recorded Investment [Line Items]
Total loans and leases	16,608	1,805
Risk Grade 5 | Commercial Real Estate
Financing Receivable, Recorded Investment [Line Items]
Total loans and leases	29,288	23,995
Risk Grade 5 | Commercial Land
Financing Receivable, Recorded Investment [Line Items]
Total loans and leases	10,749	8,914
Risk Grade 5 | Healthcare | Commercial & Industrial
Financing Receivable, Recorded Investment [Line Items]
Total loans and leases	2,888	2,502
Risk Grade 5 | Healthcare | Construction & Development
Financing Receivable, Recorded Investment [Line Items]
Total loans and leases	3,411	1,805
Risk Grade 5 | Healthcare | Commercial Real Estate
Financing Receivable, Recorded Investment [Line Items]
Total loans and leases	8,377	7,696
Risk Grades 6 - 8
Financing Receivable, Recorded Investment [Line Items]
Total loans and leases	91,807	82,505
Risk Grades 6 - 8 | Commercial & Industrial
Financing Receivable, Recorded Investment [Line Items]
Total loans and leases	23,577	28,262
Risk Grades 6 - 8 | Commercial Real Estate
Financing Receivable, Recorded Investment [Line Items]
Total loans and leases	54,473	43,185
Risk Grades 6 - 8 | Commercial Land
Financing Receivable, Recorded Investment [Line Items]
Total loans and leases	13,757	11,058
Risk Grades 6 - 8 | Healthcare | Commercial & Industrial
Financing Receivable, Recorded Investment [Line Items]
Total loans and leases	8,520	9,672
Risk Grades 6 - 8 | Healthcare | Commercial Real Estate
Financing Receivable, Recorded Investment [Line Items]
Total loans and leases	21,002	19,809
Agricultural | Commercial & Industrial
Financing Receivable, Recorded Investment [Line Items]
Total loans and leases	6,305	6,400
Agricultural | Construction & Development
Financing Receivable, Recorded Investment [Line Items]
Total loans and leases	40,258	43,454
Agricultural | Commercial Real Estate
Financing Receivable, Recorded Investment [Line Items]
Total loans and leases	49,532	53,085
Agricultural | Commercial Land
Financing Receivable, Recorded Investment [Line Items]
Total loans and leases	288,467	243,798
Agricultural | Risk Grades 1 - 4 | Commercial & Industrial
Financing Receivable, Recorded Investment [Line Items]
Total loans and leases	5,760	6,187
Agricultural | Risk Grades 1 - 4 | Construction & Development
Financing Receivable, Recorded Investment [Line Items]
Total loans and leases	40,258	43,454
Agricultural | Risk Grades 1 - 4 | Commercial Real Estate
Financing Receivable, Recorded Investment [Line Items]
Total loans and leases	46,841	52,518
Agricultural | Risk Grades 1 - 4 | Commercial Land
Financing Receivable, Recorded Investment [Line Items]
Total loans and leases	263,961	223,826
Agricultural | Risk Grade 5 | Commercial & Industrial
Financing Receivable, Recorded Investment [Line Items]
Total loans and leases	545	213
Agricultural | Risk Grade 5 | Commercial Real Estate
Financing Receivable, Recorded Investment [Line Items]
Total loans and leases	466	567
Agricultural | Risk Grade 5 | Commercial Land
Financing Receivable, Recorded Investment [Line Items]
Total loans and leases	10,749	8,914
Agricultural | Risk Grades 6 - 8 | Commercial Real Estate
Financing Receivable, Recorded Investment [Line Items]
Total loans and leases	2,225
Agricultural | Risk Grades 6 - 8 | Commercial Land
Financing Receivable, Recorded Investment [Line Items]
Total loans and leases	13,757	11,058
Funeral Home & Cemetery | Commercial & Industrial
Financing Receivable, Recorded Investment [Line Items]
Total loans and leases	22,709	17,378
Funeral Home & Cemetery | Construction & Development
Financing Receivable, Recorded Investment [Line Items]
Total loans and leases	10,840	9,874
Funeral Home & Cemetery | Commercial Real Estate
Financing Receivable, Recorded Investment [Line Items]
Total loans and leases	86,830	71,344
Funeral Home & Cemetery | Risk Grades 1 - 4 | Commercial & Industrial
Financing Receivable, Recorded Investment [Line Items]
Total loans and leases	20,811	17,085
Funeral Home & Cemetery | Risk Grades 1 - 4 | Construction & Development
Financing Receivable, Recorded Investment [Line Items]
Total loans and leases	10,840	9,874
Funeral Home & Cemetery | Risk Grades 1 - 4 | Commercial Real Estate
Financing Receivable, Recorded Investment [Line Items]
Total loans and leases	79,149	64,487
Funeral Home & Cemetery | Risk Grade 5 | Commercial & Industrial
Financing Receivable, Recorded Investment [Line Items]
Total loans and leases	1,898	287
Funeral Home & Cemetery | Risk Grade 5 | Commercial Real Estate
Financing Receivable, Recorded Investment [Line Items]
Total loans and leases	5,720	3,711
Funeral Home & Cemetery | Risk Grades 6 - 8 | Commercial & Industrial
Financing Receivable, Recorded Investment [Line Items]
Total loans and leases		6
Funeral Home & Cemetery | Risk Grades 6 - 8 | Commercial Real Estate
Financing Receivable, Recorded Investment [Line Items]
Total loans and leases	1,961	3,146
Independent Pharmacies | Commercial & Industrial
Financing Receivable, Recorded Investment [Line Items]
Total loans and leases	110,956	108,783
Independent Pharmacies | Construction & Development
Financing Receivable, Recorded Investment [Line Items]
Total loans and leases	1,193	2,149
Independent Pharmacies | Commercial Real Estate
Financing Receivable, Recorded Investment [Line Items]
Total loans and leases	26,877	20,597
Independent Pharmacies | Risk Grades 1 - 4 | Commercial & Industrial
Financing Receivable, Recorded Investment [Line Items]
Total loans and leases	99,284	93,976
Independent Pharmacies | Risk Grades 1 - 4 | Construction & Development
Financing Receivable, Recorded Investment [Line Items]
Total loans and leases	1,193	2,149
Independent Pharmacies | Risk Grades 1 - 4 | Commercial Real Estate
Financing Receivable, Recorded Investment [Line Items]
Total loans and leases	17,303	12,509
Independent Pharmacies | Risk Grade 5 | Commercial & Industrial
Financing Receivable, Recorded Investment [Line Items]
Total loans and leases	6,502	5,734
Independent Pharmacies | Risk Grade 5 | Commercial Real Estate
Financing Receivable, Recorded Investment [Line Items]
Total loans and leases	2,411	2,495
Independent Pharmacies | Risk Grades 6 - 8 | Commercial & Industrial
Financing Receivable, Recorded Investment [Line Items]
Total loans and leases	5,170	9,073
Independent Pharmacies | Risk Grades 6 - 8 | Commercial Real Estate
Financing Receivable, Recorded Investment [Line Items]
Total loans and leases	7,163	5,593
Registered Investment Advisors | Commercial & Industrial
Financing Receivable, Recorded Investment [Line Items]
Total loans and leases	92,901	94,338
Registered Investment Advisors | Construction & Development
Financing Receivable, Recorded Investment [Line Items]
Total loans and leases	2,138	1,232
Registered Investment Advisors | Commercial Real Estate
Financing Receivable, Recorded Investment [Line Items]
Total loans and leases	8,152	7,905
Registered Investment Advisors | Risk Grades 1 - 4 | Commercial & Industrial
Financing Receivable, Recorded Investment [Line Items]
Total loans and leases	88,782	88,614
Registered Investment Advisors | Risk Grades 1 - 4 | Construction & Development
Financing Receivable, Recorded Investment [Line Items]
Total loans and leases	2,138	1,232
Registered Investment Advisors | Risk Grades 1 - 4 | Commercial Real Estate
Financing Receivable, Recorded Investment [Line Items]
Total loans and leases	8,114	7,780
Registered Investment Advisors | Risk Grade 5 | Commercial & Industrial
Financing Receivable, Recorded Investment [Line Items]
Total loans and leases	2,050	2,381
Registered Investment Advisors | Risk Grade 5 | Commercial Real Estate
Financing Receivable, Recorded Investment [Line Items]
Total loans and leases	38	125
Registered Investment Advisors | Risk Grades 6 - 8 | Commercial & Industrial
Financing Receivable, Recorded Investment [Line Items]
Total loans and leases	2,069	3,343
Veterinary Industry | Commercial & Industrial
Financing Receivable, Recorded Investment [Line Items]
Total loans and leases	47,744	45,604
Veterinary Industry | Construction & Development
Financing Receivable, Recorded Investment [Line Items]
Total loans and leases	22,694	14,094
Veterinary Industry | Commercial Real Estate
Financing Receivable, Recorded Investment [Line Items]
Total loans and leases	135,470	136,721
Veterinary Industry | Risk Grades 1 - 4 | Commercial & Industrial
Financing Receivable, Recorded Investment [Line Items]
Total loans and leases	44,419	42,175
Veterinary Industry | Risk Grades 1 - 4 | Construction & Development
Financing Receivable, Recorded Investment [Line Items]
Total loans and leases	22,694	14,094
Veterinary Industry | Risk Grades 1 - 4 | Commercial Real Estate
Financing Receivable, Recorded Investment [Line Items]
Total loans and leases	119,320	117,879
Veterinary Industry | Risk Grade 5 | Commercial & Industrial
Financing Receivable, Recorded Investment [Line Items]
Total loans and leases	1,016	1,190
Veterinary Industry | Risk Grade 5 | Commercial Real Estate
Financing Receivable, Recorded Investment [Line Items]
Total loans and leases	3,362	4,205
Veterinary Industry | Risk Grades 6 - 8 | Commercial & Industrial
Financing Receivable, Recorded Investment [Line Items]
Total loans and leases	2,309	2,239
Veterinary Industry | Risk Grades 6 - 8 | Commercial Real Estate
Financing Receivable, Recorded Investment [Line Items]
Total loans and leases	12,788	14,637
Other Industries | Commercial & Industrial
Financing Receivable, Recorded Investment [Line Items]
Total loans and leases	402,962	295,163
Other Industries | Construction & Development
Financing Receivable, Recorded Investment [Line Items]
Total loans and leases	155,313	96,482
Other Industries | Commercial Real Estate
Financing Receivable, Recorded Investment [Line Items]
Total loans and leases	354,321	260,847
Other Industries | Risk Grades 1 - 4 | Commercial & Industrial
Financing Receivable, Recorded Investment [Line Items]
Total loans and leases	382,016	272,771
Other Industries | Risk Grades 1 - 4 | Construction & Development
Financing Receivable, Recorded Investment [Line Items]
Total loans and leases	142,116	96,482
Other Industries | Risk Grades 1 - 4 | Commercial Real Estate
Financing Receivable, Recorded Investment [Line Items]
Total loans and leases	336,073	255,651
Other Industries | Risk Grade 5 | Commercial & Industrial
Financing Receivable, Recorded Investment [Line Items]
Total loans and leases	15,437	18,463
Other Industries | Risk Grade 5 | Construction & Development
Financing Receivable, Recorded Investment [Line Items]
Total loans and leases	13,197
Other Industries | Risk Grade 5 | Commercial Real Estate
Financing Receivable, Recorded Investment [Line Items]
Total loans and leases	8,914	5,196
Other Industries | Risk Grades 6 - 8 | Commercial & Industrial
Financing Receivable, Recorded Investment [Line Items]
Total loans and leases	5,509	$ 3,929
Other Industries | Risk Grades 6 - 8 | Commercial Real Estate
Financing Receivable, Recorded Investment [Line Items]
Total loans and leases	$ 9,334

Loans and Leases Held for Inv_6

Loans and Leases Held for Investment and Allowance for Loan and Lease Losses - Summary of Risk Grades of Each Category of Loans (Parenthetical) (Details) - USD ($) $ in Thousands	Jun. 30, 2019	Dec. 31, 2018
Financing Receivable, Recorded Investment [Line Items]
Total loans and leases	$ 2,225,497	$ 1,850,480
Risk Grades 1 - 4
Financing Receivable, Recorded Investment [Line Items]
Total loans and leases	2,046,709	1,702,491
Risk Grade 5
Financing Receivable, Recorded Investment [Line Items]
Total loans and leases	86,981	65,484
Risk Grades 6 - 8
Financing Receivable, Recorded Investment [Line Items]
Total loans and leases	91,807	82,505
Loans Insured or Guaranteed by US Government Authorities
Financing Receivable, Recorded Investment [Line Items]
Total loans and leases	498,800	305,400
Loans Insured or Guaranteed by US Government Authorities | Risk Grades 1 - 4
Financing Receivable, Recorded Investment [Line Items]
Total loans and leases	410,800	236,100
Loans Insured or Guaranteed by US Government Authorities | Risk Grade 5
Financing Receivable, Recorded Investment [Line Items]
Total loans and leases	24,600	10,100
Loans Insured or Guaranteed by US Government Authorities | Risk Grades 6 - 8
Financing Receivable, Recorded Investment [Line Items]
Total loans and leases	$ 63,400	$ 59,200

Loans and Leases Held for Inv_7

Loans and Leases Held for Investment and Allowance for Loan and Lease Losses - Age Analysis of Past Due Loans and Leases (Details) - USD ($) $ in Thousands	Jun. 30, 2019	Dec. 31, 2018
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Not Accruing & Past Due	$ 68,413	$ 78,712
Current	2,157,084	1,771,768
Total loans and leases receivable	2,225,497	1,850,480
Less Than 30 Days Past Due & Not Accruing
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Not Accruing & Past Due	13,445	12,320
30-89 Days Past Due & Accruing
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Not Accruing & Past Due	2,940	21,022
30-89 Days Past Due & Not Accruing
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Not Accruing & Past Due	11,424	4,484
Greater Than 90 Days Past Due
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Not Accruing & Past Due	40,604	40,886
Commercial & Industrial
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Not Accruing & Past Due	22,314	25,690
Current	707,607	593,058
Total loans and leases receivable	729,921	618,748
Commercial & Industrial | Less Than 30 Days Past Due & Not Accruing
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Not Accruing & Past Due	2,664	4,109
Commercial & Industrial | 30-89 Days Past Due & Accruing
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Not Accruing & Past Due	1,192	1,454
Commercial & Industrial | 30-89 Days Past Due & Not Accruing
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Not Accruing & Past Due	4,402	1,585
Commercial & Industrial | Greater Than 90 Days Past Due
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Not Accruing & Past Due	14,056	18,542
Commercial & Industrial | Agriculture
Financing Receivable, Recorded Investment, Past Due [Line Items]
Current	6,305	6,400
Total loans and leases receivable	6,305	6,400
Commercial & Industrial | Funeral Home & Cemetery
Financing Receivable, Recorded Investment, Past Due [Line Items]
Current	22,709	17,378
Total loans and leases receivable	22,709	17,378
Commercial & Industrial | Healthcare
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Not Accruing & Past Due	7,027	8,554
Current	39,317	42,528
Total loans and leases receivable	46,344	51,082
Commercial & Industrial | Healthcare | Less Than 30 Days Past Due & Not Accruing
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Not Accruing & Past Due	906	41
Commercial & Industrial | Healthcare | 30-89 Days Past Due & Accruing
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Not Accruing & Past Due		1,027
Commercial & Industrial | Healthcare | 30-89 Days Past Due & Not Accruing
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Not Accruing & Past Due	623	665
Commercial & Industrial | Healthcare | Greater Than 90 Days Past Due
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Not Accruing & Past Due	5,498	6,821
Commercial & Industrial | Independent Pharmacies
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Not Accruing & Past Due	5,170	8,998
Current	105,786	99,785
Total loans and leases receivable	110,956	108,783
Commercial & Industrial | Independent Pharmacies | Less Than 30 Days Past Due & Not Accruing
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Not Accruing & Past Due		1,399
Commercial & Industrial | Independent Pharmacies | 30-89 Days Past Due & Accruing
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Not Accruing & Past Due		29
Commercial & Industrial | Independent Pharmacies | Greater Than 90 Days Past Due
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Not Accruing & Past Due	5,170	7,570
Commercial & Industrial | Registered Investment Advisors
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Not Accruing & Past Due	1,809	3,293
Current	91,092	91,045
Total loans and leases receivable	92,901	94,338
Commercial & Industrial | Registered Investment Advisors | Less Than 30 Days Past Due & Not Accruing
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Not Accruing & Past Due	1,201
Commercial & Industrial | Registered Investment Advisors | 30-89 Days Past Due & Accruing
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Not Accruing & Past Due		232
Commercial & Industrial | Registered Investment Advisors | 30-89 Days Past Due & Not Accruing
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Not Accruing & Past Due	399	320
Commercial & Industrial | Registered Investment Advisors | Greater Than 90 Days Past Due
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Not Accruing & Past Due	209	2,741
Commercial & Industrial | Veterinary Industry
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Not Accruing & Past Due	1,607	1,506
Current	46,137	44,098
Total loans and leases receivable	47,744	45,604
Commercial & Industrial | Veterinary Industry | 30-89 Days Past Due & Not Accruing
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Not Accruing & Past Due	576	600
Commercial & Industrial | Veterinary Industry | Greater Than 90 Days Past Due
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Not Accruing & Past Due	1,031	906
Commercial & Industrial | Other Industries
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Not Accruing & Past Due	6,701	3,339
Current	396,261	291,824
Total loans and leases receivable	402,962	295,163
Commercial & Industrial | Other Industries | Less Than 30 Days Past Due & Not Accruing
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Not Accruing & Past Due	557	2,669
Commercial & Industrial | Other Industries | 30-89 Days Past Due & Accruing
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Not Accruing & Past Due	1,192	166
Commercial & Industrial | Other Industries | 30-89 Days Past Due & Not Accruing
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Not Accruing & Past Due	2,804
Commercial & Industrial | Other Industries | Greater Than 90 Days Past Due
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Not Accruing & Past Due	2,148	504
Construction & Development
Financing Receivable, Recorded Investment, Past Due [Line Items]
Current	324,732	248,904
Total loans and leases receivable	324,732	248,904
Construction & Development | Agriculture
Financing Receivable, Recorded Investment, Past Due [Line Items]
Current	40,258	43,454
Total loans and leases receivable	40,258	43,454
Construction & Development | Funeral Home & Cemetery
Financing Receivable, Recorded Investment, Past Due [Line Items]
Current	10,840	9,874
Total loans and leases receivable	10,840	9,874
Construction & Development | Healthcare
Financing Receivable, Recorded Investment, Past Due [Line Items]
Current	92,296	81,619
Total loans and leases receivable	92,296	81,619
Construction & Development | Independent Pharmacies
Financing Receivable, Recorded Investment, Past Due [Line Items]
Current	1,193	2,149
Total loans and leases receivable	1,193	2,149
Construction & Development | Registered Investment Advisors
Financing Receivable, Recorded Investment, Past Due [Line Items]
Current	2,138	1,232
Total loans and leases receivable	2,138	1,232
Construction & Development | Veterinary Industry
Financing Receivable, Recorded Investment, Past Due [Line Items]
Current	22,694	14,094
Total loans and leases receivable	22,694	14,094
Construction & Development | Other Industries
Financing Receivable, Recorded Investment, Past Due [Line Items]
Current	155,313	96,482
Total loans and leases receivable	155,313	96,482
Commercial Real Estate
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Not Accruing & Past Due	32,035	41,964
Current	850,342	697,066
Total loans and leases receivable	882,377	739,030
Commercial Real Estate | Less Than 30 Days Past Due & Not Accruing
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Not Accruing & Past Due	771	1,934
Commercial Real Estate | 30-89 Days Past Due & Accruing
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Not Accruing & Past Due	1,034	19,568
Commercial Real Estate | 30-89 Days Past Due & Not Accruing
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Not Accruing & Past Due	3,682	2,899
Commercial Real Estate | Greater Than 90 Days Past Due
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Not Accruing & Past Due	26,548	17,563
Commercial Real Estate | Agriculture
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Not Accruing & Past Due	2,226
Current	47,306	53,085
Total loans and leases receivable	49,532	53,085
Commercial Real Estate | Agriculture | Greater Than 90 Days Past Due
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Not Accruing & Past Due	2,226
Commercial Real Estate | Funeral Home & Cemetery
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Not Accruing & Past Due	1,961	3,010
Current	84,869	68,334
Total loans and leases receivable	86,830	71,344
Commercial Real Estate | Funeral Home & Cemetery | Less Than 30 Days Past Due & Not Accruing
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Not Accruing & Past Due	137	248
Commercial Real Estate | Funeral Home & Cemetery | Greater Than 90 Days Past Due
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Not Accruing & Past Due	1,824	2,762
Commercial Real Estate | Healthcare
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Not Accruing & Past Due	8,110	9,127
Current	213,085	179,404
Total loans and leases receivable	221,195	188,531
Commercial Real Estate | Healthcare | Less Than 30 Days Past Due & Not Accruing
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Not Accruing & Past Due		42
Commercial Real Estate | Healthcare | 30-89 Days Past Due & Accruing
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Not Accruing & Past Due	1,034	1,668
Commercial Real Estate | Healthcare | Greater Than 90 Days Past Due
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Not Accruing & Past Due	7,076	7,417
Commercial Real Estate | Independent Pharmacies
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Not Accruing & Past Due	5,831	5,593
Current	21,046	15,004
Total loans and leases receivable	26,877	20,597
Commercial Real Estate | Independent Pharmacies | 30-89 Days Past Due & Accruing
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Not Accruing & Past Due		3,400
Commercial Real Estate | Independent Pharmacies | Greater Than 90 Days Past Due
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Not Accruing & Past Due	5,831	2,193
Commercial Real Estate | Registered Investment Advisors
Financing Receivable, Recorded Investment, Past Due [Line Items]
Current	8,152	7,905
Total loans and leases receivable	8,152	7,905
Commercial Real Estate | Veterinary Industry
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Not Accruing & Past Due	7,339	13,491
Current	128,131	123,230
Total loans and leases receivable	135,470	136,721
Commercial Real Estate | Veterinary Industry | Less Than 30 Days Past Due & Not Accruing
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Not Accruing & Past Due	634	1,644
Commercial Real Estate | Veterinary Industry | 30-89 Days Past Due & Accruing
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Not Accruing & Past Due		3,757
Commercial Real Estate | Veterinary Industry | 30-89 Days Past Due & Not Accruing
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Not Accruing & Past Due	3,682	2,899
Commercial Real Estate | Veterinary Industry | Greater Than 90 Days Past Due
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Not Accruing & Past Due	3,023	5,191
Commercial Real Estate | Other Industries
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Not Accruing & Past Due	6,568	10,743
Current	347,753	250,104
Total loans and leases receivable	354,321	260,847
Commercial Real Estate | Other Industries | 30-89 Days Past Due & Accruing
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Not Accruing & Past Due		10,743
Commercial Real Estate | Other Industries | Greater Than 90 Days Past Due
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Not Accruing & Past Due	6,568
Commercial Land
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Not Accruing & Past Due	14,064	11,058
Current	274,403	232,740
Total loans and leases receivable	288,467	243,798
Commercial Land | Less Than 30 Days Past Due & Not Accruing
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Not Accruing & Past Due	10,010	6,277
Commercial Land | 30-89 Days Past Due & Accruing
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Not Accruing & Past Due	714
Commercial Land | 30-89 Days Past Due & Not Accruing
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Not Accruing & Past Due	3,340
Commercial Land | Greater Than 90 Days Past Due
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Not Accruing & Past Due		4,781
Commercial Land | Agriculture
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Not Accruing & Past Due	14,064	11,058
Current	274,403	232,740
Total loans and leases receivable	288,467	243,798
Commercial Land | Agriculture | Less Than 30 Days Past Due & Not Accruing
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Not Accruing & Past Due	10,010	6,277
Commercial Land | Agriculture | 30-89 Days Past Due & Accruing
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Not Accruing & Past Due	714
Commercial Land | Agriculture | 30-89 Days Past Due & Not Accruing
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Not Accruing & Past Due	$ 3,340
Commercial Land | Agriculture | Greater Than 90 Days Past Due
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Not Accruing & Past Due		$ 4,781

Loans and Leases Held for Inv_8

Loans and Leases Held for Investment and Allowance for Loan and Lease Losses - Age Analysis of Past Due Loans and Leases (Parenthetical) (Details) - USD ($) $ in Thousands	Jun. 30, 2019	Dec. 31, 2018
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total loans and leases receivable	$ 2,225,497	$ 1,850,480
Total not accruing & past due	68,413	78,712
Current	2,157,084	1,771,768
Greater Than 90 Days Past Due
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total not accruing & past due	40,604	40,886
Loans Insured or Guaranteed by US Government Authorities
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total loans and leases receivable	498,800	305,400
Current	459,300	263,000
Loans Insured or Guaranteed by US Government Authorities | Greater Than 90 Days Past Due
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total not accruing & past due	30,500	33,400
Loans Insured or Guaranteed by US Government Authorities | Greater Than 90 Days Past Due
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total not accruing & past due	$ 9,000	$ 9,000

Loans and Leases Held for Inv_9

Loans and Leases Held for Investment and Allowance for Loan and Lease Losses - Additional Information (Details)	3 Months Ended		6 Months Ended
	Jun. 30, 2019USD ($)SecurityLoan	Jun. 30, 2018USD ($)SecurityLoan	Jun. 30, 2019USD ($)SecurityLoan	Jun. 30, 2018USD ($)SecurityLoan
Receivables [Abstract]
Theoretical increase in interest if interest on nonaccrual loans had been accrued in accordance with original terms | $	$ 1,100,000	$ 588,000	$ 2,200,000	$ 1,000,000
Credit exposure threshold for impairment evaluation (less than) | $	$ 100,000		$ 100,000
Number of contracts | SecurityLoan	0	0	3	1
Number of Restructurings | SecurityLoan	0	0	0	0

Loans and Leases Held for In_10

Loans and Leases Held for Investment and Allowance for Loan and Lease Losses - Nonaccrual Loans and Leases (Details) - USD ($) $ in Thousands	Jun. 30, 2019	Dec. 31, 2018
Financing Receivable, Recorded Investment, Past Due [Line Items]
Nonaccrual loans and leases balance	$ 65,473	$ 57,690
Loans Insured or Guaranteed by US Government Authorities
Financing Receivable, Recorded Investment, Past Due [Line Items]
Nonaccrual loans and leases balance	47,121	43,202
Unguaranteed Exposure
Financing Receivable, Recorded Investment, Past Due [Line Items]
Nonaccrual loans and leases balance	18,352	14,488
Commercial & Industrial
Financing Receivable, Recorded Investment, Past Due [Line Items]
Nonaccrual loans and leases balance	21,122	24,236
Commercial & Industrial | Loans Insured or Guaranteed by US Government Authorities
Financing Receivable, Recorded Investment, Past Due [Line Items]
Nonaccrual loans and leases balance	16,875	20,348
Commercial & Industrial | Unguaranteed Exposure
Financing Receivable, Recorded Investment, Past Due [Line Items]
Nonaccrual loans and leases balance	4,247	3,888
Commercial & Industrial | Healthcare
Financing Receivable, Recorded Investment, Past Due [Line Items]
Nonaccrual loans and leases balance	7,027	7,527
Commercial & Industrial | Healthcare | Loans Insured or Guaranteed by US Government Authorities
Financing Receivable, Recorded Investment, Past Due [Line Items]
Nonaccrual loans and leases balance	6,097	6,517
Commercial & Industrial | Healthcare | Unguaranteed Exposure
Financing Receivable, Recorded Investment, Past Due [Line Items]
Nonaccrual loans and leases balance	930	1,010
Commercial & Industrial | Independent Pharmacies
Financing Receivable, Recorded Investment, Past Due [Line Items]
Nonaccrual loans and leases balance	5,170	8,969
Commercial & Industrial | Independent Pharmacies | Loans Insured or Guaranteed by US Government Authorities
Financing Receivable, Recorded Investment, Past Due [Line Items]
Nonaccrual loans and leases balance	4,105	7,896
Commercial & Industrial | Independent Pharmacies | Unguaranteed Exposure
Financing Receivable, Recorded Investment, Past Due [Line Items]
Nonaccrual loans and leases balance	1,065	1,073
Commercial & Industrial | Registered Investment Advisors
Financing Receivable, Recorded Investment, Past Due [Line Items]
Nonaccrual loans and leases balance	1,809	3,061
Commercial & Industrial | Registered Investment Advisors | Loans Insured or Guaranteed by US Government Authorities
Financing Receivable, Recorded Investment, Past Due [Line Items]
Nonaccrual loans and leases balance	1,409	2,427
Commercial & Industrial | Registered Investment Advisors | Unguaranteed Exposure
Financing Receivable, Recorded Investment, Past Due [Line Items]
Nonaccrual loans and leases balance	400	634
Commercial & Industrial | Veterinary Industry
Financing Receivable, Recorded Investment, Past Due [Line Items]
Nonaccrual loans and leases balance	1,607	1,506
Commercial & Industrial | Veterinary Industry | Loans Insured or Guaranteed by US Government Authorities
Financing Receivable, Recorded Investment, Past Due [Line Items]
Nonaccrual loans and leases balance	1,458	1,361
Commercial & Industrial | Veterinary Industry | Unguaranteed Exposure
Financing Receivable, Recorded Investment, Past Due [Line Items]
Nonaccrual loans and leases balance	149	145
Commercial & Industrial | Other Industries
Financing Receivable, Recorded Investment, Past Due [Line Items]
Nonaccrual loans and leases balance	5,509	3,173
Commercial & Industrial | Other Industries | Loans Insured or Guaranteed by US Government Authorities
Financing Receivable, Recorded Investment, Past Due [Line Items]
Nonaccrual loans and leases balance	3,806	2,147
Commercial & Industrial | Other Industries | Unguaranteed Exposure
Financing Receivable, Recorded Investment, Past Due [Line Items]
Nonaccrual loans and leases balance	1,703	1,026
Commercial Real Estate
Financing Receivable, Recorded Investment, Past Due [Line Items]
Nonaccrual loans and leases balance	31,001	22,396
Commercial Real Estate | Loans Insured or Guaranteed by US Government Authorities
Financing Receivable, Recorded Investment, Past Due [Line Items]
Nonaccrual loans and leases balance	22,733	17,357
Commercial Real Estate | Unguaranteed Exposure
Financing Receivable, Recorded Investment, Past Due [Line Items]
Nonaccrual loans and leases balance	8,268	5,039
Commercial Real Estate | Healthcare
Financing Receivable, Recorded Investment, Past Due [Line Items]
Nonaccrual loans and leases balance	7,076	7,459
Commercial Real Estate | Healthcare | Loans Insured or Guaranteed by US Government Authorities
Financing Receivable, Recorded Investment, Past Due [Line Items]
Nonaccrual loans and leases balance	4,708	4,963
Commercial Real Estate | Healthcare | Unguaranteed Exposure
Financing Receivable, Recorded Investment, Past Due [Line Items]
Nonaccrual loans and leases balance	2,368	2,496
Commercial Real Estate | Independent Pharmacies
Financing Receivable, Recorded Investment, Past Due [Line Items]
Nonaccrual loans and leases balance	5,831	2,193
Commercial Real Estate | Independent Pharmacies | Loans Insured or Guaranteed by US Government Authorities
Financing Receivable, Recorded Investment, Past Due [Line Items]
Nonaccrual loans and leases balance	5,084	1,863
Commercial Real Estate | Independent Pharmacies | Unguaranteed Exposure
Financing Receivable, Recorded Investment, Past Due [Line Items]
Nonaccrual loans and leases balance	747	330
Commercial Real Estate | Veterinary Industry
Financing Receivable, Recorded Investment, Past Due [Line Items]
Nonaccrual loans and leases balance	7,339	9,734
Commercial Real Estate | Veterinary Industry | Loans Insured or Guaranteed by US Government Authorities
Financing Receivable, Recorded Investment, Past Due [Line Items]
Nonaccrual loans and leases balance	6,157	8,271
Commercial Real Estate | Veterinary Industry | Unguaranteed Exposure
Financing Receivable, Recorded Investment, Past Due [Line Items]
Nonaccrual loans and leases balance	1,182	1,463
Commercial Real Estate | Other Industries
Financing Receivable, Recorded Investment, Past Due [Line Items]
Nonaccrual loans and leases balance	6,568
Commercial Real Estate | Other Industries | Loans Insured or Guaranteed by US Government Authorities
Financing Receivable, Recorded Investment, Past Due [Line Items]
Nonaccrual loans and leases balance	3,747
Commercial Real Estate | Other Industries | Unguaranteed Exposure
Financing Receivable, Recorded Investment, Past Due [Line Items]
Nonaccrual loans and leases balance	2,821
Commercial Real Estate | Agriculture
Financing Receivable, Recorded Investment, Past Due [Line Items]
Nonaccrual loans and leases balance	2,226
Commercial Real Estate | Agriculture | Loans Insured or Guaranteed by US Government Authorities
Financing Receivable, Recorded Investment, Past Due [Line Items]
Nonaccrual loans and leases balance	1,669
Commercial Real Estate | Agriculture | Unguaranteed Exposure
Financing Receivable, Recorded Investment, Past Due [Line Items]
Nonaccrual loans and leases balance	557
Commercial Real Estate | Funeral Home & Cemetery
Financing Receivable, Recorded Investment, Past Due [Line Items]
Nonaccrual loans and leases balance	1,961	3,010
Commercial Real Estate | Funeral Home & Cemetery | Loans Insured or Guaranteed by US Government Authorities
Financing Receivable, Recorded Investment, Past Due [Line Items]
Nonaccrual loans and leases balance	1,368	2,260
Commercial Real Estate | Funeral Home & Cemetery | Unguaranteed Exposure
Financing Receivable, Recorded Investment, Past Due [Line Items]
Nonaccrual loans and leases balance	593	750
Commercial Land
Financing Receivable, Recorded Investment, Past Due [Line Items]
Nonaccrual loans and leases balance	13,350	11,058
Commercial Land | Loans Insured or Guaranteed by US Government Authorities
Financing Receivable, Recorded Investment, Past Due [Line Items]
Nonaccrual loans and leases balance	7,513	5,497
Commercial Land | Unguaranteed Exposure
Financing Receivable, Recorded Investment, Past Due [Line Items]
Nonaccrual loans and leases balance	5,837	5,561
Commercial Land | Agriculture
Financing Receivable, Recorded Investment, Past Due [Line Items]
Nonaccrual loans and leases balance	13,350	11,058
Commercial Land | Agriculture | Loans Insured or Guaranteed by US Government Authorities
Financing Receivable, Recorded Investment, Past Due [Line Items]
Nonaccrual loans and leases balance	7,513	5,497
Commercial Land | Agriculture | Unguaranteed Exposure
Financing Receivable, Recorded Investment, Past Due [Line Items]
Nonaccrual loans and leases balance	$ 5,837	$ 5,561

Loans and Leases Held for In_11

Loans and Leases Held for Investment and Allowance for Loan and Lease Losses - Activity in the Allowance for Loan and Lease Losses by Portfolio Segment (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2019	Jun. 30, 2018	Jun. 30, 2019	Jun. 30, 2018
Allowance for Loan Losses:
Allowance for Loan Losses, Beginning Balance	$ 35,111	$ 28,050	$ 32,434	$ 24,190
Charge offs	(595)	(968)	(817)	(1,640)
Recoveries	69	181	226	321
Provision	3,463	2,087	6,205	6,479
Allowance for Loan Losses, Ending Balance	38,048	29,350	38,048	29,350
Construction & Development
Allowance for Loan Losses:
Allowance for Loan Losses, Beginning Balance	2,236	2,428	2,042	2,030
Provision	688	(201)	882	197
Allowance for Loan Losses, Ending Balance	2,924	2,227	2,924	2,227
Commercial Real Estate
Allowance for Loan Losses:
Allowance for Loan Losses, Beginning Balance	10,623	11,244	11,044	9,180
Charge offs	(1)	(419)	(1)	(419)
Recoveries	13	29	23	33
Provision	1,954	554	1,523	2,614
Allowance for Loan Losses, Ending Balance	12,589	11,408	12,589	11,408
Commercial & Industrial
Allowance for Loan Losses:
Allowance for Loan Losses, Beginning Balance	16,543	12,201	14,562	10,751
Charge offs	(416)	(549)	(638)	(1,221)
Recoveries	56	152	198	288
Provision	724	1,573	2,785	3,559
Allowance for Loan Losses, Ending Balance	16,907	13,377	16,907	13,377
Commercial Land
Allowance for Loan Losses:
Allowance for Loan Losses, Beginning Balance	5,709	2,177	4,786	2,229
Charge offs	(178)		(178)
Recoveries			5
Provision	97	161	1,015	109
Allowance for Loan Losses, Ending Balance	$ 5,628	$ 2,338	$ 5,628	$ 2,338

Loans and Leases Held for In_12

Loans and Leases Held for Investment and Allowance for Loan and Lease Losses - Recorded Allowance for Loan Loans Receivable (Details) - USD ($) $ in Thousands	Jun. 30, 2019	Mar. 31, 2019	Dec. 31, 2018	Jun. 30, 2018	Mar. 31, 2018	Dec. 31, 2017
Allowance for loan and lease losses:
Loans and leases individually evaluated for impairment	$ 11,459		$ 9,091
Loans and leases collectively evaluated for impairment	26,589		23,343
Total allowance for loan and lease losses	38,048	$ 35,111	32,434	$ 29,350	$ 28,050	$ 24,190
Loans and leases receivable:
Loans and leases individually evaluated for impairment	117,109		102,414
Loans and leases collectively evaluated for impairment	2,108,388		1,748,066
Total loans and leases receivable	2,225,497		1,850,480
Construction & Development
Allowance for loan and lease losses:
Loans and leases individually evaluated for impairment			118
Loans and leases collectively evaluated for impairment	2,924		1,924
Total allowance for loan and lease losses	2,924	2,236	2,042	2,227	2,428	2,030
Loans and leases receivable:
Loans and leases individually evaluated for impairment			5,027
Loans and leases collectively evaluated for impairment	324,732		243,877
Total loans and leases receivable	324,732		248,904
Commercial Real Estate
Allowance for loan and lease losses:
Loans and leases individually evaluated for impairment	3,610		2,424
Loans and leases collectively evaluated for impairment	8,979		8,620
Total allowance for loan and lease losses	12,589	10,623	11,044	11,408	11,244	9,180
Loans and leases receivable:
Loans and leases individually evaluated for impairment	57,444		46,731
Loans and leases collectively evaluated for impairment	824,933		692,299
Total loans and leases receivable	882,377		739,030
Commercial & Industrial
Allowance for loan and lease losses:
Loans and leases individually evaluated for impairment	3,128		2,598
Loans and leases collectively evaluated for impairment	13,779		11,964
Total allowance for loan and lease losses	16,907	16,543	14,562	13,377	12,201	10,751
Loans and leases receivable:
Loans and leases individually evaluated for impairment	24,473		28,659
Loans and leases collectively evaluated for impairment	705,448		590,089
Total loans and leases receivable	729,921		618,748
Commercial Land
Allowance for loan and lease losses:
Loans and leases individually evaluated for impairment	4,721		3,951
Loans and leases collectively evaluated for impairment	907		835
Total allowance for loan and lease losses	5,628	$ 5,709	4,786	$ 2,338	$ 2,177	$ 2,229
Loans and leases receivable:
Loans and leases individually evaluated for impairment	35,192		21,997
Loans and leases collectively evaluated for impairment	253,275		221,801
Total loans and leases receivable	$ 288,467		$ 243,798

Loans and Leases Held for In_13

Loans and Leases Held for Investment and Allowance for Loan and Lease Losses - Recorded Allowance for Loan Loans Receivable (Parenthetical) (Details) - USD ($) $ in Thousands	Jun. 30, 2019	Dec. 31, 2018
Allowance for Loan Losses:
Total loans and leases receivable	$ 2,225,497	$ 1,850,480
Loans and leases individually evaluated for impairment	117,109	102,414
Loans Insured or Guaranteed by US Government Authorities
Allowance for Loan Losses:
Total loans and leases receivable	498,800	305,400
Loans and leases individually evaluated for impairment	$ 79,300	$ 72,400

Loans and Leases Held for In_14

Loans and Leases Held for Investment and Allowance for Loan and Lease Losses - Loans and Leases Classified as Impaired (Details) - USD ($) $ in Thousands	Jun. 30, 2019	Dec. 31, 2018
Financing Receivable, Impaired [Line Items]
Impaired loans	$ 117,109	$ 102,414
Loans Insured or Guaranteed by US Government Authorities
Financing Receivable, Impaired [Line Items]
Impaired loans	79,318	72,367
Unguaranteed Exposure
Financing Receivable, Impaired [Line Items]
Impaired loans	37,791	30,047
Commercial & Industrial
Financing Receivable, Impaired [Line Items]
Impaired loans	24,473	28,659
Commercial & Industrial | Loans Insured or Guaranteed by US Government Authorities
Financing Receivable, Impaired [Line Items]
Impaired loans	17,726	21,675
Commercial & Industrial | Unguaranteed Exposure
Financing Receivable, Impaired [Line Items]
Impaired loans	6,747	6,984
Commercial & Industrial | Agriculture
Financing Receivable, Impaired [Line Items]
Impaired loans	7	7
Commercial & Industrial | Agriculture | Unguaranteed Exposure
Financing Receivable, Impaired [Line Items]
Impaired loans	7	7
Commercial & Industrial | Funeral Home & Cemetery
Financing Receivable, Impaired [Line Items]
Impaired loans		6
Commercial & Industrial | Funeral Home & Cemetery | Unguaranteed Exposure
Financing Receivable, Impaired [Line Items]
Impaired loans		6
Commercial & Industrial | Healthcare
Financing Receivable, Impaired [Line Items]
Impaired loans	9,096	9,668
Commercial & Industrial | Healthcare | Loans Insured or Guaranteed by US Government Authorities
Financing Receivable, Impaired [Line Items]
Impaired loans	6,530	7,229
Commercial & Industrial | Healthcare | Unguaranteed Exposure
Financing Receivable, Impaired [Line Items]
Impaired loans	2,566	2,439
Commercial & Industrial | Independent Pharmacies
Financing Receivable, Impaired [Line Items]
Impaired loans	5,457	9,356
Commercial & Industrial | Independent Pharmacies | Loans Insured or Guaranteed by US Government Authorities
Financing Receivable, Impaired [Line Items]
Impaired loans	4,105	7,896
Commercial & Industrial | Independent Pharmacies | Unguaranteed Exposure
Financing Receivable, Impaired [Line Items]
Impaired loans	1,352	1,460
Commercial & Industrial | Registered Investment Advisors
Financing Receivable, Impaired [Line Items]
Impaired loans	2,076	3,347
Commercial & Industrial | Registered Investment Advisors | Loans Insured or Guaranteed by US Government Authorities
Financing Receivable, Impaired [Line Items]
Impaired loans	1,409	2,427
Commercial & Industrial | Registered Investment Advisors | Unguaranteed Exposure
Financing Receivable, Impaired [Line Items]
Impaired loans	667	920
Commercial & Industrial | Veterinary Industry
Financing Receivable, Impaired [Line Items]
Impaired loans	2,357	2,326
Commercial & Industrial | Veterinary Industry | Loans Insured or Guaranteed by US Government Authorities
Financing Receivable, Impaired [Line Items]
Impaired loans	1,876	1,819
Commercial & Industrial | Veterinary Industry | Unguaranteed Exposure
Financing Receivable, Impaired [Line Items]
Impaired loans	481	507
Commercial & Industrial | Other Industries
Financing Receivable, Impaired [Line Items]
Impaired loans	5,480	3,949
Commercial & Industrial | Other Industries | Loans Insured or Guaranteed by US Government Authorities
Financing Receivable, Impaired [Line Items]
Impaired loans	3,806	2,304
Commercial & Industrial | Other Industries | Unguaranteed Exposure
Financing Receivable, Impaired [Line Items]
Impaired loans	1,674	1,645
Commercial Real Estate
Financing Receivable, Impaired [Line Items]
Impaired loans	57,444	46,731
Commercial Real Estate | Loans Insured or Guaranteed by US Government Authorities
Financing Receivable, Impaired [Line Items]
Impaired loans	38,612	33,811
Commercial Real Estate | Unguaranteed Exposure
Financing Receivable, Impaired [Line Items]
Impaired loans	18,832	12,920
Commercial Real Estate | Agriculture
Financing Receivable, Impaired [Line Items]
Impaired loans	2,226	1,798
Commercial Real Estate | Agriculture | Loans Insured or Guaranteed by US Government Authorities
Financing Receivable, Impaired [Line Items]
Impaired loans	1,669	1,299
Commercial Real Estate | Agriculture | Unguaranteed Exposure
Financing Receivable, Impaired [Line Items]
Impaired loans	557	499
Commercial Real Estate | Funeral Home & Cemetery
Financing Receivable, Impaired [Line Items]
Impaired loans	1,958	3,143
Commercial Real Estate | Funeral Home & Cemetery | Loans Insured or Guaranteed by US Government Authorities
Financing Receivable, Impaired [Line Items]
Impaired loans	1,368	2,261
Commercial Real Estate | Funeral Home & Cemetery | Unguaranteed Exposure
Financing Receivable, Impaired [Line Items]
Impaired loans	590	882
Commercial Real Estate | Healthcare
Financing Receivable, Impaired [Line Items]
Impaired loans	22,879	20,442
Commercial Real Estate | Healthcare | Loans Insured or Guaranteed by US Government Authorities
Financing Receivable, Impaired [Line Items]
Impaired loans	14,206	14,559
Commercial Real Estate | Healthcare | Unguaranteed Exposure
Financing Receivable, Impaired [Line Items]
Impaired loans	8,673	5,883
Commercial Real Estate | Independent Pharmacies
Financing Receivable, Impaired [Line Items]
Impaired loans	7,168	5,633
Commercial Real Estate | Independent Pharmacies | Loans Insured or Guaranteed by US Government Authorities
Financing Receivable, Impaired [Line Items]
Impaired loans	6,082	4,079
Commercial Real Estate | Independent Pharmacies | Unguaranteed Exposure
Financing Receivable, Impaired [Line Items]
Impaired loans	1,086	1,554
Commercial Real Estate | Veterinary Industry
Financing Receivable, Impaired [Line Items]
Impaired loans	13,846	15,715
Commercial Real Estate | Veterinary Industry | Loans Insured or Guaranteed by US Government Authorities
Financing Receivable, Impaired [Line Items]
Impaired loans	9,466	11,613
Commercial Real Estate | Veterinary Industry | Unguaranteed Exposure
Financing Receivable, Impaired [Line Items]
Impaired loans	4,380	4,102
Commercial Real Estate | Other Industries
Financing Receivable, Impaired [Line Items]
Impaired loans	9,367
Commercial Real Estate | Other Industries | Loans Insured or Guaranteed by US Government Authorities
Financing Receivable, Impaired [Line Items]
Impaired loans	5,821
Commercial Real Estate | Other Industries | Unguaranteed Exposure
Financing Receivable, Impaired [Line Items]
Impaired loans	3,546
Commercial Land
Financing Receivable, Impaired [Line Items]
Impaired loans	35,192	21,997
Commercial Land | Loans Insured or Guaranteed by US Government Authorities
Financing Receivable, Impaired [Line Items]
Impaired loans	22,980	13,177
Commercial Land | Unguaranteed Exposure
Financing Receivable, Impaired [Line Items]
Impaired loans	12,212	8,820
Commercial Land | Agriculture
Financing Receivable, Impaired [Line Items]
Impaired loans	35,192	21,997
Commercial Land | Agriculture | Loans Insured or Guaranteed by US Government Authorities
Financing Receivable, Impaired [Line Items]
Impaired loans	22,980	13,177
Commercial Land | Agriculture | Unguaranteed Exposure
Financing Receivable, Impaired [Line Items]
Impaired loans	$ 12,212	8,820
Construction & Development
Financing Receivable, Impaired [Line Items]
Impaired loans		5,027
Construction & Development | Loans Insured or Guaranteed by US Government Authorities
Financing Receivable, Impaired [Line Items]
Impaired loans		3,704
Construction & Development | Unguaranteed Exposure
Financing Receivable, Impaired [Line Items]
Impaired loans		1,323
Construction & Development | Agriculture
Financing Receivable, Impaired [Line Items]
Impaired loans		5,027
Construction & Development | Agriculture | Loans Insured or Guaranteed by US Government Authorities
Financing Receivable, Impaired [Line Items]
Impaired loans		3,704
Construction & Development | Agriculture | Unguaranteed Exposure
Financing Receivable, Impaired [Line Items]
Impaired loans		$ 1,323

Loans and Leases Held for In_15

Loans and Leases Held for Investment and Allowance for Loan and Lease Losses - Impaired Loans and Leases With Associated Reserves and No Associated Reserves (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2019	Jun. 30, 2018	Jun. 30, 2019	Jun. 30, 2018	Dec. 31, 2018
Financing Receivable, Impaired [Line Items]
Recorded Investment, With a Recorded Allowance	$ 113,617		$ 113,617		$ 100,321
Recorded Investment, With No Recorded Allowance	3,492		3,492		2,093
Recorded Investment, Total	117,109		117,109		102,414
Loans, Unpaid Principal Balance	119,541		119,541		106,658
Loans, Related Allowance Recorded	11,459		11,459		9,091
Loans, Average Balance	115,352	$ 64,608	114,734	$ 64,188
Loans, Interest Income Recognized	785	304	1,482	586
Commercial & Industrial
Financing Receivable, Impaired [Line Items]
Recorded Investment, With a Recorded Allowance	23,943		23,943		27,639
Recorded Investment, With No Recorded Allowance	530		530		1,020
Recorded Investment, Total	24,473		24,473		28,659
Loans, Unpaid Principal Balance	26,056		26,056		31,537
Loans, Related Allowance Recorded	3,128		3,128		2,598
Loans, Average Balance	25,126	20,200	25,077	20,348
Loans, Interest Income Recognized	64	61	141	125
Commercial & Industrial | Agriculture
Financing Receivable, Impaired [Line Items]
Recorded Investment, With a Recorded Allowance	7		7
Recorded Investment, With No Recorded Allowance					7
Recorded Investment, Total	7		7		7
Loans, Unpaid Principal Balance	6		6		6
Loans, Related Allowance Recorded	7		7
Loans, Average Balance	6		6
Commercial & Industrial | Funeral Home & Cemetery
Financing Receivable, Impaired [Line Items]
Recorded Investment, With No Recorded Allowance					6
Recorded Investment, Total					6
Loans, Unpaid Principal Balance					6
Loans, Average Balance		7		7
Commercial & Industrial | Healthcare
Financing Receivable, Impaired [Line Items]
Recorded Investment, With a Recorded Allowance	9,039		9,039		9,604
Recorded Investment, With No Recorded Allowance	57		57		64
Recorded Investment, Total	9,096		9,096		9,668
Loans, Unpaid Principal Balance	9,827		9,827		10,432
Loans, Related Allowance Recorded	870		870		827
Loans, Average Balance	9,280	5,094	9,421	5,188
Loans, Interest Income Recognized	34	19	65	31
Commercial & Industrial | Independent Pharmacies
Financing Receivable, Impaired [Line Items]
Recorded Investment, With a Recorded Allowance	5,161		5,161		9,032
Recorded Investment, With No Recorded Allowance	296		296		324
Recorded Investment, Total	5,457		5,457		9,356
Loans, Unpaid Principal Balance	5,763		5,763		10,564
Loans, Related Allowance Recorded	833		833		478
Loans, Average Balance	5,459	7,978	5,385	8,038
Loans, Interest Income Recognized	5	7	15	27
Commercial & Industrial | Registered Investment Advisors
Financing Receivable, Impaired [Line Items]
Recorded Investment, With a Recorded Allowance	2,076		2,076		3,347
Recorded Investment, Total	2,076		2,076		3,347
Loans, Unpaid Principal Balance	2,138		2,138		3,839
Loans, Related Allowance Recorded	432		432		811
Loans, Average Balance	2,083	2,818	2,103	2,825
Loans, Interest Income Recognized	5	12	10	24
Commercial & Industrial | Veterinary Industry
Financing Receivable, Impaired [Line Items]
Recorded Investment, With a Recorded Allowance	2,180		2,180		2,160
Recorded Investment, With No Recorded Allowance	177		177		166
Recorded Investment, Total	2,357		2,357		2,326
Loans, Unpaid Principal Balance	2,667		2,667		2,593
Loans, Related Allowance Recorded	57		57		65
Loans, Average Balance	2,394	2,930	2,417	2,917
Loans, Interest Income Recognized	13	18	27	38
Commercial & Industrial | Other Industries
Financing Receivable, Impaired [Line Items]
Recorded Investment, With a Recorded Allowance	5,480		5,480		3,496
Recorded Investment, With No Recorded Allowance					453
Recorded Investment, Total	5,480		5,480		3,949
Loans, Unpaid Principal Balance	5,655		5,655		4,097
Loans, Related Allowance Recorded	929		929		417
Loans, Average Balance	5,904	1,373	5,745	1,373
Loans, Interest Income Recognized	7	5	24	5
Commercial Real Estate
Financing Receivable, Impaired [Line Items]
Recorded Investment, With a Recorded Allowance	54,482		54,482		45,658
Recorded Investment, With No Recorded Allowance	2,962		2,962		1,073
Recorded Investment, Total	57,444		57,444		46,731
Loans, Unpaid Principal Balance	58,497		58,497		48,035
Loans, Related Allowance Recorded	3,610		3,610		2,424
Loans, Average Balance	57,791	34,945	57,832	34,614
Loans, Interest Income Recognized	441	190	823	380
Commercial Real Estate | Agriculture
Financing Receivable, Impaired [Line Items]
Recorded Investment, With a Recorded Allowance	2,226		2,226		1,798
Recorded Investment, Total	2,226		2,226		1,798
Loans, Unpaid Principal Balance	2,226		2,226		1,732
Loans, Related Allowance Recorded	13		13		93
Loans, Average Balance	2,228		2,228
Commercial Real Estate | Funeral Home & Cemetery
Financing Receivable, Impaired [Line Items]
Recorded Investment, With a Recorded Allowance	1,821		1,821		2,859
Recorded Investment, With No Recorded Allowance	137		137		284
Recorded Investment, Total	1,958		1,958		3,143
Loans, Unpaid Principal Balance	1,961		1,961		3,281
Loans, Related Allowance Recorded	87		87		30
Loans, Average Balance	1,967	3,122	1,974	3,133
Loans, Interest Income Recognized		27	2	64
Commercial Real Estate | Healthcare
Financing Receivable, Impaired [Line Items]
Recorded Investment, With a Recorded Allowance	20,754		20,754		20,211
Recorded Investment, With No Recorded Allowance	2,125		2,125		231
Recorded Investment, Total	22,879		22,879		20,442
Loans, Unpaid Principal Balance	22,873		22,873		20,461
Loans, Related Allowance Recorded	1,266		1,266		1,145
Loans, Average Balance	23,057	12,852	23,198	12,486
Loans, Interest Income Recognized	259	64	487	80
Commercial Real Estate | Independent Pharmacies
Financing Receivable, Impaired [Line Items]
Recorded Investment, With a Recorded Allowance	7,168		7,168		5,184
Recorded Investment, With No Recorded Allowance					449
Recorded Investment, Total	7,168		7,168		5,633
Loans, Unpaid Principal Balance	7,453		7,453		5,884
Loans, Related Allowance Recorded	43		43		220
Loans, Average Balance	7,198	2,836	6,663	2,836
Loans, Interest Income Recognized	25	1	67	1
Commercial Real Estate | Veterinary Industry
Financing Receivable, Impaired [Line Items]
Recorded Investment, With a Recorded Allowance	13,146		13,146		15,606
Recorded Investment, With No Recorded Allowance	700		700		109
Recorded Investment, Total	13,846		13,846		15,715
Loans, Unpaid Principal Balance	14,650		14,650		16,677
Loans, Related Allowance Recorded	1,277		1,277		936
Loans, Average Balance	13,984	16,135	14,412	16,159
Loans, Interest Income Recognized	105	98	206	235
Commercial Real Estate | Other Industries
Financing Receivable, Impaired [Line Items]
Recorded Investment, With a Recorded Allowance	9,367		9,367
Recorded Investment, Total	9,367		9,367
Loans, Unpaid Principal Balance	9,334		9,334
Loans, Related Allowance Recorded	924		924
Loans, Average Balance	9,357		9,357
Loans, Interest Income Recognized	52		61
Commercial Land
Financing Receivable, Impaired [Line Items]
Recorded Investment, With a Recorded Allowance	35,192		35,192		21,997
Recorded Investment, Total	35,192		35,192		21,997
Loans, Unpaid Principal Balance	34,988		34,988		22,147
Loans, Related Allowance Recorded	4,721		4,721		3,951
Loans, Average Balance	32,435	5,138	31,825	5,138
Loans, Interest Income Recognized	280	25	518	25
Commercial Land | Agriculture
Financing Receivable, Impaired [Line Items]
Recorded Investment, With a Recorded Allowance	35,192		35,192		21,997
Recorded Investment, Total	35,192		35,192		21,997
Loans, Unpaid Principal Balance	34,988		34,988		22,147
Loans, Related Allowance Recorded	4,721		4,721		3,951
Loans, Average Balance	32,435	5,138	31,825	5,138
Loans, Interest Income Recognized	$ 280	25	$ 518	25
Construction & Development
Financing Receivable, Impaired [Line Items]
Recorded Investment, With a Recorded Allowance					5,027
Recorded Investment, Total					5,027
Loans, Unpaid Principal Balance					4,939
Loans, Related Allowance Recorded					118
Loans, Average Balance		4,325		4,088
Loans, Interest Income Recognized		28		56
Construction & Development | Agriculture
Financing Receivable, Impaired [Line Items]
Recorded Investment, With a Recorded Allowance					5,027
Recorded Investment, Total					5,027
Loans, Unpaid Principal Balance					4,939
Loans, Related Allowance Recorded					$ 118
Loans, Average Balance		2,526		2,509
Loans, Interest Income Recognized				5
Construction & Development | Healthcare
Financing Receivable, Impaired [Line Items]
Loans, Average Balance		1,799		1,579
Loans, Interest Income Recognized		$ 28		$ 51

Loans and Leases Held for In_16

Loans and Leases Held for Investment and Allowance for Loan and Lease Losses - Schedule of Troubled Debt Restructurings (Details) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2019SecurityLoan	Jun. 30, 2018SecurityLoan	Jun. 30, 2019USD ($)SecurityLoan	Jun. 30, 2018USD ($)SecurityLoan
Financing Receivable, Modifications [Line Items]
Number of Loans and Leases | SecurityLoan	0	0	3	1
Pre-modification recorded investment			$ 5,486	$ 612
Post-modification recorded investment			$ 5,486	$ 612
Interest Only
Financing Receivable, Modifications [Line Items]
Number of Loans and Leases | SecurityLoan				1
Pre-modification recorded investment				$ 612
Post-modification recorded investment				$ 612
Interest Only | Construction & Development | Healthcare
Financing Receivable, Modifications [Line Items]
Number of Loans and Leases | SecurityLoan				1
Pre-modification recorded investment				$ 612
Post-modification recorded investment				$ 612
Extended Maturity
Financing Receivable, Modifications [Line Items]
Number of Loans and Leases | SecurityLoan			1
Pre-modification recorded investment			$ 3,489
Post-modification recorded investment			$ 3,489
Extended Maturity | Commercial Land | Agricultural
Financing Receivable, Modifications [Line Items]
Number of Loans and Leases | SecurityLoan			1
Pre-modification recorded investment			$ 3,489
Post-modification recorded investment			$ 3,489
Payment Deferral
Financing Receivable, Modifications [Line Items]
Number of Loans and Leases | SecurityLoan			2
Pre-modification recorded investment			$ 1,997
Post-modification recorded investment			$ 1,997
Payment Deferral | Commercial & Industrial | Healthcare
Financing Receivable, Modifications [Line Items]
Number of Loans and Leases | SecurityLoan			1
Pre-modification recorded investment			$ 144
Post-modification recorded investment			$ 144
Payment Deferral | Commercial Real Estate | Healthcare
Financing Receivable, Modifications [Line Items]
Number of Loans and Leases | SecurityLoan			1
Pre-modification recorded investment			$ 1,853
Post-modification recorded investment			$ 1,853

Leases - Additional Information

Leases - Additional Information (Details) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2019USD ($)	Jun. 30, 2018USD ($)	Jun. 30, 2019USD ($)termLease	Jun. 30, 2018USD ($)	Dec. 31, 2018USD ($)
Lessor Lease Description [Line Items]
Direct financing lease, interest income	$ 267	$ 73	$ 501	$ 120
Number of additional terms | term			2
Premises and equipment, net	147,400		$ 147,400		$ 148,800
Premises and equipment, gross	162,600		162,600		159,200
Premises and equipment, accumulated depreciation	15,200		15,200		$ 10,400
Premises and equipment, depreciation expense	2,400	2,000	4,800	3,700
Operating Lease, Lease Income	$ 2,400	$ 1,900	$ 4,700	$ 3,500
Lessee, operating lease, number of leases on which options to extend lease term will certainly be exercised | Lease			1
Finance lease, remaining lease term			3 years 4 months 24 days
Minimum
Lessor Lease Description [Line Items]
Lessor, term of contract			3 years
Term of contract	10 years		10 years
Useful life			20 years
Residual value (as a percent)	20.00%		20.00%
Operating lease, remaining lease term			1 year
Maximum
Lessor Lease Description [Line Items]
Lessor, term of contract			7 years
Term of contract	15 years		15 years
Useful life			25 years
Residual value (as a percent)	50.00%		50.00%
Operating lease, remaining lease term			27 years
Lessee, operating lease, renewl term	20 years		20 years

Leases - Direct Financing Lease

Leases - Direct Financing Leases (Details) - USD ($) $ in Thousands	Jun. 30, 2019	Dec. 31, 2018
Leases [Abstract]
Gross direct finance lease payments receivable	$ 15,587	$ 12,541
Less – unearned interest	(3,063)	(2,635)
Net investment in direct financing leases	$ 12,524	$ 9,906

Leases - Finance Lease Maturity

Leases - Finance Lease Maturity (Details) - USD ($) $ in Thousands	Jun. 30, 2019	Dec. 31, 2018
Leases [Abstract]
2019	$ 1,544
2020	3,061
2021	3,007
2022	2,744
2023	2,286
Thereafter	2,945
Total	$ 15,587	$ 12,541

Leases - Maturity Analysis of F

Leases - Maturity Analysis of Future Minimum Operating Lease Payments (Details) $ in Thousands	Jun. 30, 2019USD ($)
Leases [Abstract]
2019	$ 3,889
2020	8,883
2021	8,930
2022	8,924
2023	8,956
Thereafter	48,267
Total	$ 87,849

Leases - Summary of Components

Leases - Summary of Components of Lease Expense (Details) - USD ($) $ in Thousands	3 Months Ended	6 Months Ended
	Jun. 30, 2019	Jun. 30, 2019
Leases [Abstract]
Operating lease cost	$ 169	$ 326
Short-term lease cost	166	375
Finance lease cost:
Amortization of right-of-use assets	1	2
Sublease income	(9)	(18)
Total net lease cost	$ 327	$ 685

Leases - Summary of Consolidate

Leases - Summary of Consolidated Balance Sheet Related to Finance Leases (Details) $ in Thousands	Jun. 30, 2019USD ($)
Leases [Abstract]
Right-of-use assets	$ 16
Financing lease obligations	$ 16

Leases - Summary of Weighted Av

Leases - Summary of Weighted Average Remaining Lease Term and Weighted Average Discount Rate for Leases (Details)	Jun. 30, 2019
Leases [Abstract]
Operating leases	15 years 3 months 18 days
Finance lease	3 years 5 months 1 day
Operating leases	3.50%
Finance lease	3.10%

Leases - Summary of Operating a

Leases - Summary of Operating and Finance Lease Liabilities (Details) $ in Thousands	Jun. 30, 2019USD ($)
Operating Leases
Operating leases, 2019	$ 343
Operating leases, 2020	504
Operating leases, 2021	297
Operating leases, 2022	275
Operating leases, 2023	143
Operating leases, thereafter	1,285
Operating leases, future lease payments	2,847
Operating leases, less: imputed interest	(685)
Operating leases, total lease liabilities	2,162
Finance leases
Finance leases,2019	3
Finance leases, 2020	5
Finance leases, 2021	5
Finance leases, 2022	4
Finance leases, future lease payments	17
Finance leases, less: imputed interest	(1)
Finance leases, total lease liabilities	$ 16

Servicing Assets - Narrative (D

Servicing Assets - Narrative (Details) - USD ($) $ in Millions	6 Months Ended
	Jun. 30, 2019	Jun. 30, 2018	Dec. 31, 2018
Servicing Assets At Fair Value [Line Items]
Unpaid principal balance of loans serviced for others requiring recognition of a servicing asset	$ 2,390		$ 2,630
Unpaid principal balances of loan serviced for others	$ 3,050		$ 3,220
Weighted Average
Servicing Assets At Fair Value [Line Items]
Fair value of servicing rights, discount rate	13.40%	13.00%
Fair value of servicing rights, prepayment rate	14.10%	9.60%

Servicing Assets - Summary of A

Servicing Assets - Summary of Activity Pertaining to Servicing Rights (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2019	Jun. 30, 2018	Jun. 30, 2019	Jun. 30, 2018
Servicing Asset At Fair Value Amount Roll Forward
Balance at beginning of period	$ 44,324	$ 53,120	$ 47,641	$ 52,298
Additions, net	608	4,202	1,331	9,076
Fair value changes:
Due to changes in valuation inputs or assumptions	260	(552)	(489)	(553)
Decay due to increases in principal paydowns or runoff	(3,505)	(4,081)	(6,796)	(8,132)
Balance at end of period	$ 41,687	$ 52,689	$ 41,687	$ 52,689

Borrowings - Total Outstanding

Borrowings - Total Outstanding Short and Long Term Borrowings (Details) - USD ($) $ in Thousands	Jun. 30, 2019	Dec. 31, 2018
Debt Instrument [Line Items]
Short term borrowings	$ 1,345	$ 1,441
Long term borrowings	16	16
Capital Lease Obligations
Debt Instrument [Line Items]
Long term borrowings	16	16
Notes Payable to Banks
Debt Instrument [Line Items]
Short term borrowings	1,345	1,441
Related Party Loans Transferred To Unaffiliated Commercial Bank | Notes Payable to Banks
Debt Instrument [Line Items]
Short term borrowings	$ 1,345	$ 1,441

Borrowings - Total Outstandin_2

Borrowings - Total Outstanding Short and Long Term Borrowings (Parenthetical) (Details)	Oct. 02, 2018	Aug. 17, 2018USD ($)	Oct. 20, 2017USD ($)	Apr. 18, 2017USD ($)	Feb. 23, 2015USD ($)SecurityLoan	Jun. 30, 2019USD ($)	Oct. 31, 2017USD ($)	Sep. 18, 2014USD ($)
Revolving Line of Credit with Unaffiliated Commercial Bank
Debt Instrument [Line Items]
Line of credit, maximum borrowing capacity			$ 20,000,000
Debt instrument term			12 months
Current available credit facility						$ 20,000,000
Related Party Loans Transferred To Unaffiliated Commercial Bank
Debt Instrument [Line Items]
Debt instrument, face amount					$ 4,700,000
Debt Instrument, Interest Rate, Stated Percentage						6.50%
Repayments of debt		$ 1,300,000
Debt instrument, maturity date					Oct. 5, 2019
Number of related party loans transferred | SecurityLoan					2
Collateral amount						$ 1,300,000
Debt instrument term					60 months
Related Party Loans Transferred To Unaffiliated Commercial Bank | Prime Rate
Debt Instrument [Line Items]
Basis spread on variable rate					1.00%
Note Payable Revolving Line of Credit With Unaffiliated Commercial Bank
Debt Instrument [Line Items]
Line of credit, maximum borrowing capacity				$ 25,000,000				$ 8,100,000
Debt instrument, maturity date				Apr. 30, 2019
Debt instrument term				24 months
Current available credit facility						$ 0
Capital Leasewith Unaffiliated Lease Company | Capital Lease Obligations
Debt Instrument [Line Items]
Capital lease obligations, noncurrent							$ 19,000
Term of contract							60 months
Option to purchase equipment, amount							$ 1
Line of Credit | Revolving Line of Credit with Unaffiliated Commercial Bank | London Interbank Offered Rate (LIBOR)
Debt Instrument [Line Items]
Basis spread on variable rate	1.75%
Line of Credit | Note Payable Revolving Line of Credit With Unaffiliated Commercial Bank | Prime Rate
Debt Instrument [Line Items]
Basis spread on variable rate				0.50%

Borrowings - Narrative (Details

Borrowings - Narrative (Details) - USD ($)	Jun. 30, 2019	Dec. 31, 2018
Debt Instrument [Line Items]
Short term borrowings	$ 0	$ 0
Repurchased agreements, borrowing capacity	5,000,000	5,000,000
Repurchases agreements, outstanding balance	0	0
FHLB maximum amount available	1,010,000,000	849,100,000
Short term borrowings	1,345,000	1,441,000
Federal Funds Purchased
Debt Instrument [Line Items]
Line of credit, maximum borrowing capacity	72,500,000	72,500,000
Federal Reserve Bank Advances | Federal Reserve Bank
Debt Instrument [Line Items]
Collateral amount	412,900,000	395,200,000
Remaining available credit facility	234,900,000	218,000,000
Short term borrowings	$ 0	$ 0

Fair Value of Financial Instr_3

Fair Value of Financial Instruments - Recorded Amount of Assets and Liabilities Measured at Fair Value on a Recurring Basis (Details) - USD ($) $ in Thousands	Jun. 30, 2019	Mar. 31, 2019	Dec. 31, 2018	Jun. 30, 2018	Mar. 31, 2018	Dec. 31, 2017
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investment securities available-for-sale	$ 576,275		$ 380,490
Servicing assets	41,687	$ 44,324	47,641	$ 52,689	$ 53,120	$ 52,298
US Treasury Securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investment securities available-for-sale	5,015		4,966
US government agencies
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investment securities available-for-sale	48,905		30,944
Mortgage-backed securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investment securities available-for-sale	513,349		343,581
Recurring
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Servicing assets	41,687		47,641
Equity warrant assets	720		527
Total assets at fair value	620,857		430,757
Recurring | Municipal bonds
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investment securities available-for-sale	9,006		999
Recurring | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Servicing assets	0		0
Equity warrant assets	0		0
Total assets at fair value	0		0
Recurring | Level 1 | Municipal bonds
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investment securities available-for-sale	0		0
Recurring | Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Servicing assets	0		0
Equity warrant assets	0		0
Total assets at fair value	578,357		381,590
Recurring | Level 2 | Municipal bonds
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investment securities available-for-sale	8,913		0
Recurring | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Servicing assets	41,687		47,641
Equity warrant assets	720		527
Total assets at fair value	42,500		49,167
Recurring | Level 3 | Municipal bonds
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investment securities available-for-sale	93		999
Total assets at fair value	93		999
Recurring | US Treasury Securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investment securities available-for-sale	5,015		4,966
Recurring | US Treasury Securities | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investment securities available-for-sale	0		0
Recurring | US Treasury Securities | Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investment securities available-for-sale	5,015		4,966
Recurring | US Treasury Securities | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investment securities available-for-sale	0		0
Recurring | US government agencies
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investment securities available-for-sale	48,905		30,944
Recurring | US government agencies | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investment securities available-for-sale	0		0
Recurring | US government agencies | Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investment securities available-for-sale	48,905		30,944
Recurring | US government agencies | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investment securities available-for-sale	0		0
Recurring | Mortgage-backed securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investment securities available-for-sale	513,349		343,581
Recurring | Mortgage-backed securities | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investment securities available-for-sale	0		0
Recurring | Mortgage-backed securities | Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investment securities available-for-sale	513,349		343,581
Recurring | Mortgage-backed securities | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investment securities available-for-sale	0		0
Recurring | Mutual Fund
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Mutual fund	2,175		2,099
Recurring | Mutual Fund | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Mutual fund	0		0
Recurring | Mutual Fund | Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Mutual fund	2,175		2,099
Recurring | Mutual Fund | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Mutual fund	$ 0		$ 0

Fair Value of Financial Instr_4

Fair Value of Financial Instruments - Recorded Amount of Assets and Liabilities Measured at Fair Value on a Recurring Basis (Parenthetical) (Details) - USD ($)	3 Months Ended	6 Months Ended
	Jun. 30, 2019	Jun. 30, 2019	Jun. 30, 2018
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investment securities available-for-sale with value	$ 900,000	$ 900,000
Equity Warrant Assets
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Equity warrant assets gross at fair value			$ 399,000
Gain (loss) on derivative, net	(62,000)	193,000
Municipal bonds
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value adjustment	$ 0	$ 7,000

Fair Value of Financial Instr_5

Fair Value of Financial Instruments - Recorded Amount of Assets and Liabilities Measured at Fair Value on a Non-Recurring Basis (Details) - Non-recurring Fair Value - USD ($) $ in Thousands	Jun. 30, 2019	Dec. 31, 2018
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Impaired loans	$ 102,158	$ 91,230
Foreclosed assets	6,044	1,094
Total assets at fair value	108,202	92,324
Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Impaired loans	102,158	91,230
Foreclosed assets	6,044	1,094
Total assets at fair value	$ 108,202	$ 92,324

Fair Value of Financial Instr_6

Fair Value of Financial Instruments - Analysis of Level 3 Valuation Techniques (Details) $ in Thousands	Jun. 30, 2019USD ($)	Dec. 31, 2018USD ($)
Recurring
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items]
Asset, fair value	$ 620,857	$ 430,757
Recurring | Level 3
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items]
Asset, fair value	42,500	49,167
Non-recurring Fair Value
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items]
Asset, fair value	108,202	92,324
Non-recurring Fair Value | Level 3
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items]
Asset, fair value	108,202	92,324
Municipal bonds | Recurring | Level 3
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items]
Asset, fair value	$ 93	$ 999
Municipal bonds | Discounted Expected Cash Flows | Discount rate | Recurring
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items]
Warrants, measurement input	0.0476	0.0514
Municipal bonds | Discounted Expected Cash Flows | Prepayment speed | Recurring
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items]
Warrants, measurement input	0.0500	0.0500
Impaired Loans | Non-recurring Fair Value | Level 3
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items]
Asset, fair value	$ 102,158	$ 91,230
Impaired Loans | Minimum | Discounted appraisals | Discount rate | Non-recurring Fair Value
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items]
Warrants, measurement input	0	0.08
Impaired Loans | Maximum | Discounted appraisals | Discount rate | Non-recurring Fair Value
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items]
Warrants, measurement input	0.48	0.48
Impaired Loans | Weighted Average | Discounted Expected Cash Flows | Discount rate | Non-recurring Fair Value
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items]
Warrants, measurement input	0.0677	0.0658
Foreclosed Assets | Non-recurring Fair Value | Level 3
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items]
Asset, fair value	$ 6,044	$ 1,094
Foreclosed Assets | Minimum | Discounted appraisals | Discount rate | Non-recurring Fair Value
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items]
Warrants, measurement input	0.09	0.09
Foreclosed Assets | Maximum | Discounted appraisals | Discount rate | Non-recurring Fair Value
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items]
Warrants, measurement input	0.37	0.37
Equity Warrant Assets | Recurring | Level 3
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items]
Asset, fair value	$ 720	$ 527
Equity Warrant Assets | Black-Scholes Option Pricing Model | Discount rate | Recurring
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items]
Warrants, measurement input	0.2000	0.2000
Equity Warrant Assets | Black-Scholes Option Pricing Model | Expected Volatility Rate | Recurring
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items]
Warrants, measurement input	0.2090	0.2040
Equity Warrant Assets | Black-Scholes Option Pricing Model | Risk-Free Interest Rate | Recurring
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items]
Warrants, measurement input	0.0203	0.0269
Equity Warrant Assets | Minimum | Black-Scholes Option Pricing Model | Expected Term | Recurring
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items]
Warrants, measurement input	8 years	9 years
Equity Warrant Assets | Maximum | Black-Scholes Option Pricing Model | Expected Term | Recurring
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items]
Warrants, measurement input	9 years	10 years

Fair Value of Financial Instr_7

Fair Value of Financial Instruments - Carrying Amount and Estimated Fair Value of Financial Instruments (Detail) - USD ($) $ in Thousands	Jun. 30, 2019	Mar. 31, 2019	Dec. 31, 2018	Jun. 30, 2018	Mar. 31, 2018	Dec. 31, 2017
Financial assets
Investment securities, available-for-sale	$ 576,275		$ 380,490
Servicing assets	41,687	$ 44,324	47,641	$ 52,689	$ 53,120	$ 52,298
Carrying Amount
Financial assets
Cash and due from banks	115,292		316,823
Federal funds sold	68,153
Certificates of deposit with other banks	7,250		7,250
Investment securities, available-for-sale	576,275		380,490
Loans held for sale	857,837		687,393
Loans and leases, net of allowance for loan and lease losses	2,187,425		1,810,985
Servicing assets	41,687		47,641
Accrued interest receivable	19,791		15,895
Mutual fund	2,175		2,099
Equity warrant assets	720		527
Financial liabilities
Deposits	3,721,597		3,149,583
Accrued interest payable	1,990		861
Short term borrowings	1,345		1,441
Long term borrowings	16		16
Estimate of Fair Value Measurement
Financial assets
Cash and due from banks	115,292		316,823
Federal funds sold	68,153
Certificates of deposit with other banks	7,604		7,442
Investment securities, available-for-sale	576,275		380,490
Loans held for sale	881,747		695,154
Loans and leases, net of allowance for loan and lease losses	2,182,023		1,807,528
Servicing assets	41,687		47,641
Accrued interest receivable	19,791		15,895
Mutual fund	2,175		2,099
Equity warrant assets	720		527
Financial liabilities
Deposits	3,734,139		3,117,941
Accrued interest payable	1,990		861
Short term borrowings	1,347		1,441
Long term borrowings	16		16
Level 1 | Estimate of Fair Value Measurement
Financial assets
Cash and due from banks	115,292		316,823
Federal funds sold	68,153
Certificates of deposit with other banks	7,604		7,442
Accrued interest receivable	19,791		15,895
Financial liabilities
Accrued interest payable	1,990		861
Level 2 | Estimate of Fair Value Measurement
Financial assets
Investment securities, available-for-sale	576,182		379,491
Mutual fund	2,175		2,099
Financial liabilities
Deposits	3,734,139		3,117,941
Level 3 | Estimate of Fair Value Measurement
Financial assets
Investment securities, available-for-sale	93		999
Loans held for sale	881,747		695,154
Loans and leases, net of allowance for loan and lease losses	2,182,023		1,807,528
Servicing assets	41,687		47,641
Equity warrant assets	720		527
Financial liabilities
Short term borrowings	1,347		1,441
Long term borrowings	$ 16		$ 16

Commitments and Contingencies -

Commitments and Contingencies - Summary of Commitments (Details) - USD ($) $ in Thousands	Jun. 30, 2019	Dec. 31, 2018
Fair Value Off Balance Sheet Risks Disclosure Information [Line Items]
Total unfunded off-balance-sheet credit risk	$ 1,654,099	$ 1,447,624
Commitments to Extend Credit
Fair Value Off Balance Sheet Risks Disclosure Information [Line Items]
Total unfunded off-balance-sheet credit risk	1,641,814	1,435,024
Standby Letters of Credit
Fair Value Off Balance Sheet Risks Disclosure Information [Line Items]
Total unfunded off-balance-sheet credit risk	$ 12,285	2,150
Purchase Commitment
Fair Value Off Balance Sheet Risks Disclosure Information [Line Items]
Total unfunded off-balance-sheet credit risk		$ 10,450

Commitments and Contingencies_2

Commitments and Contingencies - Additional Information (Details) $ in Millions	6 Months Ended
	Jun. 30, 2019USD ($)Customer	Dec. 31, 2018USD ($)
Concentration Risk [Line Items]
Commitment letters expiration period (in days)	90 days
Commitments for on-balance-sheet investments	$ 1.6	$ 2.8
Maximum retained credit exposure	7.5
Future minimum lease payments under non-cancelable operating leases	$ 87.8
Sixteen Relationships
Concentration Risk [Line Items]
Number of relationships that have retained unguaranteed exposure | Customer	16
Retained credit exposure	$ 193
Retained exposure, amount disbursed	137
Four Relationships
Concentration Risk [Line Items]
Future minimum lease payments under non-cancelable operating leases	$ 63.7

Stock Plans - Narrative (Detail

Stock Plans - Narrative (Details) - USD ($)	Feb. 11, 2019	Aug. 10, 2018	May 15, 2018	May 14, 2018	Jun. 30, 2019	Jun. 30, 2018	Jun. 30, 2019	Jun. 30, 2018	May 24, 2016
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Intrinsic value of options exercised							$ 326,000	$ 2,900,000
Shares, granted (in shares)					0	0	0	0
Employee Stock
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Compensation expense					$ 0	$ 0	$ 32,000	$ 29,000
Maximum annual purchase per employee							$ 25,000
Purchase date discount							15.00%
Stock Options
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Compensation expense					400,000	347,000	$ 838,000	780,000
Unrecognized compensation costs, stock options					5,100,000		$ 5,100,000
Unrecognized compensation costs period recognized							3 years 1 month 6 days
Market Restricted Stock
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Unrecognized compensation costs period recognized							3 years 3 months 18 days
Number of days share price must be maintained							20 days
Units earned as a percent of units awarded							100.00%
Shares, granted (in shares)	500,000						500,000
Valuation period	10 years
Risk free interest rate	2.62%
Expected volatility rate	37.60%
Expected dividend rate	0.78%
Additional compensation expense					166,000		$ 234,000
Compensation expense					2,000,000	947,000	3,800,000	1,900,000
Unrecognized compensation costs					19,100,000		$ 19,100,000
Market Restricted Stock | Minimum
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Share price threshold for performance criteria (in dollars per share)							$ 34
Expected term	4 years 6 months
Market Restricted Stock | Maximum
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Share price threshold for performance criteria (in dollars per share)							$ 55
Expected term	5 years 9 months 18 days
Restricted Stock Units (RSUs)
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Compensation expense					556,000	$ 921,000	$ 1,100,000	$ 1,800,000
Unrecognized compensation costs, stock options					$ 8,200,000		$ 8,200,000
Unrecognized compensation costs period recognized							4 years 8 months 12 days
Shares, granted (in shares)							69,621
Market RSU Granted on May 14, 2018 | One Employee
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Vesting period	10 years			7 years
Share price threshold for performance criteria (in dollars per share)				$ 48
Number of days share price must be maintained	20 days
Shares, granted (in shares)				75,000
Market RSU Granted on May 14, 2018 | Minimum | One Employee
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Share price threshold for performance criteria (in dollars per share)	$ 35
Market RSU Granted on May 14, 2018 | Maximum | One Employee
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Share price threshold for performance criteria (in dollars per share)	$ 48
Market RSU Granted on August 10, 2018 | Eleven Employees
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Vesting period	10 years	7 years
Shares, granted (in shares)		410,000
2015 Omnibus Plan
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Number of common voting shares authorized (in shares)			8,750,000						7,000,000
Options or restricted shares of expiration period (in years)			10 years
Percentage of fair market value of common stock			100.00%
2015 Omnibus Plan | Stock Options | Minimum
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Vesting period			3 years
2015 Omnibus Plan | Restricted Stock | Maximum
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Vesting period			7 years

Stock Plans - Stock Option Acti

Stock Plans - Stock Option Activity (Details) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2019	Jun. 30, 2018	Jun. 30, 2019	Jun. 30, 2018
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]
Shares, outstanding, beginning balance (in shares)			2,656,855	3,058,459
Shares, exercised (in shares)			30,634	144,671
Shares, forfeited (in shares)			32,042	134,623
Shares, granted (in shares)	0	0	0	0
Shares, outstanding, ending balance (in shares)	2,594,179	2,779,165	2,594,179	2,779,165
Shares, exercisable (in shares)	954,353	727,697	954,353	727,697
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]
Weighted average exercise price, outstanding, beginning balance (in dollars per share)			$ 11.27	$ 11.30
Weighted average exercise price, exercised (in dollars per share)			6.16	8.66
Weighted average exercise price, forfeited (in dollars per share)			9.34	14.11
Weighted average exercise price, outstanding, ending balance (in dollars per share)	$ 11.35	$ 11.30	11.35	11.30
Weighted average exercise price, exercisable (in dollars per share)	$ 10.24	$ 9.83	$ 10.24	$ 9.83
Weighted average remaining contractual term, exercisable			5 years 6 months 7 days	6 years 6 months 14 days
Weighted average remaining contractual term, exercisable			5 years 3 months 18 days	6 years 3 months 7 days
Aggregate intrinsic value, outstanding	$ 15,457,477	$ 53,786,948	$ 15,457,477	$ 53,786,948
Aggregate intrinsic value, exercisable	$ 6,721,334	$ 15,148,795	$ 6,721,334	$ 15,148,795

Stock Plans - Summary of Non-ve

Stock Plans - Summary of Non-vested Stock Option Activity (Details) - $ / shares	3 Months Ended		6 Months Ended
	Jun. 30, 2019	Jun. 30, 2018	Jun. 30, 2019	Jun. 30, 2018
Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Number of Shares [Roll Forward]
Shares, non-vested, beginning balance (in shares)			1,839,830	2,364,999
Shares, granted (in shares)	0	0	0	0
Shares, vested (in shares)			(167,962)	(178,908)
Shares, forfeited (in shares)			(32,042)	(134,623)
Shares, non-vested, ending balance (in shares)	1,639,826	2,051,468	1,639,826	2,051,468
Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]
Weighted average grant date fair value, non-vested, beginning balance (in dollars per share)			$ 4.60	$ 4.65
Weighted average grant date fair value, granted (in dollars per share)			0	0
Weighted average grant date fair value, vested (in dollars per share)			2.85	2.95
Weighted average grant date fair value, forfeited (in dollars per share)			9.34	6.26
Weighted average grant date fair value, non-vested, ending balance (in dollars per share)	$ 12	$ 4.79	$ 12	$ 4.79

Stock Plans - Restricted Stock

Stock Plans - Restricted Stock Unit Activity (Details) - $ / shares	Feb. 11, 2019	Jun. 30, 2019
Restricted Stock Units (RSUs)
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Roll Forward
Shares, non-vested, beginning balance (in shares)		388,187
Shares, granted (in shares)		69,621
Shares, vested (in shares)		(26,714)
Shares, forfeited (in shares)		(4,918)
Shares, non-vested, ending balance (in shares)		426,176
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]
Shares, non-vested, weighted average grant date fair value (in dollars per share)		$ 23.85
Shares, granted, weighted average grant date fair value (in dollars per share)		16.02
Shares, vested, weighted average grant date fair value (in dollars per share)		28.33
Shares, forfeited, weighted average grant date fair value (in dollars per share)		23.96
Shares, non-vested, weighted average grant date fair value (in dollars per share)		$ 22.29
Market Restricted Stock
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Roll Forward
Shares, non-vested, beginning balance (in shares)		2,709,202
Shares, granted (in shares)	500,000	500,000
Shares, vested (in shares)		0
Shares, forfeited (in shares)		(22,347)
Shares, non-vested, ending balance (in shares)		3,186,855
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]
Shares, non-vested, weighted average grant date fair value (in dollars per share)		$ 9.87
Shares, granted, weighted average grant date fair value (in dollars per share)		8.81
Shares, vested, weighted average grant date fair value (in dollars per share)		0
Shares, forfeited, weighted average grant date fair value (in dollars per share)		9.28
Shares, non-vested, weighted average grant date fair value (in dollars per share)		$ 8.45